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the number of detected spots is invariant with the intensity changes, (e) The 
threshold intensity is applied to all the cells in the image stack and the number of 
spots are computed. The spots detected are then visualized to verify accuracy and 
the detection setting can be altered to improve the accuracy of spot detection. After 
the detection settings have been optimized, the detection settings are applied to all 
the image stacks for the experiment (typically 50 – 100 stacks per experiment), and 
(f) the mRNA transcript distribution for a population of cells, and (g) observed 
intensity distribution showing that the intensity of the spots is relatively invariant, 
and therefore very little impact on the detection of the spots. .................................. 92 
Figure 4-8 Simplified NFκB/IκBα pathway. In the resting state, IκBα keeps NFκB 
sequestered in the cytoplasm, and when the cell is activated, IκBα undergoes 
phosphorylation-initiated degradation allowing the NFκB to enter the nucleus where 
 xxi 
it drives the transcription of many genes including IκBα thus resulting in an increase 
in IκBα mRNA expression within 30 minutes of activation. .................................... 94 
Figure 4-9 Heterogeneity in mRNA expression levels in Jurkat cells. Cells were 
stimulated on-chip with ionomycin/PMA or TNF-α for one hour, then fixed and 
permeabilized overnight followed by hybridization with IkBα mRNA probes. (a) 
micrographs of the cells showing the nuclear stain (green), and probe imaging (red) 
at 40x magnification and the insert image at 63x during smFISH imaging, (b) 
distribution of mRNA copy number in each cell for unstimulated cells (control) and 
cells under stimulation. Overall, there is an increase in IkBα expression after 
stimulation, and cells show a distribution in their expression levels. ....................... 95 
Figure 4-10 The assay is repeatable on chip. Jurkat cells were stimulated with in separate 
experiments conducted on different days. Quantification of the IκBα mRNA 
expression who is similar distribution of expression level in 3 trials (n = 400+ for 
each trial) .................................................................................................................. 96 
Figure 4-11 Combined Ca2+ and IkBα mRNA quantification on chip. Fluo3-loaded Jurkat 
cells were loaded on the device, and stimulated with ionomycin/PMA or no 
stimulation in the buffer while monitoring changes in Ca2+ by fluorescence imaging 
for 1 hour. (a) Ca2+ traces for the cell where only buffer was introduced, the cells 
show no appreciable increase in Ca2+ levels, (b) upon introduction of 
ionomycin/PMA the cells show a rapid increase in Ca2+ followed by a plateau (blue 
is low Ca2+ and red is high Ca2+), (c) after Ca2+ imaging the cells were subsequently 
fixed, permeabilized and hybridized with IκBα mRNA. The transcript levels for the 
cells under different stimulations, the error bars show the standard deviation from 
the mean indicated by the horizontal line for each condition, and (d) with the spatial 
information of the positions of the cells in the device, number of transcripts can be 
directly compared to the Ca2+ dynamics. .................................................................. 97 
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Figure 4-12 Coagonist, VSV amplifies Ca2+ signaling OT-1 T cells stimulated with 
agonist OVA. OT-1 spleenocytes are activated pMHC surfaces while simultaneously 
measuring Ca2+ flux. The cells were activated on surfaces coated with (a) OVA, (b) 
OVA/VSV, (c) VSV. The cells show no change in calcium on VSV peptide, and 
rapid Ca2+ flux with OVA antigenic peptide. However the presence of OVA/VSV 
peptides results in some cell that have a much higher Ca2+ level compared to the 
cells on OVA surface only. (d) average Ca2+ response show a higher Ca2+ level with 
the coagonist, and (e) and (f) show the area under the curve and the maximum Ca2+ 
peak for the individual cells showing that coagonism increases the number of cell 
with higher levels of Ca2+ responses. The mean for each condition is represented by 
the horizontal bar and the vertical bar represents the standard deviation. .............. 101 
Figure 4-13 Effect of coagonism on pZAP70 and pErk. After Ca2+ measurements the 
cells were fixed, permeabilized and stained against phosphorylated Erk and ZAP-70. 
(a) fluorescent image of anti-pZAP70, and (b) phosphorylation levels of ZAP-70 and 
Erk in cells stimulated with antigenic peptide, OVA, antigenic peptide OVA in the 
presence of coagonist peptide VSV, and only coagonist VSV. .............................. 102 
Figure 4-14 Correlation of Ca2+ signaling parameters and Erk and ZAP-70 
phosphorylation. The maximum peak for each Ca2+ trace was deduced from the Ca2+ 
data, and then matched to the corresponding pZAP70 and pErk intensity for the 
three stimulating conditions; agonist (OVA), agonist/coagonist (OVA/VSV), and 
coagonist (VSV).  (a-c) Ca2+ correlations with ZAP70 phosphorylation, and (d-f) 
Ca2+ correlations with Erk phosphorylation. .......................................................... 104 
Figure 4-15. IFNγ mRNA expression dynamics in OT1 CD8+ T cells after stimulation 
with OVA peptide. T cells were stimulated with OVA peptide for different durations 
before being analyzed for IFNγ mRNA expression. (a) micrograph of maximum 
projection for imaging IFNγ mRNA fluorescently-labeled probes, (b) number of 
mRNA transcripts per cell for 0, 1, 4 , 18 and 24 hours of stimulation, the horizontal 
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bar is the mean transcript count and the vertical bars show the standard deviation for 
the cell population and (c) the population average expression levels.  * number of 
cells = > 600 per condition. .................................................................................... 106 
Figure 4-16. IFNγ expression in OT-1 T cells under different stimulating conditions. OT-
1 CD8+ T cells were stimulated with OVA, anti-TCR and a negative stimulation 
control on BSA surface for 4 hours. (a) Representative micrograph of the maximum 
Z-projection for smFISH probe imaging. The probes are tagged with TAMRA 
fluorophore, (b) mRNA transcript count for the 4 conditions, each data point 
represents the total mRNA count for an individual cell, and the mean and standard 
deviation are shown for each condition, (n = 400 – 600 cells per condition), and (c) 
histograms showing the distribution of total mRNA count per cell for OT-1 T cells 
treated under different conditions. .......................................................................... 107 
Figure 4-17. OT-1 Ca2+ dynamics with and without coagonist VSV.  OT-1 T cells were 
stimulated with the indicated peptide in the presence of anti-CD28 and anti-LFA1. 
Heatmaps were plotted for the temporal Ca2+ dynamics for the individual cells under 
stimulation with, (a) OVA agonist, (b) OVA agonist and VSV coagonist, (c) VSV 
coagonist only, and (d) taking the population average for the three conditions, 
overall T cells show a higher Ca2+ response in the presence of a coagonist compared 
to having only the agonist. ...................................................................................... 108 
Figure 4-18. Analyzing Ca2+ dynamics parameters show an overall higher calcium 
response in the presence of a coagonist. (a) The maximum Ca2+ reached for each 
cell, the average and standard deviation within each population are shown, and (b) 
area under the Ca2+ curve showing the total calcium dose during the first 10 minutes 
of stimulation. ......................................................................................................... 109 
Figure 4-19. mRNA expression levels. After 6 hours of stimulation, cells were fixed, and 
subsequently hybridized with mRNA probes for IL2 and IFNγ. (a) T cells stimulated 
on OVA peptide surface show higher mRNA expression level, and a larger dynamic 
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range compared to cells on OVA/VSV and VSV surface, (b) OVA-stimulated 
surface show a slightly higher IL2 mRNA expression level, and no detectable spots 
were observed in cells that were on VSV surface.  *number of cells = 600 – 800 for 
each condition. ........................................................................................................ 111 
Figure 4-20. Direct correlation of Ca2+ response and IL-2 and IFNγ mRNA expression 
levels.  With the identity of each cell conserved throughout the assays, direct 
correlations between the Ca2+ dynamics and mRNA expression were drawn at a 
single cell level. Overall the data shows no correlation between the Ca2+ does and 
IL2 or IFNγ mRNA, thus demonstrating that the observation of cells exhibiting high 
Ca2+ may not be enough in identifying functionally responsive T cells. Ca2+ dose vs 
IFNγ expression for (a) OVA, and OVA/VSV, and Ca2+ dose vs IL-2expression for 
(c) OVA, and (d) OVA/VSV. ................................................................................. 112 
Figure 4-21. Ca2+ dynamics clustering using k-means clustering algorithm. The 
individual calcium traces for OT-1 T cells on either OVA or OVA/VSV surface. For 
the OVA/VSV surface the OVA density was 0.2 compared to the condition with 
OVA only. Heatmaps showing individual calcium traces arranged by the clusters, 
(a) OVA, (b) OVA/VSV. The clusters are indicated on the heatmaps. Average 
calcium trace for each cluster for (c) OVA and (d) OVA/VSV. Distinct calcium 
traces are observed for each cluster. ....................................................................... 114 
Figure 4-22. Clustering of OT-1 T cells stimulated on OVA surface by PCA of the Ca2+ 
dynamics and mRNA expression. The color for each data point represents the 
clusters of the cell from the k-means clustering of the calcium dynamics above as 
indicated in the legend. (a,b) for the OVA-treated cells the 4 clusters from k-means 
clustering are separated, showing a positive correlation between the calcium 
dynamics and mRNA expression levels, and (c,d) for the OVA/VSV treated cells, 
the calcium clusters are diffuse in the PCA analysis showing no direct correlation 
with the mRNA expression levels........................................................................... 116 
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Figure 4-23. Clustering of OT-1 T cells stimulated on OVA surface by PCA of  the Ca2+ 
dynamics and mRNA expression. The variance contribution is 83.4 % for PC1 and 
14.7 % for PC2. (a) plot of the three principal components , the color of each point 
represents the IFNγ mRNA count (blue = low, and red = high), (b) PC1 and PC2 
plot show that the IFNγ mRNA count is described by the first PC. (c,d) The color of 
each point represents the IFNγ mRNA count (blue = low, and red = high), (c) a plot 
for the 3 principal components, and (d) plot of first 2 PCs show no distinct subsets 
for IL-2 mRNA expression. .................................................................................... 117 
Figure 4-24. Clustering of OT-1 T cells stimulated on OVA/VSV surface by PCA of  the 
Ca2+ dynamics and mRNA expression. The variance contribution is 98.6 % for PC1 
and ~ 1 % for PC2. (a) plot of the three principal components , the color of each 
point represents the IFNγ mRNA count (blue = low, and red = high), (b) PC1 and 
PC2 plot show that the IFNγ mRNA count is described by the first PC. (c,d) The 
color of each point represents the IFNγ mRNA count (blue = low, and red = high), 
(c) a plot for the 3 principal components, and (d) plot of first 2 PCs show no distinct 
subsets for IL-2 mRNA expression......................................................................... 118 
Figure 4-25. PCA clustering of the combined data for OVA, OVA/VSV and VSV 
conditions for calcium dynamics and IFNγ mRNA expression. The variance 
contribution is 85.6 % for PC1 and ~ 14.1 % for PC2. All the data for the T cell 
activation with OVA, OVA/VSV, and VSV was pooled together and PCA was 
performed. 3 distinct groups are observed that correspond to the cells under the 
different treatment conditions are observed. The color for each point represents the 
stimulating condition for that cell. .......................................................................... 119 
Figure 5-1 Device operation.  (a) Single inlet/single outlet device for the separation of 
leukocytes from whole blood, (b) depiction of the separation of the removal of red 
blood cells. The red blood cells are very flexible and can pass through very small 
gaps, therefore in the device the red blood cells can pass through the 2 μm 
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constriction at the cell trap while the more rigid leukocytes are directed to the cell 
trap and remain in the cell traps, (c) micrograph of the device showing the array of 
cell traps in the device, and (d) jurkat cells after being separated from red blood cells 
and trapped in the device. ....................................................................................... 128 
Figure 5-2. Microfluidic platform enables rapid analysis of minute quantities of blood. 
Multiple analysis can be performed on chip starting with the removal of reds blood 
cells and trapping of leukocytes for subsequent analysis including differential 
leukocyte counting, stimulation and time-lapse analysis and measurement of 
activation marker expression and gene expression of specific cells. The platform is 
very simple, and the flow is driven by gravity-driven flow implemented by 
suspending the outlet tubing to a height, h ≈ 15 cm. .............................................. 130 
Figure 5-3. Capture of Jurkat cells mixed with red blood cells. Jurkat Jurkat cells mixed 
with red blood cells (1,000 red blood cells per Jurkat cells), and then introduced into 
the device. (a) device micrograph, (b) Jurkat cells capture in the device, (c) cell 
tracker red imaging of Jurkat cells. After trapping the cell were loaded with Fluo3 
calcium-sensitive dye and stimulated with ionomycin (1 μg/ml) with simultaneous 
calcium imaging. (d) heatmap showing the individual cell response upon stimulation 
with ionomycin, and (e) individual curves and the average (red) calcium response.
................................................................................................................................. 132 
Figure 5-4 Whole blood in the device. (a) Whole blood in device at 10-fold dilution, (b) 
demonstration of the escape of red blood cells through the cell traps allowing the red 
blood cells to exit the device channel, and (c) the first 2 rows on the platform 
showing trapping of leukocytes. ............................................................................. 135 
Figure 5-5. Fluorescence imaging to characterize surface marker expression levels. 
Stimulated cells were stained for CD66b (a), and CD11b (b) expression levels. (c) 
Merged micrograph image. ..................................................................................... 136 
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Figure 5-6 Surface marker expression of neutrophils after stimulation with LPS. 
Leukocytes separated from whole blood and stimulated with LPS were stained for 
CD66b and CD11b surface marker expression. (a) micrograph for fluorescence 
imaging in green and red channel (merged) for imaging of expression of CD66b and 
CD11b showing cells that express both CD11b and CD66b and a cell expressing 
CD11b only, and (b) Expression levels of CD66b (x-axis) and CD11b (y-axis). The 
cells were divided into a quadrant representing CD66blow and CD11blow, CD66blow 
and CD11bhigh, CD66bhigh and CD11bhigh, and CD66bhigh and CD11blow. Neutrophils 
constitutively express CD66b and CD11b, and higher levels of CD11b when 
stimulated. (n = 401) ............................................................................................... 137 
Figure 6-1. Micropipette assay setup. A red blood cell (RBC) bearing the ligand (pMHC) 
is aspirated on a micropipette and the cell bearing the interacting receptor (TCR) is 
aspirated on another micropipette. The cells are brought into contact for a defined 
duration using a piezo-driven micromanipulator. If there is bond formation, the RBC 
shows detectable elongation upon retraction of the RBC which indicates an adhesion 
event. ....................................................................................................................... 143 
Figure 6-2. Design concept overview. The figure depicts the design concept for 
developing a platform. A ligand-coated surface or cell and receptor bearing cell 
needs to come into contact for a defined period of time and then adhesion events are 
detected and the process is repeated > 50 times to get adhesion probability. From the 
adhesion probability data kinetic parameters can be computed.............................. 145 
Figure 6-3. PDMS valves. The deformability of the PDMS polymer can be modulated by 
varying the crosslinking ratio used in the polymer curing. Two main types of valves 
are used (a) top-down valves that require a 2-layer PDMS device, the top channel is 
a control layer that is pressurized to deflect the bottom flow channel, and a single-
layer (in-plane) valve where both the control and flow layer are on the same plane, 
and the control channel is deflected into the flow layer. With both valves the control 
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and flow layer are separated by a thin PDMS membrane, and the aspect ratio of this 
membrane determines that maximum deflection that can be achieved. ................. 147 
Figure 6-4. Combined single-layer valve control and cell trapping platform. (a) device 
outline showing the cell trapping module (blue) and the control layer (red), the cell 
trapping module has 2 or 3 inlets (1-3) and two outlets (4,5). The control layer has a 
single inlet (6) and no outlet, (b) micrograph of device showing the cell trapping 
area and the membrane channel. Each cell trap has a corresponding membrane 
channel on the opposing side, and (c) illustration of how the device works showing 
beads loaded in the device, membrane actuation to allow the beads to contact the 
membrane wall bearing the ligand, and after membrane retraction where some beads 
bind and remain stuck to the wall of the membrane. .............................................. 150 
Figure 6-5. Device design layout. (a) top view of device design showing the cell trapping 
module (blue), and the single-layer membrane valve (red), (b) cross-sectional view 
(Z  Z’) , (c) cross-sectional view showing the position of the cell in the device, 
and (membrane actuation that deflects into the cell trapping module channel to 
contact the loaded cell/bead. ................................................................................... 151 
Figure 6-6. Interacting molecules on the device platform.  On the platform the receptor is 
on the cells/beads loaded in the trapping microstructures and the ligands are coated 
on the side of the membrane using biotin-BSA physisorption and biotin-streptavidin 
coupling, and laminar coflow for restricted coating of the ligands to the membrane 
wall only.................................................................................................................. 153 
Figure 6-7. Laminar flow in microfluidic channels enable coflow of multiple streams and 
mixing between adjacent streams is by diffusion. The flow in microfluidic channels 
is laminar, and convective transport between adjacent streams is minimized. In a 3 
inlet channel device, the relative flow rates introduced will determine the width of 
the individual streams. (a) the streams will have equal widths if the flow rates are the 
same for all inlets, and (b) changing the relative flow rates will alter the widths of 
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the streams, thus allowing for patterns of different widths to be made in the device, 
and these can also evolve over time. ....................................................................... 154 
Figure 6-8. Laminar flow-enabled selective device functionalization with stimulating 
molecules. (a) coflowing of solutions of biotin-BSA and BSA (or BAS-FITC for 
visualization) with the biotin-BSA stream flowing over the membrane wall enables 
the membrane well to be biotinylated to coupling of biotinylated ligands using 
biotin-streptavidin coupling. Micrographs for visualizing the fluorescently tagged 
stream (BSA-FITC) to verify the fidelity of the maintenance of the laminar flow 
stream in the device, (b) upstream, and (c) in the center of the device. ................. 155 
Figure 6-9. Cell and bead loading in the device.  (a) Device setup during loading, (b) cells 
loaded in the device, and (c) beads loaded in the device.  Cell and bead loading has 
an efficiency > 90 % for single cell/bead loading................................................... 157 
Figure 6-10. Membrane deflection characterization.  The membrane channels were filled 
with 50 % glycol w/w and the inlet of the control module was connected to a 
pressure source with a electronically-controlled solenoid valve controlling the 
opening and closing of the valve. (a) micrographs of the device before pressure is 
applied and at 10, 30, and 40 psi showing the deflection of the membrane into the 
cell trapping channel, (b) deflection of the membrane as a function of pressure for 
different devices, (c) deflection at the indicated pressures on different channels 
along the device, and (d) membrane deflection with beads loaded in the device at 25 
psi and 35 psi. ......................................................................................................... 159 
Figure 6-11. Visualizing the contact between membrane wall and beads by confocal 
microscopy. To get a clear view of the contact point between the membrane and the 
bead, confocal imaging was performed, the device membrane channels were filled 
with FITC dye, and red fluorescent beads were loaded in the device. (a) Beads 
loaded, membrane valve closed, and (b) membrane valve open, the beads are in 
contact with the membrane. .................................................................................... 161 
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Figure 6-12. Observing adhesion to the ligand-coated membrane wall.  Upon contact with 
the membrane, the receptor-bearing beads can form a bond with the ligand on the 
membrane, when the membrane is retracted if the bead forms an attachment with the 
membrane it will be dragged out of the trap for a distance and may detach if the drag 
force becomes larger than the bond force.  When the bead detaches it may return to 
the trap or flow along the channel. In the figure the third bead from the left 
disappeared during membrane retraction as a result of being washed away with the 
flow induced during membrane movement. ........................................................... 161 
Figure 6-13. Adhesion events between biotin and streptavidin interactions. Repeated 
contacts between the biotinylated membrane and streptavidin-coated beads loaded in 
the device, and adhesion events were counted. (a) Contact time dependent adhesion 
events at 2s and 5 s contact time, and (b) density dependent adhesion frequency 
showing no change in adhesion frequency at the two concentrations used in the 
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Figure 6-14. Setup using membrane-bead actuation. (a) Streptavidin beads are loaded in 
the device after the device membrane wall is coated with biotin-BSA. The 
membrane is then actuation for 10 s to ensure all the beads attach to the membrane 
via the biotin-streptavidin interaction, and then the membrane is retracted, and we 
can see that the beads are attached to the membrane. (b) Molecule configuration on 
the membrane side. The streptavidin beads also have streptavidin molecules coupled 
to biotinylated beads, and (c) second set of beads bearing the receptor are loaded 
into the traps ............................................................................................................ 165 
Figure 6-15. Bead-bead contact enables better visualization of contact area. (a) Pairing of 
streptavidin beads (on the membrane), and biotinylated beads (in the trap), (b – d) 
membrane actuation at increasing pressures shows that the bead pairs come into 
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Figure 6-16. Flow-based adhesion frequency platform. The device consists of 2 inlets for 
use in laminar coflow. The device is a single layer PDMS mold, and is molded from 
a 2-layer SU8 mold. The main channel is 20 μm and cell traps are 10 μm wide with 
2 μm restriction channels. The first configuration had cell traps on one side of a 
channel and restriction channels 2 μm tall, and the second configuration has cell 
traps on both sides of the main channel. ................................................................. 169 
Figure 6-17. Fluid flow setup for device operation. (a) device inlets/outlets, (b) beads 
are loaded through inlet 1, while P1 =  1 atm, P2 & P3 are off, and the outlet is at 
atmospheric pressure, and (c) the beads are moved to the ligand-coated surface by 
pressure-driven flow, P1 = 0.5 psi, P2 and P3 are off. .............................................. 170 
Figure 6-18. Using magnetic force to drive movement of ligand-coated beads. In the 
proposed setup two electromagnets are setup. Cells or beads are loaded in the 
device, and then magnetic, ligand-coated beads are loaded on the adjacent traps. 
Ligand-coated beads come into contact with the receptor-bearing beads/cells by 
turning on electromagnetic 1 for a defined time and then electromagnet 1 is turned 
off and electromagnetic 2 is turned on to break the contact. Adhesion is observed by 
the ability to observe movement of the receptor-bearing bead/cell. ....................... 172 
Figure 8-1. SU-8 master mold fabrication. ..................................................................... 182 
Figure 8-2 Device PDMS molding for a single-layer PDMS device. PDMS prepolymer is 
mixed with the curing agent at a ratio of 10:1 w/w prepolymer to crosslinker. The 
PDMS is degassed is a vacuum desiccator, then poured on the silicon master mold. 
The PDMS is baked at 70 degrees Celsius for at least 2 hours. The cured PDMS 
mold is then peeled off the mold, individual devices are cut out, and access holes are 
punched at the device inlets and outlets with a blunt 19-gauge needle. The devices 
are treated with oxygen plasma and bonded to a coverslip. ................................... 183 
Figure 8-3 Device preparation for the Calcium assay. (a) This a simple assay that requires 
the microfluidic chip, tubing with a 19-gauge pin, syringe filter and a syringe, (b & 
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c) the syringe is filled with PBS used to prime the device to remove bubbles, (d) can 
see a puddle of fluid at the inlet of the device, (e) insert a pipette tip filled with 
solutions for coating the device at the inlet, and (f) allow the solution to perfuse for a 
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multilayer lithography and thermal bonding between the PDMS layers. (a) The cell 
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layer mold are cut out and aligned to the cell trap layer mold. PDMS is poured on 
the master mold and then baked at 70 degrees for at least 2 hours, the PDMS is 
peeled off, access holes are punched and devices are bonded to a coverslip. ........ 193 
Figure 8-6 Microfluidic device components. (a) overall depiction of the device showing 
the top view of the stimulus and device layer which consists of the cell trapping 
module, and (b) an illustration of the different layers of the device module, the cell 
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membrane connect fluid exchange between the stimulus layer and the cell trap layer.
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Figure 8-7 Characterization of the pulse signal showing the periodicity in each row (5 s) 
and the risetime. The period is approximately the same regardless of the position in 
the device and the rise time is on average 150 ms. ................................................. 194 
 xxxiii 
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fluid inlet by gravity-driven flow, (c) cell loading by gravity-driven flow and 
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fixation, hybridization and immunostaining steps, and (e) imaging. ...................... 200 
Figure 8-11 Ca2+ dynamics and subsequent mRNA quantification. Jurkat cells were 
stimulated while simultaneously measuring the calcium dynamics and subsequently 
mRNA transcripts were hybridized. On a population average, the higher average 
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higher average mRNA level expression. ................................................................ 205 
Figure 8-12 IFNγ and IL-2 mRNA expression of OT-1 T cells. OT-1 CD8+ spleenocytes 
were stimulated with either OVA or VSV peptides in the presence of anti-CD28 and 
anti-LFA1 for 6 hours. As expected T cells stimulated on OVA surface showed 
significantly higher IFNγ mRNA expression levels compared to those on VSV, 
nonstimulatory surface but the IL-2 mRNA expression was comparable. ............. 206 
Figure 8-13 Membrane-based adhesion device replica molding. (a) Device 2-layer master 
mold, (b) 22:1 PDMS prepolymer-to-crosslinker ratio was poured and partially 
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Profiling immune cell signaling pathways requires techniques that allow for precise 
spatial cell positioning, control of the cellular microenvironment, and the ability to 
perform high-throughput multiplexed measurements at a single-cell resolution. 
Traditional tools often focus on bulk measurements that can mask the inherent cell 
heterogeneity or assays that enable a single snapshot of individual cells, therefore missing 
information on the temporal dynamics. Emerging microscale tools have been applied to 
improve on traditional approaches and also to introduce new ways of analyzing immune 
cell signaling events.  
 
Immune cell signaling specifically in T cells involves cell-cell interactions via surface-
anchored molecules, and receptor interactions with soluble cues that induce intracellular 
signaling cascades. These signaling events involve morphological changes in cell shape, 
and molecular changes such as calcium dynamics, mRNA and protein expression, and 
proliferation. The signaling cascades span a large dynamic range from seconds to days. 
Therefore assays that enable long-term monitoring of the signaling dynamics and 
multiplexed measurements of different molecules are necessary in obtaining a 
comprehensive understanding of the immune signaling pathways. Moreover, the cell 
heterogeneity within seemingly homogenous cell populations necessitates the need for 
platforms that allow for high-throughout, single-cell analysis. Most of the conventional 
assays allow for the evaluation of cell behavior in the context of a population of cells. 
However, this will mask some of the heterogeneity within a cell population that may have 
functional consequences. Experimental assays that enable a diverse range of 
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perturbations and multiple measurements to be conducted will be critical in enabling a 
more comprehensive understanding of cell signaling dynamics. On the other hand, the 
development of microfluidic systems has enabled the emergence of new assays that 
facilitate cell handling allow for high-throughput, single-cell analysis. In addition, T cells 
are non-adherent and highly mobile once activated. Therefore, cell handling and spatial 
confinement is important in image-based approaches used in monitoring the dynamic 
changes in signaling.  
 
This thesis presents microscale tools and image-based approaches for analyzing immune 
cell responses. The first application is designed for short-term (~ 1 hour) monitoring of 
calcium signaling in T cells upon stimulation with surface ligands. The platform enables 
high-density trapping of individual cells and monitoring of calcium dynamics with ~ 300 
cells in a single field of view. I further developed a high-density cell trap array coupled 
with a dynamic soluble signal generator that enables temporal changes in the cellular 
microenvironment to be performed while simultaneously monitoring calcium changes in 
the cells. Building on these above mentioned platforms an integrated platform was 
developed to enable defined cell spatial positioning, stimulation with both surface-
anchored molecules and soluble cues, monitoring of dynamic changes with fluorescence 
live imaging, incubation times of up to 24 hours and multiple assays to quantify changes 
in mRNA using single molecule Fluorescene In Situ Hybridization (smFISH) and protein 
expression by immunofluorescence staining. We further sought to advance the 
throughput at which the receptor/ligand interaction kinetics are measured in a more 
physiological context. I developed a microfluidic-based tool combined with automated 
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operation and image processing that will allow for parallelization of the receptor/ligand 
interaction kinetics measurements. Finally, I utilize the microscale tools capabilities to 
develop an assay for separating leukocytes from less than 1 μL of whole blood. The 
platform enables leukocyte immunophenotyping from minute quantities of blood, and has 
potential applications when handling blood samples from small experimental animals like 
mouse, and for performing routine monitoring of a patient’s immune response.  
 
Overall, the systems developed in this study enable robust single-cell handling and easy 
fluid exchanges that facilitate the control of the cell microenvironment. In addition, the 
platforms developed are easy to use, and do not require sophisticated auxiliary equipment 









Fundamental to the maintenance of a healthy individual is the ability of the immune 
system to keep checks and balances in immune cells to protect the body from pathogenic 
insults and prevent overactive immune cells that may result in autoimmunity. Our 
understanding of the mechanism underlying the immune system response has been 
informative in the development of immunotherapies, vaccines, and in understanding 
some of the causes of autoimmunity and chronic illness. A number of technologies 
including the development of transgenic mouse models (1, 2), intravital microscopy (3), 
and in vitro models for immune cell analysis have facilitated the understanding of the 
immune system. In this thesis the focus is on the development of tools that will facilitate 
in vitro studies of immune cell response, with a particular focus on the T cells that are 
part of the adaptive immune system. However, the tools developed are applicable to other 
immune cells, as well as to other mammalian cells beyond those in the immune system. 
Our goal is to bridge some of the gaps in the existing assays and enhance the information 
that can be collected. 
1.1 T cell immune function 
T cells are a critical component of the adaptive immune system and are responsible for 
mounting an immune response during foreign insults. In addition, T cells have to tolerate 
self-antigens that are more abundant on cells to prevent aberrant T cell activation that can 
lead to autoimmune diseases. This intricate balance in T cell response is of great interest 
in immunology and understanding of the mechanism underlying T cell self-tolerance, and 
antigen recognition can be informative for disease diagnosis, therapeutics, and vaccine 
 2 
development. T cells are able to recognize foreign antigen with high sensitivity, 
specificity, and speed, a phenomena that has been of great interest to study.  
 
   
Figure 1-1 T cell and antigen presenting cell (APC)initial interaction via the TCR and 
pMHC molecules. The initial interaction between a T cell and an APC occurs through the 
TCR and the pMHC on the APC. The coreceptor, CD8 or CD4 binds to the nonvariant 
portion of the MHC molecule. 
 
 T cell activation is initiated by the interaction of the T cell receptor (TCR) complex with 
a cognate peptide on a major histocompatibility complex (pMHC)  (Figure 1-1). The 
interaction between the TCR and pMHC triggers intracellular signaling cascades that lead 
to proliferation, cytokine production, apoptosis, and T cell-mediated killing of infected 
cells (4-6). The high abundance of self-antigens that do not elicit an immune response 
highlights the TCR’s high sensitivity to a cognate antigen peptide that is in low 
abundance on the cell surface. Even early events in T cell signaling such as calcium flux 
show high sensitivity to antigenic peptides in a pool of endogenous self-peptides (7). 
Furthermore, the peptide sequences of self and antigenic peptides may differ by a single 
amino acids; thus the T cell interaction that elicits a response is highly specific (7). 
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Studies demonstrated that as few as a single specific pMHC can trigger calcium signaling 
(8), and that even a single TCR-pMHC interaction can trigger cytokine production (9). 
Finally, the events in T cell signaling are very rapid, occurring within seconds of T cell 
engagement with a cognate pMHC, and the signal propagation span a large dynamic 
range (10). These signaling events include the rapid intracellular protein phosphorylation, 
immediate burst in calcium, the upregulation of activation surface markers, secretion of 
cytokines and proliferation (4-8, 11, 12). The dynamic nature of these signaling events 
necessitates the need for experimental tools that allow multiparameter data to be collected 
at different timescales to obtain a comprehensive understanding of signal transduction 
pathways.  
1.2 Ca2+ signaling in T cell lymphocytes 
Ca2+ is a second messenger in T cell signaling. In the resting state, T cells maintain a low 
Ca2+ concentration in the cytosol (~ 100 nM), and a higher concentration in the 
endoplasmic reticulum (~ 100 µM), while the extracellular calcium level is ~ 1 mM. 
Once activated, the cytosolic calcium increases by a 10-fold through the release of 
calcium from the intracellular calcium stores in the ER, and the calcium levels are 
sustained for a duration of time by calcium influx from the extracellular space through 
the Calcium Release-Activated Channels (CRAC). At the early time points, Ca2+ drives 
cytoskeleton rearrangements and cell motility that helps stabilize the contact between the 
T cell and the APC. A sustained Ca2+ elevation over a duration of minutes to hours 
regulates specificity in gene activation. The gene activation is dependent on the nature of 
the calcium dynamics, and may depend on the amplitude, duration and dynamics of the 
Ca2+ signal. For example, activation and nuclear translocation of NFAT transcription 
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factor is driven by a sustained high Ca2+ level. NFAT drives the transcription of IL-2 
cytokine genes. In addition to the CRAC channels and the ER intracellular stores that are 
key to the cytosolic Ca2+ concentration, there are channels that also regulate the calcium 
dynamics in the T cell by pumping Ca2+ from the cytosol. The Sarco-endoplasmic 
reticulum Ca2+-ATPases removes Ca2+ from the cytosol to the ER. Plasma membrane 
Ca2+-ATPases (PMCA) pump Ca2+ from the cytosol into the extracellular space. These 
Ca2+ pumps modulate the Ca2+ dynamics and stability of the Ca2+ signal (4, 5, 13-20).  
The development of calcium-sensitive dyes in combination with use of fluorescence 
microscopy enables the direct visualization of calcium dynamics in the cells (21, 22). 
Cells can be easily loaded with the Ca2+ - sensitive dye and changes in cytosolic Ca2+ 
inside the cell can be monitored using fluorescence microscopy or flow cytometry (5, 14, 
18-20, 23, 24). However, in vitro the challenge in measuring Ca2+ dynamics lies in 
sample handling and the application of the appropriate perturbations to elucidate 
function.  T cells are nonadherent and are highly mobile when activated, making it 
difficult to capture the Ca2+ dynamics in vitro using fluorescence microscopy imaging. 
While flow cytometry can be used in analyzing the Ca2+ response, only a snapshot for 
each cell can be obtained and the Ca2+ dynamics are captured on a population level. 
Therefore, it is difficult to identify small subsets of cells within the population with 
interesting behaviors that may have functional consequences. As a result, evaluating the 
Ca2+ response dynamics at a single cell level may be important in analyzing T cell 
behavior especially in polyclonal T cell populations.    
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1.3 Single-cell measurements enable cell heterogeneity to be analyzed 
The inherent heterogeneity in cellular response to perturbations arising from stochasticity 
in gene (25-28) and protein expression (29), and differences in cell state have inspired the 
need to perform assays at single-cell resolution (27, 30-35). This heterogeneity can give 
rise to emergent behavior and have interesting implications on function (36-45) . Cohen 
et al showed cancer drug resistance in a subpopulation of seemingly identical human lung 
carcinoma cells evidenced by heterogeneity in protein dynamics that then influenced cell 
fate. Other studies have also demonstrated drug resistance on an individual cell level that 
would otherwise not be apparent in ensemble measurements (37, 40, 41, 43). As a result, 
population averages may mask these interesting behaviors that are contributed by a small 
subset of the cell population (25, 27, 35).  In the context of immune cells, differential 
responses to stimulation has been observed even in a seemingly homogenous T cell 
population with subsets of T cells emerging that are either responsive, anergic, inhibitory 
or autoreactive (46, 47). Ma et al demonstrated heterogeneity in cytokine and chemokine 
secretion in tumor-specific T cells upon stimulation with distinct cell subtypes (48). 
These differences may have implications on the responsiveness of the cells to drug 
treatment.  
 
Therefore, efforts have been focused on developing assays that enable single-cell analysis 
while evaluating hundreds to thousands of cells to enable population statistics to be 
obtained. Flow cytometry enables high-throughput analysis of tens of thousands of cells 
for protein expression. However, for dynamic measurements, flow cytometry can only 
provide population level dynamics and only a snapshot of each individual cell. Being able 
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to monitor changes on an individual cell through time can be insightful in linking early 
and late time signaling events, therefore allowing a comprehensive understanding of 
signaling transduction pathways (30, 33, 49). 
 
1.4 Analytical tools for immune cell signaling evaluation 
Many analytical tools for measuring immune cell response rely on bulk measurements 
that give a population average, and with cell heterogeneity interesting behaviors may not 
be elucidated. Experimental approaches for characterizing single-cell immune response 
have been focused on measuring signatures of the central dogma (DNA, RNA and protein 
content), with each strategy enabling one or more of these signatures to be evaluated. 
Ideally, a technique allowing DNA, RNA, and protein expression would be insightful in 
understanding transcription and translation relationships. 
 
Flow cytometry has been extensively used to monitor immune cell signaling including 
calcium flux, and expression of surface markers, and intracellular proteins (31). The 
robustness of the assay, ease of use, and the ability to assay a large number of cells makes 
it an attractive standard assay to perform. The development of polychromatic dyes and 
barcoding has enabled a large number of proteins to be assayed at the same time (50, 51). 
However, flow cytometry often requires a large number of cells that may become a 
challenge when only a small number of cells (~ 1000 cells) are available, especially when 
studying very rare cells such as antigen-specific cells. In addition, flow cytometry relies 
on the availability of specific antibodies for the identification for cellular markers, and 
this can limit the scope of analysis to antibody availability. Although still in its infancy, 
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mass cytometry has the potential to revolutionize cytometry analysis by increasing the 
number of different molecules that can be analyzed simultaneously (52-57). In addition to 
flow cytometry, fluorescent-based microscopy techniques have been implemented to 
enable spatial and temporal visualization of signaling events. Surface markers and 
intracellular protein expression can be visualized using target antibodies. Time-lapse 
fluorescence microscopy together with calcium-sensitive dyes can enable the calcium 
dynamics of individual cells to be monitored (12, 14, 17-22, 58-61).  
 
However, while there have been great advances in the imaging techniques, development 
in robust cell handling and techniques that allow manipulation of the cell 
microenvironment has been lagging. T cells are suspension cells and are not easily 
anchored on the surface without perturbing their function, and become highly mobile 
when activated. In microscopy imaging, it will be challenging to image T cells 
continuously as they may drift out of focus or move out of the field of view. In addition, 
it will be difficult to introduce soluble stimulation while simultaneously imaging. 
Therefore, an ideal platform for immune cell studies would enable ease of cell handling, 
the ability to alter the microenviroment for cell perturbation studies, and the ability to 
acquire data for different molecular signatures. A number of cellular traits can be assayed 
including surface marker expression, protein secretion, receptor/ligand interaction 
kinetics (58, 62-64), cell motility, proliferation, and intracellular protein or transcript 
expression (46, 59, 65-67). The emergent of microfluidic technology has helped bridge 
the gaps in sample handling and controlling of cellular microenvironment and also in 
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improving the repeatability and throughput of the assay. More details on microfluidics 
are discussed below. 
1.5 Microfluidic systems for cell analysis 
1.5.1 Microfluidics general 
The ability to obtain high-content, high-throughput data from single cells to better 
understand cell heterogeneity has often been limited by the lack of tools that provide a 
robust way to control handling and manipulation of individual cells in a high-throughput 
manner. Miniaturization allows for the fabrication of feature sizes that match cell 
dimensions, which facilitates the integration of cell handling and fluid manipulation. 
Microfluidics involves the manipulation of fluids and particles in micron-sized channels 
(68-71). At this scale, the microstructures match the size of individual cells and small 
organisms enabling manipulation and ease of handling of biological specimen (70-74). In 
addition, at this scale the fluid flow is laminar, thus facilitating deterministic design of 
robust experimental tools.  Microfluidic systems offer reduced sample size, which 
facilitates efficient use of precious reagents. Thus microfluidic platforms have been 
poised to address some of the limitations in conventional, macroscale experimental 
approaches such as throughput, reagent consumption, and precision in environmental 
control. Through automation and parallelization, microfluidic systems have been 
demonstrated to result in orders of magnitude increase in experimental throughput, and 
also enabling the study of multiple experimental conditions on the same chip. The 
development of on-chip valves allows for the integration of multiple, individually-
addressable chambers on the same chip, which facilitates experimental parallelization and 
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integration of different functional modules (75-80). Many researchers have leveraged the 
intricacies of microfluidics in developing tools for cell handling (29, 81-85) and 
microenvironment manipulation (86-99).  In addition integration of multiple processes 
enables high-throughput analysis and ease of sample handling while performing multiple 
steps on the same chip (78-80, 100-102). 
 
1.5.2 Microfluidic device fabrication  
Microfluidic devices have been fabricated in silicon, glass, metals, ceramic, plastics and 
elastomers (70, 72, 103-109). The introduction of soft lithography has enabled rapid 
prototyping and batch processing (73, 108-110) allowing one to go from a design to 
testing of a device within 2 days (Figure 1-2). Soft lithography utilizes elastomeric 
polymers, such as poly (dimethylsioloxane) (PDMS) that are biocompatible, optically 
transparent down to 230nm, gas permeable, water impermeable, and relatively cheap 
(103, 109, 111, 112). PDMS-based devices are easier to fabricate compared to devices 
fabricated in glass or silicon, and allow laboratories without prior experience with 
microfabrication techniques to explore microfluidic technology.  
 
 
Figure 1-2 Process outline for the rapid prototype development in PDMS-based 
microfluidics development.  The design, fabrication and testing of a PDMS-based system 
can take ~2 days from the 2-dimensional design created with a computer aided design 
software, AutoCAD, pattern transfer into a 3D SU8 master mold, PDMS molding and 
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device assembly, and finally testing. From this iterations can be made to the fabrication 
process or the design. 
 
1.5.3 Microfluidic platforms for single-cell analysis 
Performing single cell analysis of nonadherent cells would require robust cell handling to 
minimize cell loss and allow tracking of individual cells over periods of time. 
Microfluidic systems have features that match the dimensions of single cells, thus 
facilitating the development of tools that can handle hundreds to thousands of individual 
cells. Several techniques have been developed that enable trapping of particles such as 
beads and cells inside microfluidic channels. Particle trapping has been achieved by 
hydrodynamic trapping (30, 81, 83, 113-116), dielectrophoresis (117, 118), optical 
tweezers and magnetic force to confine particles within a particular region, using surface 
patterned surfaces to immobilize cells (84, 113, 114, 116, 119-127), microwell platforms 
(84, 128), and droplet encapsulation (129-132). Hydrodynamic trapping is cheaper to 
implement and does not require sophisticated peripheral equipment, in contrast to optical 
and magnetic trapping, and is simpler and cheaper than chemical trapping, and cells are 
less susceptible to unintended perturbations. Single-cell trapping allow for single-cell 
data to be obtained that can be used to analyze population heterogeneity, and has found 
use in microarray applications.  
 
A number of microfluidic platforms have been developed with specific applications in 
immunology (48, 133). One of the prominent microscale tools developed is the 
microengraving-based platforms (133-135), designed to facilitate the acquisition of large 
data sets of individual cells secreting different cytokines in a dynamic manner, thus 
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allowing the polyfunctionality nature of immune cells to be elucidated. Microengraving 
technique relies on gravity for cells to settle in microwells in a stochastic manner, and 
protein secretion can be measurement at a single-cell level. On the other hand, 
hydrodynamic flow and restrictive microstructures have been used to confine cells in 
defined spatial positions, allowing time-lapse microscopy to be performed with ease (59, 
81, 136). Confinement of individual cells is particularly important for long-term imaging 
of suspension cells such as T cells that will tend to float out of focus or out of the field of 
view during imaging if they are not anchored. Overall, the key advantage of these 
microfluidic tools is being able to pack a large number of cells on a very small footprint 
that increases the throughput of each experiment.  
 
Previously, our lab developed a high-density cell trap array that allows for deterministic 
positioning of individual cells in a densely-packed array (81). This platform was 
developed to enable time-series measurements on suspension cells that tend to float out 
of focus or field of view during imaging if they are not anchored to the surface. In 
addition to the precise placement of individual cells in defined positions, the device was 
also used to apply soluble chemical stimulation while simultaneously observing the 
cellular response using fluorescence microscopy. In this thesis, I build upon this platform 
to demonstrate the versatility in applications to different biological systems to advance 
multiplexed, high-throughput analysis of single cells under diverse range of input signals. 
In addition, we further develop the platform to add more functionality and enable rapid 
fluid exchanges that create a dynamic microenvironment for the cells. 
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1.6 Thesis Outline 
This thesis presents new and improved approaches and toolsets for analyzing individual 
immune cell responses to a diverse range of external stimuli including surface-anchored 
molecules and soluble cues. In this study, we exploit the power of microfluidics in 
handling small amounts of fluids, developing microstructures that match the size of a cell 
for robust cell handling, and the emergent physics at the micron scale to develop 
platforms for single-cell analysis under a diverse range of stimulations.  
 
Chapter 2 (High-throughput, cell-trap array for calcium profiling in T cells), 
Presents a platform for rapid analysis of calcium measurements in T cells upon 
stimulation with surface-anchored molecules or soluble cues. This work builds on the cell 
trap array developed in our lab (81) to provide an easy-to-use platform for calcium assay 
measurements upon T cell activation on surfaces decorated with stimulating molecules. 
The tool provides a well-controlled system, allows hundreds of cells to be assayed 
simultaneously, and the cells are kept in defined positions throughout the experiment, 
thus enabling multiple assays to be correlated at a single-cell level. With the surface 
modification, surface ligands are incorporated allowing cellular response to surface-
anchored molecules to be elucidated, thus providing a more physiological molecule 
configuration in the in vitro calcium assay. As a result, calcium dynamic data on a single-




Chapter 3 (A generalizable, tunable microfluidic platform for delivering fast 
temporally varying chemical signals to probe single-cell response dynamics), 
presents the design and fabrication of a microfluidic-based platform for precise 
application of temporally-varying soluble stimulation. This work presents a new, and 
generalizable approach in designing stimulus generating modules, and this method can be 
implemented in other existing chip designs. Moreover, by incorporating the stimulus 
generating module with the high-density cell trap array that ensures spatial confinement 
of cells, dynamic stimulus can now be applied to nonadherent cells that would otherwise 
be washed away by chemical solutions in the current setups used in dynamic soluble 
stimulation setups. 
 
Chapter 4 (Platform for multiplexed functional assays) demonstrates the versatile 
utility of the microfluidic platform developed in Chapter 3 as a tool for the analysis of 
important biological questions in immune cells. In this chapter, I present the analysis of 
the dynamic nature of T cell response by characterizing calcium response upon 
stimulation and then correlating the calcium response to the expression of cytokine 
mRNA and protein expression using single- molecule Fluorescence In Situ Hybridization 
(smFISH) and immunofluorescence staining, respectively. The platform enables high-
density trapping of individual cells in spatially defined positions and robust fluid 
exchanges; thus allowing for longitudinal analysis of nonadherent cells like T cells, and 
incorporation of multiple image based assays at different time points to characterize 
mRNA and protein expression.  In addition, the platform’s simplicity will make it easily 
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transferable to other laboratories for multiplexed assays at different time points at a 
single-cell level. 
 
Chapter 5 (Leukocyte separation, stimulation and immunophenotyping from whole 
blood), demonstrates a way to achieve separation of white blood cells from whole blood 
on chip. This will allow for the use of whole blood or minimally processed blood on chip 
and significantly reduce the volume of blood required for analysis by > 3 orders of 
magnitude. Ultimately, we would like to take advantage of the small scale offered by 
microfluidics to reduce the volume of samples required for an assay. This can be 
important when using patient samples such as blood, where it is necessary to reduce the 
burden on the patient. Previous platforms that use filtration often suffer from clogging by 
red blood cells, and other platforms use antibody capture, which can be costly. In this 
work, we explored the use of our modified cell trap for the separation of white blood cells 
from whole blood, thus requiring only 1-5 μL of whole blood for an assay.  
 
Chapter 6 (Towards a high-throughput platform for measurement of receptor-
ligand interaction kinetics at single-cell resolution), presents a microfluidic platform 
for measuring the kinetics of cell-cell interactions via receptor-ligand interactions that are 
fundamental in T cell immunology. Presented earlier in the thesis are assays for 
evaluating the intracellular signaling signatures after stimulation via receptor-ligand 
interactions. Here, I focus on the initial molecular engagement between receptors and 
ligands on cell surfaces. These juxtacrine interactions may be the first step in initiating a 
signaling cascade. For example, in T cell antigen activation signaling is initiated by 
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interaction of the T cell receptor with a peptide-MHC molecule on an antigen presenting 
cell surface. Current platforms such as biomembrane force probe (58), micropipette 
adhesion frequency (62, 137, 138) assay and atomic force microscopy developed to 
measure receptor/ligand interaction kinetics are laborious, and low-throughput as they 
only allow a single cell to be analyzed at a time. Here we combine some of the intricate 
features developed in microfluidic systems to design a platform that could be used to 
measure interaction kinetics of cell membrane bound receptors and ligands. This is a first 
step towards parallelization of the micropipette adhesion frequency assay to enable 
multiple cell pairs to be interrogated simultaneously. In the future, this assay could also 
be combined with fluorescence-based calcium imaging demonstrated in the previous 
chapters to allow for direct observation of both adhesion events and subsequent calcium 
signaling. 
 
In summary, this thesis seeks to advance the field of immunology through the 
development of microscale tools that allow for robust cell handling, precise control of the 
cellular microenvironment and multiplexed measurements of different types of molecular 
signatures using image-based approaches.  
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2 HIGH-THROUGHPUT, CELL TRAP ARRAY FOR CALCIUM 
PROFILING IN T CELLS 
 
Ca2+ is an important second messenger in a number of biological processes, and the 
availability of fluorescent calcium-indicator dyes makes it easier to visualize calcium 
dynamics in cells  (21, 22, 139). Immune cells show variation in calcium levels when 
activated, and calcium is used to assess the activation state of cells. To efficiently handle 
immune cells in vitro and be able to continuously monitor calcium changes would require 
a reliable way to handle the suspensions cells under investigation. This work builds on 
the cell trap array platform developed in our lab to provide an easy-to-use platform for 
calcium assay measurements upon T cell activation on surfaces decorated with 
stimulating molecules. The tool provides a well-controlled system, and allows hundreds 
of cells to be assayed simultaneously; the cells are kept in defined positions throughout 
the experiment, thus enabling multiple assays to be correlated at a single-cell level. As a 
result, calcium dynamic data on a single-cell level can be captured; this would not be 
achievable using the gold standard assay, flow cytometry. 
2.1 Introduction 
Ca2+ is a known second messenger in T cell activation and sustained calcium signaling is 
essential for NFAT activation, which initiates IL-2 gene transcription. Seminal papers 
have demonstrated the role of Ca2+ oscillations in modulating gene transcription(16, 140). 
Therefore, the ability to track the calcium signaling dynamics can be insightful in 
predicting the immune cell functional outcome. At the resting state the calcium level in 
the cytosol is ~ 100nM, and the endoplasmic reticulum (ER) is 100-800 μM, while the 
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extracellular calcium level is 1mM once activated, the cytosolic calcium increases to 1 
μM (14). Upon TCR engagement with a cognate pMHC, a signaling cascade ensues that 
includes the phosphorylation of Src family protein tyrosine kinases, Lck and Fyn (Figure 
2-1). These kinases phosphorylate ITAMs bound to the TCR subunits, followed by the 
recruitment and subsequent phosphorylation of ZAP70 at the ITAMS. The 
phosphorylated ZAP70, Lck and Fyn then facilitate the phosphorylation of other protein 
kinases including the adaptor protein LAT, which in turn activates PCLγ via 
phosphorylation.  PLCγ modulates the PIP2 hydrolysis to IP3 which then binds to the IP3 
receptor on the ER membrane thus activating calcium release from the intracellular stores 
into the cytosol. The calcium depletion in the intracellular stores is sensed by STIM1 
proteins that translocates to the plasma membrane to activate the CRAC channels through 
the interaction with the ORA1 proteins. The opening of the CRAC channels then allows 
calcium influx from the extracellular space, thus enabling a sustained calcium inside the 
cell necessary for signal propagation involving translocation of transcription factors into 
the nucleus. These transcription factors drive gene transcription for cytokine production, 
differentiation and proliferation. Therefore, Ca2+ can be used as an indicator for T cell 
activation.   
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Figure 2-1 Simplified calcium signaling pathway in T cells. The TCR/pMHC interaction 
initiates the signaling cascade leading calcium release from the intracellular stores in the 
endoplasmic reticulum (ER). The depletion of the intracellular stores leads to the 
activation of the calcium release-activated channels (CRAC) that allow calcium influx 
from the extracellular space. The calcium influx through the CRAC channels allow 
prolonged calcium elevation that drives the nuclear translocation of a number of 
transcription factors including NFAT that drives IL-2 gene transcription. 
 
The development of calcium-sensitive dyes and intravital microscopy has enabled the 
direct visualization of calcium dynamics exhibited by T cells while interaction with APCs 
in vivo (23, 61, 139, 141). However, in vitro models are useful in enabling individual 
effects and pathways to be teased out, and also in performing rapid screening of T cell 
responsiveness that can be useful in determining an individual’s immune status. 
Conventional assays for visualizing calcium dynamics in vitro include flow cytometry 
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where the cells are briefly exposed to the antigen then run through the flow cytometer or 
an antigen in solution in a tetramer form. The dynamic data is then captured at a 
population level, but only a snapshot of the calcium level of each individual cell is 
obtained. Other assays include stimulating ligands anchored on supported lipid bilayers 
or solid surfaces (20), and monolayer of APCs pulsed with the antigen.  
 
While these provides a more physiological condition, it is challenging to determine when 
the cells are in contact with the surface, and the T cells being suspension cells can easily 
float out of focus or move out of the field of view, making it challenging to keep track of 
the individual cells. In addition, it is challenging to control the distribution of the cells on 
the surface and often only a few cells can be analyzed. In addition, analysis on 
functionalized lipid bilayers or solid surfaces or APC monolayers does not offer control 
of the microenvironment to enable soluble stimulation or further downstream analysis.  
On the other hand, the advent of microfluidic platforms for biological studies has seen the 
development of platforms that enable precise cell handling (81, 136), and better control 
of the cell microenvironment that could facilitate the direct measurement of calcium 
signaling in immune cells. Recently, Dura et al developed a microfluidic platform to 
enable a deterministic and timed pairing of T cells and APCs coupled with live imaging 
to enabling real-time analysis of calcium flux in T cells upon engagement with an antigen 
presenting cell(59). With this platform the authors were able to demonstrate how 
microfluidics can bridge the technical challenges in cell handling faced with suspension 
cells, and capture the dynamics of calcium response that occurs within seconds of 
activation. However, there is still room for improvement in increasing the number of cells 
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assayed in the field of view and simplicity in the device operation to allow for use by 
non-experts.  
 
Inspired by the high-density cell trap array developed in our lab (81), I developed a 
simple calcium assay that incorporates the ability to stimulate immune cells with surface 
anchored molecules in addition to the soluble stimulation previously demonstrated. This 
platform offers a higher throughput, and fast assay that enables the immune response of 
different immune cells to be elucidated. The high-density trap array enables a large 
number of cells to be assayed in the same experiment, thus eliminating the need to pool 
data from different experiments.  
 
2.2 Materials and methods 
2.2.1 Cell culture 
OT-1 CD8+ T cells were harvested from the spleen of an OT-1 transgenic mouse on the 
same day of the calcium experiment. Briefly, the mouse spleen was grinded in HBSS 
buffer with calcium and magnesium in a cell strainer, followed by lysis of erythrocytes 
using a mouse erythrocyte lysis kit (R&D Systems, Cat: WL2000), and CD8+ T cells 
were by negative selection using  Mouse CD8+ T cell Enrichment kit (StemCell 
Technologies, Cat:19853).  Cells were suspended in R10 medium (RPMI 1640 with 2 
mM L-glutamine, 10% fetal bovine serum, 0.01M HEPES buffer, 100ug/ml gentamicin, 
and 0.2mM 2-beta mercaptoethanol).  
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For Jurkat E6-1 human acute T lymphoma cells (ATCC), the cells were cultured in RPMI 
1640 medium with 2 mM L-Glutamine and HEPES (ATCC) supplemented with 10 % 
fetal bovine serum (Sigma-Aldrich) and 100 units mL-1 penicillin-streptomycin (Life 
Technologies), in a 37 °C, 5 % CO2 humidified incubator. 
 
2.2.2 Device fabrication 
Devices were fabricated using standard soft lithography techniques (109, 110), and the 
fabrication protocol is shown in Appendix A.1 and Figure 8.1. For the master mold 
fabrication, a 15 μm adhesion layer using SU 2015 (Microchem) was spun on a silicon 
wafer and fully cross-linked under UV. Then 2-3 μm layer was spun and cross-linked 
with the photomask to pattern the features of the restriction channels using a mix of SU8 
2002 and SU8 2005 at a ratio of 3:2 (SU8 2002:SU8 2005) to address the challenges 
faced in the weak adhesion of SU8 2002. Finally, the microstructures for the main 
serpentine channel and the cell traps was fabricated using SU8 2015. After the master 
fabrication, the master molds were treated with trodecafluoro-1,1,2,2-tetrahydrooctyl-1-
trichlorosilane (United Chemicals Technology) vaporized in a desiccator under vacuum 
to allow ease of release of PDMS from the mold. PDMS mixture of prepolymer:curing 
agent (10:1) was degassed to remove bubbles and poured over the master mold in a petri 
dish. The PDMS was cured in an oven at 70 degrees for 2 hours. The PDMS was peeled 
off the mold, the individual devices were cut out, and access holes were punched at the 
inlet and outlet of the device using a 19-gauge blunt needle (Figure 8.2). Tygon tubing 
with internal diameter 1/32” (McMasterr Carr # 5155T11), and 19-gauge stainless steel 
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tubing (McMasterr Carr # 8987K51) to make pins were used as connections at the outlet 
of the device. 
2.2.3 Device functionalization with stimulating proteins 
Devices were primed with PBS 1X to remove bubbles by pressurizing the device using a 
PBS-filled syringe through the device outlet. After priming, 10 μL of biotin-BSA (0.5 
mg/ml) was perfused through the device at ~ 10 μ h-1 for 1 hour, then PBS was perfused 
through the device to remove excess biotin-BSA. Streptavidin (10 μL, 0.2 mg ml-1) was 
then coupled to the biotin molecules, and finally a mixture of the biotinylated stimulating 
ligands (5 μL); pMHC (10 μg ml-1), anti-CD28 (2 μg ml-1), and anti-LFA1 (2 μg ml-1), 
was perfused at ~ 10 μ h-1. 
 
2.2.4 Calcium imaging  
A protocol for the assay is included in Appendix A.2. Cells were loaded with Fluo3-AM 
dye (Life Technologies # F14242) in R10 medium at a final dye concentration of 5μg/ml 
for 45 minutes in the cell incubator. Cells were then washed twice in PBS, and then 
resuspended in the calcium imaging buffer (phenol red-free RPMI 1640 with 10% FBS). 
Surface modified device was mounted on the microscope with the outlet tubing attached. 
The device was primed with the imaging buffer using a syringe filled with the imaging 
buffer and pushing the fluid through the outlet until there was a puddle of buffer at the 
inlet. 5μL of cell suspension at 5 x 106 cells/ml was aspirated into a pipette tip, and the 
pipette tip placed in the device inlet. Imaging in the fluorescent mode was initiated once 
cells started loading. Images were acquired every 3-5 s for 20-30 minutes at 37 degrees.     
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2.3 Microfluidic device design 
 
Figure 2-2 Device design overview. The device is a simple, single inlet, single outlet 
platform with microstructures for confining cells in defined positions. (a) device 
overview with 4 chambers, the device has a serpentine channel along which the cell traps 
are arrayed as shown in (b), (c) shows a cross-sectional view indicated in (b), (d) shows a 
top view micrograph of the device made in PDMS, showing the cell traps, and (e) is a 
micrograph showing the cells trapped in the device. 
 
The device is a single-layer PDMS device fabricated using standard lithography 
techniques as detailed in Appendix A. The devices were designed with 1-8 chambers 
(Figure 2-2), and each chamber has 1,000 cell traps on a 1 mm2 footprint. The device has 
a serpentine main channel (30 μm width and 20 μm height), single inlet and a single 
outlet. Along the serpentine channel are cell trap microstructures that have dimensions of 
8 – 12 μm depending on the size of the cells to be used in the experiments. The devices 
with 8 μm traps are for primary murine cells that have sizes ranging 6 -8 μm in diameter, 
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and the 10 μm traps for the larger human cells. Each cell trap has a shallow restriction 
channel (10 μm wide and 2 μm height) that allows the cell to sit inside the cell trap but 
not go through the trap. The cell trapping mechanism is passive hydrodynamics. In the 
device, there is flow through the main serpentine channel, and cross-flow through each 
trap. This cross-flow directs the cells towards the trap, and once a trap is occupied by a 
cell, the cell block flow through the trap allowing cells to pass through and achieve single 
cell loading. The device represents a high-density cell trap that enables hundreds of cells 
to be analyzed simultaneously, and with a motorized stage, all the chambers can be 
assayed increasing the throughput per experiment to ~ 10, 000 cells. In the previous 
studies in our lab, the cell trap array for deterministic cell trapping and subsequent 
soluble stimulation with live imaging was developed enabling the cell response to a range 
of concentrations could be assayed on a single chip (81). We sought to expand this line of 
work, by exploring other modalities of cell stimulation, and incorporating surface-
anchored molecules to immune cells. Surface-anchored molecules are a critical 
component T cell signaling, and the interaction between the TCR and pMHC initiate 
signaling events including calcium. To develop an assay for Ca2+ measurements upon 
stimulation through the TCR, we optimized an approach to functionalize the device with 
stimulating ligands for T cells (pMHCs), and costimulatory ligands such as anti-CD28 
using biotin/avidin coupling (Figure 2-3).  
 
2.3.1 Device surface functionalization  
Surface protein modification in microfluidic channels has been done using covalent 
modification, bioaffinity interactions and protein physisorption (142, 143). Protein 
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physisorption involves the adsorption of a protein from solution onto the surface of glass 
and/or PDMS via van der Waals, hydrogen bonds interactions, hydrophobic interactions 
or electrostatic interactions. The process is relatively fast, does not have complex 
protocols, and free of toxic chemicals. However, protein adsorption will depend on the 
specific protein, the protein configuration on the surface will be random thus not all the 
molecules on the surface will be functional, the interaction is generally weak, and the 
protein adsorption may alter protein properties or function. On the other hand, covalent 
modification may be more reliable and enables a better control of the protein orientation 
through site-specific reactions. However, the processes can be very long, involve toxic 
reagents, and solvents that are not compatible with PDMS used in microfluidic platforms 
for biological applications. Finally, bioaffinity interactions between naturally occurring 
molecules such as biotin/streptavidin and antibody/ligand interactions can also be used to 
in surface modification. These are noncovelent, but stronger interactions compared to 




Figure 2-3 Interacting molecules in the experimental setup. The device channels is coated 
with the stimulating ligands using biotin-streptavidin coupling. The device is first coated 
with biotin-tagged BSA, followed by the streptavidin and finally biotin-tagged ligands; 
pMHC that interacts with the TCR and coreceptor CD8, anti-CD28 and anti-LFA1 that 
interact with costimulatory molecules CD28 and LFA-1 on the T cell surface. 
 
 
In our case, we employed protein physisorption and biotin-streptavidin coupling to 
decorate the device surfaces with the stimulating ligands. The approach allows for 
biotinylated ligands to be decorated on the device surface. In our case, we focused on the 
molecules involved in the initial interaction TCR/pMHC and coreceptor CD8, and 
costimulatory molecules LFA-1 and CD28 (Figure 2-3).  However, the approach is 
broadly applicable to biotinylateds ligands. This approach relies on prior biotinylation of 
the stimulatory ligands, and usually the ligands have a single biotin tag. Site-specific 
biotin tag on the ligand ensures that all the ligands on the surface assume the same 
desired configuration. Biotin and avidin form a high affinity (10-15M), noncovalent link 
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(144) ideal for incorporating other interacting molecules as it is unlikely to rupture. 
Avidin is a 66-69 kDa tetrameric glycoprotein, and biotin (Vitamin H) is a small 
molecule that can be conjugated to proteins using amine modification, thus allowing 
ligand proteins to be coupled to avidin. Protein biotin modification is readily employed 
using well-established N-Hydroxysuccinimide (NHS ester) chemistry, and there are 
available biotinylation kits that makes it convenient to biotin tag proteins in the 
laboratory.  The approach starts with the physisorption of biotin-tagged BSA. BSA 
readily adsorbs to glass and PDMS, and therefore guarantees full coverage on the surface. 
Once the BSA is physisorbed, streptavidin is introduced to couple to the biotin, and 
finally biotin ligands can be introduced to link to the streptavidin (Figure 2-3).  To ensure 
that there was full coverage on the surface and that the amount of protein was not limiting 
in the process, the protein solutions were perfused in the device at a flowrate of ~ 10μLhr-
1 using gravity driven flow (Appendix B).   
 
Fluorescently labeled proteins were used to verify protein coating on the device surface. 
We first optimized the adsorption of the BSA to the device surface. In this case, we 
aimed to ensure uniformity in the device coating. After coating with a FITC-labeled 
BSA, fluorescent images were acquired at 20x magnification, and by measuring the 
average intensity at different positions on the device micrograph, the uniformity of the 
protein loading was confirmed.  
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Figure 2-4 Uniform coating of stimulating ligands on the device surface. The device was 
decorated with the stimulating and costimulatory ligands using protein physisorption and 
biotin/streptavidin interaction. (a) Overview of the device coating sequence, (b) device 
setup and fluorescent micrograph after coating of FITC-labeled BSA, and (c) average 
intensity measurements of the different rows on the device, show a uniform intensity 
indicating uniform distribution of the protein on the device surface. For each row, 
intensity is measured at 10 different positions, and the average and standard deviation are 
plotted, (d) along each row shown in b, the fluorescence intensity is uniform.  
 
2.4 Cell loading and fluorescent-based calcium imaging 
Once the devices are decorated with the stimulating ligands, cell loaded with a calcium 
indicator dye, Fluo3-AM are introduced in the device using gravity-driven flow. The 
device is mounted on a microscope stage during the loading, and imaging starts when the 
cells start loading in the device. At 10x magnification, there are about 300 cells in the 
field of view (Figure 2-5a), and the throughput can be further increase with an automated 
XY stage to image at different positions on the device. The cells are docked in spatially-
defined positions and time-lapse fluorescence imaging is performed to track the calcium 
dynamics over a defined time (Figure 2-5b). Figure 2-5c shows a calcium trace for an 
individual cell demonstrating the power of this platform to provide single-cell data and 
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capture the dynamics of each cell while also analyzing a large number of cells to allow 
population statistics to be deduced. Importantly, the setup is relatively simple, with no 
need for any specialized equipment required to run the device.  
 
Figure 2-5 Imaging setup. (a) depiction of the device setting, the cell loading is achieved 
by placing a pipette tip containing the cell suspension at the inlet, and a tubing at the 
outlet that drives the flow in the device using gravity,  and a representative micrograph of 
the fluorescence image obtained during the time-lapse image in monitoring calcium 
dynamics using a fluorescent, calcium indicator dye, (b) some time lapse images showing 
changes in cell intensity over time upon stimulation, and (c) individual cell trace for the 




2.4.1 Calcium data analysis 
 
Figure 2-6 Automated image processing outline.  To facilitate the analysis of the 
fluorescence changes in the individual cell, a custom-made automated image processing 
and analysis software was written in MATLAB. The software allows the identification of 
individual cell positions on the images and mean intensities of each cells is measured on 
each image slice of the image stack. This would allow the time series intensity changes 
for each cell to be determined.  
 
 
The intensity of each cells was determined throughout the time series stack using a 
custom-made MATLAB-based software (Appendix A.2.1.5), and the main steps in the 
analysis are show in Figure 2-6. Background intensities were subtracted from all the 
intensity values. Because the cells do not load at the same time, the time zero for each 
individual cell was determined by setting a threshold intensity below which the position 
will be considered unoccupied. A jump in intensity above the set threshold would 
indicated that a cell was  now occupying the region and that point would be considered 
the time zero for that specific cell (Figure 2-7 a, b). The intensity is then normalized to 
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the initial cell intensity for each cell to account for the unequal dye loading within the cell 
population (Figure 2-7c). This analysis is applied to all the cells to generate individual 
cell traces (Figure 2-7d & e).  
 
 
Figure 2-7 Calcium intensity analysis. (a) Intensity trace for an individual cell (red), and 
background. For the cell trace, a jump in intensity from the background intensity 
indicates the time at which the cell was trapped in the device and therefore represents 
time zero for the individual cell, (b) cell trace shifted to the true time zero, (c) cell’s 
intensity normalized with the initial intensity to account for differences in dye loading 
among cells, and representative (d) heatmap and (e) individual calcium curves (grey) and 
the population mean with SEM for calcium analysis in a single device, in a single field of 
view.  
 
2.5 Dynamic Ca2+ flux in Jurkat hybridoma cell line 
As a proof of concept, we measured the Ca2+ response of Jurkat T cell line under 
stimulation with anti-CD3/anti-CD28 that elicits a strong stimulation, and also with a 
nonspecific soluble stimulation, ionomycin/PMA (Figure 2-9). Here we sought to 
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demonstrate the multifaceted application of our platform to perform both soluble 
stimulation, and stimulation with surface-anchored molecules. Calcium dynamics were 
captured in each individual cell, while analyzing hundreds of cells to ensure population 
statistics can also be obtained from the data.  
 
Figure 2-8 Calcium parameters derived from the calcium curve. From the Ca2+ time 
series data, multiple descriptive parameters can be derived to describe the extent of Ca2+ 
activation including, the time is takes for the cell to respond (resting time), the maximum 
Ca2+ peak, the peak rise time and area under the curve. 
 
From this dynamic data, we can obtain population statistics such as the average response. 
In addition, from the individual Ca2+ traces, useful parameters such as maximum peak, 
area under the Ca2+ curve, time the cell takes to respond, and the decay rate constant as 
illustrated in Figure 2-8. These parameters help us to understand the different behaviors 
that the cell exhibit that may be informative on the functional potential of the cell.  
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Figure 2-9 Jurkat T cell rapid Ca2+ flux upon stimulation. (a) cross-linking of the TCR 
with anti-CD3 and costimulatory molecule with anti-CD28 elicits Ca2+ signaling, (b) 
stimulation of Jurkat T cells with calcium ionophore, ionomycin and PMA. The results 
show that both surface-anchored molecules and soluble chemicals can be used on the 
platform for cell perturbation.    
 
2.6 Calcium signaling dynamics in primary OT-1 T cells 
To demonstrate the utility of our platform, we analyzed the calcium dynamics in naïve 
OT-1 T cells obtained from a transgenic mouse whose T cells are reactive to ovalbumin 
peptide (SIINFEKL), commonly referred to as OVA. We show in Figure 2-10a the cells 
exhibit an increase in cytosolic Ca2+ upon encounter with the antigen-coated surface. 
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Cells loaded in a device coated with a nonstimulatory peptide, VSV show no appreciable 




Figure 2-10 OT-1 T cells show a specific, rapid calcium increase upon interaction with 
antigenic OVA peptide. Fluo3-loaded OT-1 T cells were stimulated with OVA peptide 
and costimulatory molecules anti-CD28 and anti-LFA1. The heatmaps show the 
individual ca2+ responses to stimulation with (a) OVA, and (b) VSV 
 
2.7 Evaluating Calcium signaling alterations in a tumor microenvironment 
Cancer immunotherapy is of great interest, and it has been demonstrated that CD8+ T 
cells against tumor antigens have been found in cancer patients. As a result, 
immunotherapy has been seen as a promising therapeutic intervention in cancer patients. 
However, the presence of the T cells against tumor antigens have yielded poor results in 
getting rid of tumors. The tumor microenvironment is unique, and has been shown to 
have an impact on T cell activity. T cells residing in the tumor draining lymph nodes 
have been shown to exhibit attenuated functional activity compared to T cells in 




Using a tumor mouse model B16, we tested Ca2+ activation of the T cells harvested from 
different compartments to elucidate the impact of the tumor microenvironment on T cell 
Ca2+ signaling. The T cells were harvested from the lymph nodes and spleen of a healthy 
mouse for the control and from the tumor draining lymph node (TDLN) and spleen of a 
tumor-bearing mouse 7 days after tumor implantation. T cells harvested from the TDLN 
exhibited lower Ca2+ response to antigenic stimulation compared to splenic T cells in a 
mouse 7 days after tumor implantation. Interestingly, the splenic T cells from the tumor 
mouse showed comparable Ca2+ behavior to splenic T cells from a healthy mouse (Figure 
2-11). These results demonstrate that the tumor microenvironment may have an impact 
on T cell signaling. This behavior was also prominent at a population level; the average 
response, maximum Ca2+ amplitude, and total Ca2+ response of TDLN T cells was lower 
compared to the splenic T cells and T cells from a healthy mouse (Figure 2-12). This 
preliminary finding is in agreement with observations that have been made on the lack of 
functional responsiveness in tumor-antigen specific T cells in cancer patients (145). 
Therefore, our platform can be used to screen T cells from individual on their capacity to 




Figure 2-11. The tumor microenvironment has a negative impact on calcium signaling in 
T cells. Fluo3-loaded T cells were stimulated with OVA:H2-Kb and anti-CD28 and anti-
LFA1 costimulatory molecules. The T cells were harvested from either a healthy mouse 
or mouse implanted with a tumor. Calcium traces for T cells from (a) a healthy mouse 
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spleen, (b) a healthy mouse lymph node, (c) spleen of a B16 mouse on day 7, and (d) 
cells from the tumor draining lymph nodes (TDLN) on day 7 post tumor implantation. 
Overall, T cells in the tumor draining lymph nodes show an attenuated Ca2+ response 
compared to the cells from the spleen of the tumor-implanted mouse. In addition, T cells 





Figure 2-12. Population and single-cell analysis show distinct attenuation of calcium 
signal in T cells from TDLN. (a) Population average calcium show an overall lower 
calcium level in the T cells from the TDLN, (b) area under the Ca2+ curve distribution, 
and (c) maximum Ca2+ level. For both the area under the curve and calcium peak 
intensity distributions, the cells from TDLN were significantly different (p < 0.0001) 
from the other three conditions shown. On the other hand, there was no statistical 




Figure 2-13 Stimulation with TCR antibody did not elicit a large Ca2+ flux in T cells from 
the TDLN.  An antibody against TCR was used to provide a strong stimulation to thes T 
cells. (a) Calcium response traces for the TDLN T cells showing that the majority of the 
cells did not show an appreciable increase in Ca2+, (b) Calcium response traces for 
splenic T cells, the cells showed a rapid increase and sustained Ca2+ level, (c) population 
average response, (c) distribution of the area under the curve, and (c) maximum Ca2+ 
level. Overall, the T cells for the TDLN show disrupted Ca2+ signaling even when 
stimulated with an antibody against the TCR. 
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2.7.1 Simultaneous Ca2+ imaging and force mapping 
 
Figure 2-14 Combined Ca2+ and force measurements using a DNA-based tension force 
probe. Using covalent modification a DNA-force probe is anchored to the surface, and 
pMHC is coupled to the DNA force probe using biotin-streptavidin coupling. When the 
cells are loaded in the device interact with the pMHC anchored on the DNA-force probe. 
(a) Fluo3-loaded cells in the device for Ca2+ changes visualization, (b) Fluo3-intensity 
changes, and (c) combined Ca2+ changes and probe fluorophore intensity changes of an 
individual cell. 
 
With the adaptation of covalent modification using silane chemistry, other molecules 
such as a DNA-based tension force probe can be coated on the device, enabling the 
threshold force exerted by the cells to be directly measured (148). Force has been shown 
to be important in T cell activation, and recent studies have demonstrated the importance 
of force through the TCR-pMHC bond in T cell Ca2+ signaling (58). In this study, 
external force was applied to TCR-pMHC bond to elucidate the impact of force on the 
bond and T cell activation. However, under physiological conditions the force is likely 
generated by the cell, and the development of DNA-based tension probes has enabled the 
visualization of force exerted by cells through receptor-ligand bonds (148). The pMHC is 
attached to a tension force probe, and when the T cell exerted a force on the TCR-pMHC 
bond, the DNA opens up resulting in the increase in fluorescence intensity of the probe as 
the fluorophore moves away from the fluorescence quencher. In Figure 2-14 we show 
that combining this force measurement with our calcium assay, we can visualize both the 
Ca2+ and force dynamics at a single cell resolution. In addition, the utility of the platform 
can be expanded to include capture antibodies on the device surface that capture secreted 
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proteins. This approach would then allow both Ca2+ and force measurements, and 
downstream signaling such as cytokine secretion to be measured in the same sample, and 
thus direct correlations can be drawn. However, it is noteworthy to mention that because 
the measurements described above are fluorescence based, the number of different 
measurements that can be obtained is ultimately limited by the spectral resolution. 
Therefore, on most microscopy setups up to 4 different measurements can be done while 
keeping the identity of each cell. 
 
2.8 Conclusions and Future directions 
Ca2+ is a critical component in the signaling transduction pathways in T cells. The Ca2+ 
behavior is rapid and show interesting dynamics that can have functional implications. 
We developed a simple platform for measuring Ca2+ levels of hundreds of T cells upon 
stimulation with surface ligands or soluble cues at a single-cell resolution. The platform 
enables dynamic data for each individual cell to be captured, and enough cells to be 
analyzed is a single experiment to derive relevant population statistics. Often flow 
cytometry is used to evaluate calcium changes in stimulated cells, however only a 
snapshot of each cell can be obtained and the calcium dynamics are determined on a 
population level. Ligand-coated surfaces have been utilized for monitoring dynamics. 
However, the number of cells analyzed is low primarily due to the high mobility of 
activated T cells that makes it difficult to track the cells over time. 
 
Therefore, the key challenges with existing techniques are ability to handle and spatially 
confine nonadherent T cells to enable time-lapse imaging, the ability to incorporate 
different stimulating ligands on the surface, and being able to analyze hundreds to 
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thousands of cells in a single experiment. The high-density trap array allows 
deterministic, spatial position of hundreds of cells that allows ~ 300 cells to be viewed in 
a field of view at 10x magnification. Coupled with surface modification, this platform 
offers a rapid assay for evaluating immune cell functional response. With this platform 
we demonstrated the attenuated Ca2+ response to OVA antigen stimulation of OT-1 T 
cells residing in the tumor microenvironment. Such a measurement can be informative in 
evaluating cancer patient’s ability to mount an immune response against tumors, and also 
monitor the immune system competency against infections.  
 
Furthermore, we demonstrated the ability to simultaneously measure both the Ca2+ 
response and the force that the cell exerts on the TCR-pMHC bond during interaction and 
activation. Mapping the threshold force exerted by the cell through the TCR-pMHC bond 
in enabled by DNA-based tension force probes. Knowing the force that the T cell exerts 
gives insights on the interaction between the TCR and pMHC that may have functional 
consequences. As previously demonstrated by Liu et al, force regulates TCR-pMHC 
interactions and have a direct impact on calcium signaling (58), however the 
biomembane force probe used in this study is low throughput and uses an external force 
to infer on the effect of force on bond kinetics and calcium signaling. With the tension-
force probe, the cell provides the force applied on the bond, which is more physiological. 
Therefore, the platform will allow for the direct correlations of the force applied by the 
cell through the TCR-pMHC bond and calcium signaling dynamics at a single-cell 
resolution while analyzing hundreds of cells in a single experiment.  
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Overall, this work provides a new application of the high-density cell trap array in 
enabling rapid calcium functional response analysis in a large number of cells stimulated 
with selected ligands with great potential for multiplexed with other assays including 








3 A GENERALIZABLE, TUNABLE MICROFLUIDIC PLATFORM 
FOR DELIVERING FAST TEMPORALLY VARYING 
CHEMICAL SIGNALS TO PROBE SINGLE-CELL RESPONSE 
DYNAMICS 
 
The work presented in this chapter has been published in Analytical Chemistry1.  
 
The cellular microenvironment is highly dynamic, and the cell has the ability to interpret 
and transforms these signals into a functional outcome. Understanding how biological 
systems transduce dynamic, soluble chemical cues into physiological processes requires 
robust experimental tools for generating diverse temporal chemical patterns. This chapter 
focuses on the development of an integrated platform for applying dynamic soluble 
chemical cues to a dense array of cells while using fluorescence microscopy to visualize 
cell behavioral response (Figure 3-1). This device achieves fast fluid exchanges that are 
useful in analyzing cell response to a dynamic environment and determining the response 
kinetics of specific signaling pathways.  
 
                                                 
 
 
1 Chingozha, L., et al. (2014). "A Generalizable, Tunable Microfluidic Platform for 
Delivering Fast Temporally Varying Chemical Signals to Probe Single-Cell Response 
Dynamics." Analytical Chemistry 86(20): 10138-10147 
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Figure 3-1. Cellular perturbation by dynamic stimulation. A multilayer microfluidic 
platform is developed to deliver temporal chemical cues to spatially-confined suspension 
cells while measuring changes in Ca2+ level using a calcium-sensitive dye as an output 
readout. This platforms handles hundreds of cells in individual positions, thus allowing 
both population statistics and individual cell analysis to be performed. 
 
3.1 Introduction 
Biological systems are exposed to a dynamic environment, and can processes complex 
signals while filtering out random noise. How cells respond to dynamic signals to give 
rise to productive output behavior is of interest to understand cell signaling transduction 
pathways. In dissecting, cellular response, the cell is usually treated as a black box, and 
an input signal is applied and an output behavior of the cell can be measured. From the 
input/output signals relationships, insights on cellular response can be drawn, and 
working models can be proposed. From the experimental perspective, a controlled 
application of the input signal and a defined approach in measuring the output behavior is 
critical, and the ability to vary the signal pattern may enable insightful observations to be 
made. The cellular microenvironment can vary spatially and temporally, and the ability to 
mimic the cell microenvironment enables the recapitulation of in vivo dynamic in vitro. 
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For example, chemical perturbations in the form of step inputs, oscillations, and constant 
stimulation have been demonstrated to have an impact on cell response (149-151). From 
these studies, it is clear that the temporal signals that span a large dynamic range drive 
cell behavior, and since it is difficult to ascertain the nature of the input signal in vivo, the 
development of tools that allow the generation of a variety of complex signals would 
enable multiple signals to be assayed in probing biological systems. Conventional 
approaches only allow constant concentrations or a step input to be applied with limited 
resolution. 
 
Microfluidics approaches offer more robust way to introduce complex, spatio-temporal 
signal through the use of laminar coflow shifting (150), on- and off-chip valves, flow 
switching, acoustic waves (99) and diffusion through porous membranes (88, 152). In 
general, the generation of chemical gradients in microfluidic platforms can be categorized 
into two groups; using convection and diffusion-based approaches. Diffusion-based 
approaches incorporate sinks and sources where the chemical cue diffuses through a 
porous membrane (88), hydrogels (87), restricted channels or from pressure-balanced 
sources (96) to the sink where the biological specimen is located. Using diffusion to 
generate a chemical gradient ensures that the systems is shear free as shear stress can 
have an impact of cell behavior. However, the time required to establish a gradient may 
be on the order of minutes (96), thus limiting the dynamic range that can be applied to the 
system. With convection-based approaches fast dynamics can be generated, however 
there is need to ensure that the shear stress does not impact cell response since high shear 
stress can alter cell physiology (153, 154). The characteristic laminar flow in microfluidic 
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channels has been utilized for creating both temporal and spatial gradients. Laminar flow 
interface shifting enables rapid fluid switching to create oscillating chemical gradients. In 
addition, rapid fluid switching over cells has been impended in generating temporal 
chemical cues.  These systems enabling the application of spatio-temporal signals have 
been developed for a range of biological specimens including small organisms such as 
the nematode (1, 151), unicellular organisms such as bacteria (155) and yeast (156), and 
for mammalian adherent cells (89, 152, 157). The platforms are unable to accommodate 
nonadherent cells like T cells that will drift or get washed away during application of a 
soluble stimulus. This is especially challenging in convection-based approaches, but even 
when using diffusion, nonadherent cells can drift out of focus or field of view during 
imaging. As a result, a way to ensure the cells are spatially confined during the chemical 
perturbation is needed.  
 
The field of microfluidics has also advanced in developing platforms for single-cell 
handling and spatial confinement of suspension to enable time-lapse imaging (59, 81-85, 
136). Combining these cell handling approaches with chemical gradient generators would 
enable the development of the next generation of devices for chemical gradient 
perturbation of suspension-based cells while simultaneously monitoring cell behavior 
using microscopy-based methods. The challenge lies in effectively coupling the cell 
trapping module with chemical gradient generation while maintaining robust cell trapping 
and efficiency in gradient generation. For instance, the flow profiles used in the gradient 
generation may not be compatible with the cell trapping criteria.  
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In this chapter, I introduce a multilayer microfluidic chip that enables the robust 
application of soluble cues to a dense array of cells with simultaneous fluorescence time-
lapse imaging. The platform uses convective transfer for rapid switches combined with a 
perforated membrane that ensures controlled flow to ensure low shear stress on the cells, 
and incorporates the high-density cell trap array to allow the handling of a large number 
of nonadherent cells. The high-density cell trap array ensures hundreds of cells are 
analyzed in a single experiment to get population statistic with single-cell resolution.  
 
3.2 Materials and Methods 
3.2.1 Device fabrication 
A more detailed explanation of the device fabrication is given in Appendix A.2 and 
Appendix A.3. The two-layer PDMS devices were fabricated in PDMS (Dow Corning 
Sylgard 184, Essex-Brownwell Inc) and negative master molds were fabricated in SU8 
(Microchem) using the standard multi-layer soft lithography techniques 
(110)_ENREF_36. The master mold for the cell trap module was fabricated in a three-
step photolithography process of heights 2 µm, 15 µm, and 15 µm respectively fabricated 
with SU8 2002, SU8 2005 and SU8 2010. The first two layers make the cell-trapping 
module, and the third layer is an array of micro posts for the making the pores in PDMS. 
The mold for the stimulus chamber was 50 µm, fabricated with SU8 2050. The negative 
molds were exposed to silane vapor, tridecafluoro-1,1,2,2-tetrahydrooctyl-1-
trichlorosilane (UCT Special Ties, LLC) in a desiccator to allow release of the PDMS 
mold form the SU8 mold. For the PDMS devices, 10:1 PDMS prepolymer to cross-
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linking ratio was spun on the cell trap master mold to make a thin layer (~10-12 µm) 
encompassing the cell-trapping module with the PDMS mold being thinner than the 
micro posts such that the posts were still protruding to make pores in the PDMS layer. 
The mold was partially cured at 70 °C for 15 minutes and then aligned and thermally 
bonded to a partially cured PDMS mold of the stimulus chamber, also made from 10:1 
PDMS prepolymer to crosslinker ratio.  The assembled mold was baked for complete 
curing of the PDMS overnight. Access holes were punched at the inlets and outlets with 
19-gauge blunt needle and the two-layer device assembly was plasma-bonded to a 
coverslip.   
 
3.2.2 Cell culture and cell preparation for calcium imaging 
Jurkat E6-1 human acute T lymphoma cells  (ATCC) were cultured in RPMI 1640 
medium with 2 mM L-Glutamine and HEPES (ATCC) supplemented with 10 % fetal 
bovine serum (Sigma-Aldrich) and 100 units mL-1 penicillin-streptomycin (Life 
Technologies), in a 37 °C, 5 % CO2 humidified incubator. For the cytosolic Ca2+ level 
measurements, cells were loaded with 5 μM Fluo3-AM (Life Technologies) calcium 
indicator dye in Hank’s balanced salt solution (HBSS) without calcium and 0.02 % 
pluronic acid (Sigma Aldrich) to enhance calcium dye uptake by cells for 1 hour at room 
temperature, and washed with HBSS without calcium (Cellgro). Cells were then pre-
treated with 1 µM thapsigargin (Sigma Aldrich) in HBSS without calcium for 5 minutes 
before being loaded in the device by gravity-driven flow. Thapsigargin depletes the 
intracellular calcium stores(158), which facilitates the opening of  the calcium-activated 
release channels (CRAC) allowing entrance or exit of Ca2+ from the cytosol into the 
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extracellular space. Cells were exposed to oscillatory Ca2+ signals of varying frequencies 
while images were acquired every 2 seconds for 30 minutes on a fluorescent inverted 
microscope. 
 
3.2.3 Device setup 
The devices were primed with HBSS with 2 % bovine serum albumin (Sigma Aldrich) to 
prevent nonspecific cell adhesion to the device surface and remove bubbles from the 
device. The stimulus chamber inlets were connected to two pressurized reservoirs (at a 
pressure of 1 psi), one containing HBSS with 2 mM EGTA and the other HBSS with 1.5 
mM Ca2+. Cells were loaded into the cell trap module using gravity-driven flow (~ 4 kPa) 
corresponding to a flow rate of ~5 µL/hr. Once the cells were loaded, alternating 
solutions of the 1.5 mM Ca2+ and EGTA buffer were delivered to the cells using off-chip 
pinch valves at user-defined durations with simultaneous fluorescence imaging to track 
calcium dynamics, as indicated by the reporter Fluo-3 AM, in individual cells. Valve 
control and image acquisition were performed using custom MATLAB-based scripts 
(Mathworks Inc.).  
 
3.2.4 Signal delivery characterization 
The delivery of chemical cues into the cell trap chamber was characterized using 
fluorescein dye with cells loaded in the device. Briefly, alternating solutions of 
fluorescein (50 μg/ml) in PBS and PBS in pressurized reservoirs were delivered to the 
stimulus chamber at user-defined oscillating periods (2 s – 2 mins) using off-chip pinch 
valves, while simultaneously acquiring fluorescence images at 10 fps. Fluorescence 
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intensity of the images was measured at all the rows in the cell trap chamber to determine 
the delivery of signal from the stimulus chamber to the cell trap channel.  
 
3.2.5 Imaging and data analysis 
Images were acquired every 2 seconds for thirty minutes on a fluorescent microscope 
using MATLAB interfaced with Micromanager Software (159) for image acquisition and 
automated valve control. All the image processing and analysis were performed with 
custom-made scripts in MATLAB. Briefly, to analyze the calcium dynamics the average 
intensity for each cell was determined and in every frame, the background was subtracted 
from the mean intensity for the individual cell being analyzed. The mean intensity for 
each cell was then normalized to the initial intensity to account for the differences in the 
initial dye loading for each cell. The average response for the cell population was also 




3.3 Device design and operation 
3.3.1 General design concept 
 
Figure 3-2. Microfluidic platform design overview. (a) The devices has two layers, the 
fluid layer (red) where the stimulus and the buffer are introduced, and the cell trap layer 
(blue) where the cells reside, (b) top view micrograph showing the cell trap layer. The 
cell trap layer has a serpentine main channel, with cell trapping microstructures along the 
channel. Overall, the layer has 20 rows with 50 cell traps on each row. The traps are 10 
μm wide and accommodate an individual cell as shown. The pores on the cell trap layer 
connect the layer to the top fluid layer allowing fluid exchange from the top layer to the 
cells, (c) 3D rendering showing the cell trap positions and the direction of the flow from 
the fluid layer, and (d) a cross-sectional perspective showing the fluid flow and 
distribution. The fluid (buffer or stimulus) is introduced from the stimulus channel at a 
flowrate Q, and a component of this flow (q) goes through the pores to the cell trap layer. 
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The device was designed to accommodate hundreds of suspension cells, and deliver 
temporal chemical cues over a large dynamic range. The device is a two-layer PDMS 
platform that incorporates a cell trapping modules and a dynamic stimulus generating 
module as shown in Figure 3-2a. The cell trapping module consists of a dense array of 10 
μm cell traps with each trap accommodating an individual cell (Figure 3-2b). This cell 
trap modules in molded on a thin PDMS membrane that also has 8-10 μm-sized pores. 
Overall each device has 1,000 cell traps on a 1 mm2 footprint. The pores on the 
membrane make a fluidic connection between the cell trap module and the stimulus 
channel module (Figure 3-2 & Figure 3-3), allowing a fraction of flow, q to go through 
the cell trap layer. Introducing the stimulus into the cell trap layer using this approach 
ensures the stimulus reaches the cell trap layer at the position where the cells are thus 
avoiding dead volume effects that would otherwise smear the signal. In addition, the 
resistance of the cell trap layer and the pores ensures that the flow through the cells is 





Figure 3-3 Device design view. (a) cross-sectional view showing the cell layer (blue) and 
the stimulus layer (red), (b) 3D rendering showing the PDMS layers and the cell position, 
and cross-sectional views depicting, (c) the pores on the PDMS membrane  and (d) the 
cell position on the platform. 
 
The key feature in our design is the monolithic integration of PDMS porous membrane 
with cell-trapping microstructures.  The ability to make a porous PDMS membrane as 
previously described (160, 161) allows us to interface the cell-trapping microstructures 
with pores in the same module for stimulus delivery from the stimulus chamber using 
convective flow. The use of convective flow ensures fast transport to all cells 
simultaneously compared to relying on diffusion through the device and the cell trap 
prevents cell displacement during flow. The porous membrane is made using soft 
lithography and the pore size and pore length are user-defined allowing more flexibility 
in membrane properties compared to commercial polycarbonate membranes. During 
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fabrication, it is crucial that the desired PDMS membrane thickness is smaller than the 
height of the posts on the master mold so as to ensure that through holes are made in the 
PDMS. In our design, the membrane thickness was ~10 µm and our posts on the mold 
were 15 µm. The aspect ratio (height/diameter) of the posts is critical in making a robust 
mold. We aimed for an aspect ratio between 1.5 and 2, as higher aspect ratios would 
cause the posts to collapse. In addition, we observed that the density of the posts on the 
master mold was critical in ensuring the stability of the posts during development of the 
SU8 mold and replica mold. With a sparse post density, the posts would collapse. 
Therefore, our designs had 10 µm posts with a pitch of 35 µm. 
 
The predefined perforations in the PDMS membrane enable stimulus and buffer delivery 
from the stimulus chamber bulk flow into the cell trap area using off-chip pinch valves. 
Using vertical flow to exchange fluids in the cell trap allows the entire cell trapping layer 
to be exposed to the same concentration of stimulus at the same time, and circumvents 
diffusion that would otherwise limit the temporal resolution of the signal delivery. 
Moreover, having a monolithically integrated membrane makes this approach 
generalizable to existing microfluidic platforms for delivering soluble cues. Furthermore, 
using PDMS to make the porous membrane rather than using commercial membranes not 
only enables the integration with cell-handling microstructures, but also enables ease of 
fabrication of the device using established soft lithography methods for thermal bonding 
PDMS to PDMS, and plasma-bonding the PDMS assembly to glass. Even though our 
device is a multi-layer PDMS device, which may add to the complexity of the fabrication, 
 55 
the alignment of the two layers does not require a microscope, and the cells will be in 
contact with the coverslip, which also allows for high-resolution imaging. 
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Figure 3-4. Schematic of the device setup.  (a) device showing access holes for the inlets 
and outlets, (b) pipette tip containing the cell suspension is placed at the cell inlet, and 
cells are loaded in the device using gravity-driven flow with the inlets and outlet of the 
stimulus layer closed, (c) overall setup during the cell stimulation experiment, the buffer 
and stimulus reservoirs are at 0.5 psi. The flow into the stimulus layer is controlled by 
alternating the opening and closing of valve A and B, and (d) waveforms are created by 
alternating the opening and closing of the valves, and (e) example of a waveform that can 




To operate the platform, pressure sources are required for the buffer and stimulus 
reservoirs (Figure 3-4), and fluid flow is controlled by electronic pinch valves. Cell 
loading is achieved by gravity-driven flow, and the stimulus dynamics are achieved by 
alternating the opening and closing of the pinch valves attached to the inlet tubing. This is 
a relatively simple setup that can be easily adopted into other laboratories.  
 
3.3.2 Single-cell loading in device 
 
Figure 3-5. High-density single cell trapping. Cells are loaded in the device using gravity-
driven flow, and each trap holds a single cell. The single-cell loading efficiency is > 95 - 
98 % with some traps having double loading or no cells loaded.  At 10x magnification 




Cells are loaded in the device using gravity-driven flow and are directed into the traps by 
hydrodynamic flow (Figure 3-4b). With the addition of the stimulus generator we wanted 
to ensure that we would still retain the ability to efficiently load individual cells in our 
device. The pore size of the perforated membrane was designed as a 10 µm feature on the 
design and due to the shrinkage of the PDMS, the actual pore size on the device was 
measure to be ~ 8 µm. This pore size is optimal in ensuring that the cells being loaded in 
the device do not easily go through the pores into the stimulus layer. Figure 3-5 shows 
the cell trap array with cells loaded in the device. Each cell is adjacent to a pore that 
delivers the soluble signal to the cells. The device offers high-density cell trapping with ~ 
360 cells in the field of view at 10x magnification. 
 
3.3.3 Fluid flow design 
Having optimized the cell loading, we then focused on having precise stimulus delivered 
to the cell while maintaining a low shear stress environment. The lateral dimensions of 
the stimulus chamber were determined by the overall size of the cell trap chamber. In our 
case the stimulus chamber had a lateral dimension of 2 mm by 2 mm and a height of 50 
μm. Figure 3-6 shows a simplified analytical model for the flow resistances in the device, 
and the resistances can then be used to estimate the flow in the cell trap layer, q.  
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Figure 3-6 Analytical modeling of flow resistances in the device.  (a) depiction of the 
fluid flow in the device, the fluid is introduced into the stimulus layer at a flow rate, Q, 
and based on the relative resistances, a flow rate of q goes through the cell trap layer, and 
(b) the resistance model  
 
The resistance of the system is contributed by Rstimulus chamber (low resistance), Rcell trap 
(high resistance), and the resistance Rpore of the pores in the membrane (high resistance). 





The membrane resistance depends on the underlying chip design of the cell trap and the 
dimensions of the pore; diameter, (Dpore), length (Lpore) and number of pores (Npore). The 
pore dimensions are user-defined during mask design (Dpore, Npore) and in the fabrication 
steps (Lpore), and are subject to printing and lithography resolution and aspect ratio 
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restrictions, which is easily variable. In our studies, we experimentally varied the pore 
dimensions (Dpore from ~ 7-10µm, Lpore from ~ 8-12 µm, and Npore from 200-800 pores) 
and theoretically determined the flow resistance and average velocity in the cell trap 
chamber. With these designs we characterized the fidelity of the signal in the device over 
a large temporal range. The optimal designs allowed us to keep the flow rate in the cell 
chamber relatively small and therefore shear stress is under control, yet still be able to 
obtain high fidelity in the signal delivery.  The input flow rates were measured to be ~0.5 
ml/min resulting in an exchange time of 6 ms in the stimulus chamber, which translates to 
theoretical flow rates of 1-10 μL/hr in the cell trap chamber.  At these flow rates the 
corresponding shear stress was 0.1 – 5 dynes/cm2.  The tunability of the device design 
will allow a user to vary the device dimensions to fit the need. However, there is a 
tradeoff between high temporal resolution and low shear stresses. In general, in order to 
achieve a high temporal resolution while maintaining low shear stress, we can vary the 
pore dimensions or the overall size of the device.   
 
We further characterized fluid flow and exchange using a 3D simulation in COMSOL 
Multiphysics using the coupled fluid and mass transfer equations. To reduce the 
computational needs for the simulation, the model was based on a truncated version of 
the device with only 3 rows of the cell trap array as shown in Figure 3-7a. With a 
pressure difference between the inlet and outlet of the stimulus layer of 0.5 psi, an 
average velocity of 2 mm/s in the cell trap chamber was achieved (Figure 3-7b). This 
value is in close agreement with the average velocity determined in the lumped resistance 
analytical model (2.73 mm/s). Transient mass transfer was then simulated using the flow 
 61 
profile with a switching periods of 10s. Figure 3-7c shows the changes in the 
concentration gradient in the stimulus and cell trap layer at time, t = 0, 100 ms, and 10 s. 
A steady concentration in the cell trap layer was reached within 0.2 s. Thus, signal 
patterns can be obtained with fast rise time.  
 
Figure 3-7 Fluid and mass transfer simulation in Comsol Multiphysics module. A 3-
dimensional comsol model for a truncated version of the device consisting of 3 rows of 
the arrays was created in comsol multiphysics. (a) velocity distribution, and (b) the 
dynamic changes in the soluble cue concentration, at time t = 0 the soluble cue is 
delivered to the top layer and a constant concentration is achieved in the bottom cell trap 
layer within 100 ms.  
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To visualize the signal delivery, we used a fluorescent dye as a proxy for the stimulus, 
and alternated solutions of PBS buffer and fluorescent dye over a range of periodicities (2 
s – 2 minutes). Figure 3-8a shows a fluorescent micrograph of a dye-filled device. By 
measuring the fluorescence intensity at different rows, we showed that the signal is 
uniformed throughout all the rows (Figure 3-8b, c), and repeatable for a defined duration 
of time. Within each row, the signal is also uniform (Figure 3-8d), demonstrating that the 
asymmetric position of the stimulus layer inlets do not have an effect on the signal 
delivery to the cell trap layer. Therefore, cells loaded in the platform will experience the 
same microenvironment changes at the same time. As a result, differences observed in 
cell behavior can be attributed to cell-to-cell variation and not experimental artifacts.  
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Figure 3-8 Waveforms generated over a large dynamic range with rapid rise. The signal 
delivery in the device was measured using a fluorescent dye in PBS as a proxy for the 
signal and PBS as the switching buffer. Alternating solutions of PBS with fluorescent dye 
and PBS were delivered to the device. (a) fluorescent micrograph of the field of view 
when the device was filled with fluorescent dye, (b) signal traces of multiple rows in the 
platform for a period of 20 s, (c) zoomed out traces of signal generation showing that the 
signal is delivered with very small rise and fall time, and that the overlapping traces from 
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the different positions in the device, (d) signal traces at different positions on the device 
for the same row showing uniformity of the signal within each row, (e) period (right-hand 
y axis) and the rise time (left-hand y axis) for the 10 rows of the traps in the device show 
that there are negligible differences between the top and bottom row. The average rise is 
~ 0.15 s, and (f) 2 s period representing the lowest period achieved in the platform. 
 
 
The perforated membrane design enables a fast delivery of the soluble cue, thus allowing 
rapid generation of a uniform signal throughout the entire device. The low resistance in 
the stimulus layer relative to the high flow resistance in the cell trap layer allows small 
amounts of the stimulus to bleed through the pores into the cell trap layer. Since the pores 
are evenly distributed through the entire device, the signal is established rapidly. Figure 
3-8e shows further quantification of the signal at each row, and observed a negligible 
difference in periodicity (<0.01%) between the upstream and downstream rows. The 
average rise-time was ~ 154 ms which is consistent with our COMSOL simulation (< 200 
ms). Therefore, our platform can achieve switching frequencies of up to 0.5 Hz, and will 
be a versatile tool in modulating the cell microenviroment and application of different 
types of signal patterns. The nature of the signal pattern generated is controlled by the 
off-chip valve components, thus other off-chip accessories can be coupled to generate 
complex patterns, and our perforated membrane design enables the temporal gradients to 
be established with a short rise time.  
 
3.4 Cell response to dynamic extracellular Ca2+ changes 
To demonstrate the utility of the platform we measured changes in intracellular Ca2+ 
response of Jurkat E6.1 cells upon exposure to stimulation. We used a Ca2+-sensitive dye, 
Fluo3 to visualize Ca2+ changes in the cells.  
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3.4.1 Ca2+ response to oscillating extracellular Ca2+ concentration 
We then further analyzed the effect of an oscillating extracellular Ca2+ concentration on 
the intracellular Ca2+ concentration. Ca2+ is a ubiquitous messenger in a number of 
signaling processes, and the Ca2+ patterns in the cell can influence signal transduction. 
We sought to demonstrate how our platform can be used to induce Ca2+ patterns that can 
be used to elucidate how the Ca2+ signals affect different cell signaling pathways. 
Dometsch et al. demonstrate that the amplitude and frequency of Ca2+ oscillations 
influenced the efficiency and the type of genes expressed by the cell (140). In general, 
calcium oscillations in both excitable (neurons), and nonexcitable cells such as immune 
cells has been shown to result in differential signaling and gene expression (16, 17, 60, 
140) thus making Ca2+ an important molecule to study and manipulate. Intracellular and 
plasma membrane Ca2+ channels regulate the Ca2+ levels. In immune cells, at the resting 
state, the cytosolic Ca2+ level is 1 µM while in the ER the CA2+ level is 100 µM, while 
the extracellular Ca2+ level is ~ 1 mM. The Ca2+ channels and pumps are activated to 
enable Ca2+ entry and exit from the stores.  
 
To activate the CRAC channels that enable Ca2+ entry from the extracellular space, cells 
were pretreated with thapsigargin to deplete intracellular Ca2+ stores. Thapsigargin 
inhibits sarco/endoplasmic reticulum Ca2+ ATPASE (SERCA) thus blocking the ability 
of the cell to pump calcium into the ER (162). The depletion of the ER Ca2+ intracellular 
stores, leads to the opening up of the CRAC channels to allow Ca2+ entry into the cytosol 
from the extracellular space. Upon treatment with treatment with TP, cell will show a rise 
in cytosolic Ca2+ due to the release of Ca2+ from the ER stores (Figure 3-9). Once treated 
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with TP, the calcium levels in the intracellular Ca2+ stores remain low since the SERCA 
pumps are inhibited from pumping Ca2+ into the ER, and therefore the CRAC channels 
remain open. As a result the cytosolic Ca2+ can be modulated by altering the extracellular 
Ca2+ concentration.  
 
Figure 3-9. Calcium elevation upon treatment with thapsigargin. Once the cells are 
loaded in the device, 1 µM TP in PBS without calcium is added, leading to intracellular 
calcium depletion observed by the elevation in calcium level of the individual cells as 
shown in the heatmap. 
 
 
After treatment with TP, the cells were exposed to alternation solutions of 0 mM and 2 
mM Ca2+ concentration at user defined durations ranging from 10 s to 120s while 
simultaneously imaging to monitor changes in the Ca2+ level. In Figure 3-10a, we show a 
snapshot an array of cells loaded with Fluo3 dye in the device during the time-lapse 
stimulation. Alternating the extracellular Ca2+ level resulted in changes in the cytosolic 
calcium level in the individual cells as shown in Figure 3-10. These cells were exposed to 
a 20 s pulse of 2 mM Ca2+ followed by 100s of 0 mM Ca2+. On average the population 
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response follows the input signal. However further analysis of the individual cell 
response revealed four distinct behaviors that the cells exhibited (Figure 3-10d). Cells 
were categorized as oscillatory (85%), peak then plateau (7%), peak then drop to basal 
level (4%), and cells that show no response (4%). These response demonstrate the 
inherent heterogeneity in cellular responses and would be masked in average population 
statistics. These differences may have functional implications as gene expression may be 
regulated by the amplitude, duration and frequency of the Ca2+ signals (16, 140). 
 
 
Figure 3-10 Heterogeneous cell response to extracellular calcium stimulation. Cell were 
loaded with Ca2+ dye then pretreated with thapsigargin for 5 minutes before being loaded 
in the device. Once cells were loaded alternating solutions of Ca2+ and no Ca2+ HBSS 
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buffer were introduced into the device at for a duration of 20 s and 100 s respectively. (a) 
fluorescence micrograph of the Fluo3-loadeds cells in the device, (b) heatmap showing 
the changes in fluorescence intensity corresponding to changes in Ca2+ level (blue is low 
Ca2+ and red is high Ca2+) for each individual cell, (c) average population response to the 
stimulus show an oscillatory response that follows the input signal, and (d) the four 
distinct signal patterns observed within the population. Even though the average response 
show that the cells follow the input signal, a fraction of cells show no response to the 
stimulus, some cells only show a peak at the first stimulation before returning to baseline, 
while some cells show a peak at the first stimulation then plateau to a level higher than 
the baseline, and some cells exhibit an oscillatory signal entrained with the input signal.  
 
 
We the evaluated the dynamic range over which these immune cell would show a 
response to changes in Ca2+ level. In Figure 3-11 we showed the response of the cells to a 
range of periodicities of the stimulus. Over the range assayed, the average response is 
synchronized with the input signal. However, for the 10 s period of stimulation, we start 
to observe a lag in the output signal, thus potentially showing that we have reached at the 
limitation of the response kinetics in the control of Ca2+ entry or exit from the cell.   
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Figure 3-11 Population average responses follow the input signal.  Cells were exposed to 
alternating solutions of Ca2+ and no Ca2+, while measuring the cell response for each 
individual cell, and an average for the population was computed. For each data set the 
number of cells analyzed, n = 100 -200 cells. ( a-e) the figures show the average Ca2+ 
response and the grey bars indicate the time when the cells were exposed to Ca2+. The 
cells show an increase in intensity within 1 s of exposure to the Ca2+ stimulus.  (f) 
Interestingly with the 10 s period, the cells output response show a lag compared to the 
input signal showing the limit to which a cell can process and responds to a signal. 
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We further demonstrate the ability of our platform to assay hundreds of cells in a single 
experiment and expose the cells to a stimulus over a range of periodicities. In Figure 
3-12, the Ca2+ response of individual cells (blue) is shown, each panel represent a single 
experiment where 150 – 200 cells were analyzed, and the average of the population could 
be computed (red). Figure 3-12a,b show that at smaller periods of both the stimulus and 
buffer exposures, the cell fail to return to baseline after the stimulus is removed in 
contrast to Figure 3-12c-f, indicating a limit in how fast these cells are able to respond. In 
addition, even though the cells are exposed to the same Ca2+ level, they show varying 





Figure 3-12 individual cell response of hundreds of cells to varying stimulation 
periodicities. The cells were exposed to 0 and 2 mM Ca2+ for varying periods as 
indicated. The figure panels show the response of each individual cell (blue), and the 
population average (red). All the intensity values are normalized to the initial intensity for 
each cell to account for differences in dye loading. Even though the cells are exposed to 
the same Ca2+ level, they show differences in amplitude of the signal output. At the short 
periods (a,b), the cells lose their ability to return to baseline after the Ca2+ is removed 
because the input signal is faster than the ability of the cell to respond.  
 
 
One can envision that by having a platform that enables the modulation of the Ca2+ 
temporal signal by varying the amplitude, duration and concentration of the Ca2+ level, 
the specificity of the Ca2+ signal in modulating many biological functions can then be 
elucidated. Therefore, this platform setup in combination with computational modelling 
may be useful in studying signal transduction pathways under a dynamic environment to 
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identify the time scales involved in the response and determine the rate determining steps. 
Moreover, dynamic input signals are important in evaluating system dynamic both in 
vitro and in vivo where the system is largely unknown, and therefore treated like a black 
box. Evaluating systems under dynamic input signals like oscillatory pattern may provide 
more information as a number of parameters for both the input and output can be 
measured and relationships deduced.  
 
3.5 Conclusions and future directions 
Overall, we have developed a versatile platform for stimulating a dense array of cells 
with spatially independent, temporally diverse chemical signals while performing time-
lapse imaging to monitor cell response.  The coupling of a cell trapping array and a 
stimulus delivery module enable the application of temporal soluble cues to nonadherent 
cells. Previous designs have focused on applications with adherent cells that are easily 
adhered to the surface before flowing a soluble cue over them without displacing them 
(86, 88, 89). However, nonadherent cells will be washed off the surface if they are not 
anchored, and we resolve this by incorporating the cell trap array (81) in our design. In 
addition, the high density trap allow us to analyze a large number of cells in a field of 
view, thus enough cells can be analyzed in a single experiment to also provide population 
statistics. Beyond the application of a stimulus to elucidate cellular functions, this 
platform can offer a new approach in evaluating drug response by enabling timed 
exposures with simultaneous observation of response.  
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The facile integration of the monolithic perforated membrane is a new approach to 
applying stimulation using well controlled convective transport and also eliminates dead 
volume upstream of the cell trap array. Previous designs have used commercially 
available polycarbonate porous membranes to deliver temporal signals by diffusion (88, 
152). However, commercial membranes do not offer the ability to easily alter the pore 
dimensions, and the assembly of the membranes on a microfluidic platform will require 
specialized bonding. Our perforated membrane is molded in PDMS, the same material 
used in most microfluidic platforms for biological applications. Therefore, we use the 
standard replica molding, and plasma and thermalbonding techniques. Moreover, the 
design concept is applicable to any chip design. Our approach is additive, involving the 
addition of functional modules to existing chip designs. As a result the idea of a 
perforated membrane can be translated to platforms developed for small organism and 
single cell handling to allow for dynamic soluble to be applied in a more controlled 
manner while minimizing dead volume effects and shear stress effects.  
 
With a dense array of cells, the ability to deliver uniform, temporal signal enables cell 
heterogeneity within a cell population to be elucidated. Here we demonstrated how 
varying the extracellular Ca2+ level can be used to modulate the Ca2+ levels in Jurkat 
cells. These Ca2+ signals may have functional consequences. Further probing into the 
subsequent signaling molecules by measuring gene and protein expression could provide 
more insightful information on the functional relevance of the signal variations and also 
any functional implications of the cell heterogeneity.  
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4 PLATFORM FOR MULTIPLEXED FUNCTIONAL ASSAYS 
 
A manuscript has been prepared for publication of this work. 
Thus far, I have demonstrated the use of microfluidics in single-cell analysis and dynamic 
soluble stimulation. The platforms in Chapter 2 and 3 were developed for soluble and 
surface-anchored stimulation in T cells, and calcium was used as a readout. Here, we 
extend the application of the platform developed in chapter 3 to perform multiplexed 
assays, thus enabling multiple different readouts to be measured on the same cell 
population. We envision that this platform addresses some of the technological gaps in 
conventional and microfluidic-based assays and its simplicity will make it easily 
transferable to other labs. 
4.1 Introduction 
 
T cell signaling involves a cascade of dynamic events that span from seconds to days, and 
distinct changes in molecular expressions enable the measurement of features indicative 
of T cell activation. Most studies involve perturbation of the cells with a stimulus that can 
be either an antigenic peptide on the surface or lipid bilayer, or on an antigen presenting 
cell, or soluble chemical cues followed by measurement of changes in cytosolic Ca2+ 
level, surface marker expression, cytokine secretion, cytotoxicity or proliferation (3, 163-
165). These cell signaling cascades involve different molecular species; small molecules, 
DNA, RNA, protein expression, and protein phosphorylation that require different 
techniques for the determination of their expression level and dynamics. For example, 
flow cytometry has been applied to the measurement of protein expression through the 
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use of specific antibodies and fluorescent labeling, and RT-PCR is used to determine 
mRNA expression levels. Generally these assays are applied separately on a different 
batch of cells, therefore how these different molecular signatures are related is often 
deduced by performing measurements in independent experiments with the assumption 
that the cells would behave the same. Moreover, these events occur at different 
timescales: Ca2+ signaling occurs within seconds of activation whereas cytokine secretion 
starts hours after activation. Therefore, to make direct correlations one would need to 
perform multiple assays on the same sample while keeping the identity of each cell for 
single-cell analysis. A comprehensive analysis of cell signaling requires multiplexed 
assays for  applying a diverse range of perturbations, capturing dynamic information, and 
evaluating different molecular signatures at both single-cell and population level.  
Microfluidics is well poised to address some of the technical challenges in cell handling 
and fluid exchanges that facilitate the nature of input signals that can be introduced and 
the ability to perform multiple wash steps and staining for specific markers (3, 69-71, 74, 
77, 166, 167). The ability to integrate multiple functional modules makes it easier to 
incorporate multiple assays on a single chip. So far, we have demonstrated the power of 
microfluidics in enabling the analysis of a large number of cells at a single-cell 
resolution, thus allowing cell heterogeneity to be observed. These developments have 
been focused on obtaining one type of readout, specifically the measurement of Ca2+ 
changes in the cell. Ideally we would want a platform that (1) allows robust single-cell 
handling of hundreds of cells on a small footprint to assay enough cells for population 
statistics to be computed, (2) enables precise perturbation of cell signaling by allowing 
the application of a range of stimulation modalities such as surface ligands and soluble 
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cues, and (3) enables the ability to perform multiple assays on the same sample of cells to 
allow direct correlations to be deduced. The challenges lies in having robust fluid 
exchanges as most assays involve multiple wash steps and buffer exchanges, and the 
ability to retain the biological specimen throughout the duration of the experiment. 
 
Here, I realize the use of the integrated microfluidic platform that will enable different 
types of molecular signatures to be measured at different time points. This platform 
builds on the microfluidic system developed in Chapter 3 with addition of simplicity to 
device operation and the ability to perform multiple assays on the same device. The data 
collected includes dynamic data such as calcium signaling and static molecular 
signatures, thus enriching the quality of data obtained from a single experiment. The 
platform has the following characteristics that makes it an attractive platform for immune 
cell signaling studies where signaling involves a number of different molecular 
signatures, and dynamic signals.  
1. Cell trapping capability that allows suspension cells to be kept in a defined spatial 
position necessary for performing live cell imaging. These cells could otherwise 
float out the focal plane or the field of view.  
2. The defined spatial position of each individual cells then enables the live imaging 
data that captures the early signaling data to be correlated with smFISH mRNA 
and immunofluorescence staining data, thus allowing molecular signatures of cell 
response that occur at different time points to be measure in the same cell using 
multiple assays. This feature allows us to probe the signaling dynamics in T cells.  
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3. The high density trap enables a large number of cells to be studied simultaneously 
in a single experiment, thus eliminating the need to pull data from different 
experiments.  
4. This platform is easy to use and can be placed in a cell incubator for defined 
periods of time depending on the duration of the stimulation. The cells remain 
viable in the device, with a viability comparable to the conventional well-plate 
format. 
5. This platform enables different modes of stimulation to be applied to the cells; 
cells can be stimulated using soluble cues as we have previously demonstrated, 
and also through surface-anchored ligands. We previously demonstrated the 
ability to apply dynamic soluble stimulation that can enable cell response kinetics 
to be measured. 
 
4.2 Materials and Methods 
4.2.1 Cell Culture 
Primary OT-1 spleenocytes were harvested from the spleen of an H-2Kb OT-1 TCR 
transgenic mouse that produces T cells whose TCR is specific for the chicken ovalbumin 
peptide (SIINFEKL), and its derived peptides. Briefly, the mouse spleen was grinded in 
HBSS buffer with calcium and magnesium in a cell strainer, followed by lysis of 
erythrocytes using a mouse erythrocyte lysis kit (R&D Systems, Cat: WL2000), and 
CD8+ T cells were by negative selection using  Mouse CD8+ T cell Enrichment kit 
(StemCell Technologies, Cat:19853).  Cells were suspended in R10 medium (RPMI 1640 
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with 2 mM L-glutamine, 10% fetal bovine serum, 0.01M HEPES buffer, 100ug/ml 
gentamicin, and 0.2mM 2-beta mercaptoethanol).  
 
4.2.2 Device fabrication 
The device consists of a membrane with cell trap microstructure and pores thermally 
bonded to a 50um chamber at the top with the bottom bonded to a coverslip. The devices 
were fabricated in PDMS using multilayer soft lithography techniques. Masks were 
designed using a computer-aid design software (AutoCAD), and printed on high 
resolution transparency. Master molds for the device were fabricated in SU8. Briefly, for 
the device layer, multilayer lithography was used to make 2, 10 and 15um features using 
SU8 2002 and SU8 2015, and a single layer 70um master for the top layer was fabricated 
with SU8 2050. The PDMS device molding is shown in Appendix D. PDMS (10:1) was 
spun on the device master to make a film of 10um thickness such that the pillar structures 
were protruding to make the pores in the PDMS membrane. PDMS was poured on the top 
layer master and partially baked for 25 minutes. Individual devices were cut out from the 
top layer and aligned to the device layer, followed by baking at 70 degrees overnight. 
Individual devices were cut out and access holes were punched, and then the device 




4.2.3 Stimulating ligands and antibodies 
Peptides, OVA (SIINFEKL) and VSV (RGYVYQGL) loaded on biotinylated H2-Kb 
MHC I were obtained from the NIH Tetramer facility. Costimulatory antibodies, anti-
CD28 and anti-CD11a were obtained from eBioscience.  
 
4.2.4 Device preparation 
Tubing was connected to the access holes of the devices, and the assembled devices were 
autoclaved prior to use. As outlined in Appendix D the devices were primed with PBS to 
remove bubbles, followed by treatment to functionalize the device with specific 
biotinylated molecules. Biotinylated BSA (1mg/ml) was perfused at a flow rate of 
~10μL/hr for one hour, rinsed with PBS, followed by streptavidin (0.5mg/ml) coupling to 
the biotin surface and finally biotinylated ligands such as pMHC and costimulatory 
antibodies, anti-CD28 and anti-CD11a (10μg/ml) were coupled to the immobilized 
streptavidin.  
 
4.2.5 Calcium imaging and analysis 
Cells were loaded with Fluo3-AM dye (5ug/mL) in R10 medium for 45 minutes in the 
cell incubator and washed twice with PBS and then resuspended in RPMI with FBS cell 
media without phenol red. Surface-functionalized device was mounted on the microscope 
stage, and a pipette tip containing the cell suspension was placed at the cell inlet. Once 
the field of view had been established the cell outlet tubing valve was opened and 
fluorescence images were captured (every 2s) once cells started flowing in the device. 
Images were captured for 30 minutes for each condition. All calcium imaging 
experiments were conducted at 37 degrees. Stacks acquired for each condition were 
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analyzed using a custom-made MATLAB-based software. The intensity of each 
individual cells was determined in all the images and normalized to the first 5 images 
after background subtraction. Heatmaps, and individual curves were plotted and 
characteristics parameters such as area under the curve and maximum peaks were 
determined.  
 
4.2.6 Immunofluorescence staining on chip 
For surface marker staining, cells were incubated with antibody for 45 minutes, washed 
with PBS then imaged on a epifluorescent microscope. Intracellular cytokine staining was 
used to determine cytokine production by the cells. Cells were treated with Brefeldin A in 
the last 4 hours of the stimulation period to prevent the secretion of the cytokines upon 
stimulation. Cells were fixed in 4% formaldehyde, permeabilized in chilled 100 % 
methanol, stained with the corresponding antibodies, and then imaged. 
 
4.2.7 smFISH probe design and hybridization 
Probes for mRNA quantification using smFISH were designed using an online software 
(available at: https://www.biosearchtech.com/stellarisdesigner/) by inputting the mRNA 
coding sequence of the molecule of interest obtained from National Center for 
Biotechnology Information (NCBI) database  
http://www.ncbi.nlm.nih.gov/guide/howto/find-transcript-gene/. The probes were 20-
nucleotides long with a fluorophore tag. Here, we had IL2 and IFNγ mRNA probes 
tagged with Quasar 670 and TAMRA fluorophores respectively, and the probe sequences 
are in Appendix A.4.2. For mRNA quantification, stimulated cells were fixed in 4% 
formaldehyde, and permeabilized in chilled 100 % methanol. The cells were then washed 
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in hybridization wash buffer (2X SSC and 10% formamide in nuclease-free water). 
smFISH probes were pooled in hybridization buffer (0.1g/ml dextran sulfate, 10% 
formamide, 200 ug/ml BSA in nuclease-free water) to a final concentration of 200 nM for 
each probe set. Cells were incubated overnight in the probe solution, then washed with 
prewarmed hybridization wash buffer.  
 
4.2.8 smFISH imaging and analysis 
After hybridization, imaging anti-fade buffer (10% glucose, glucose oxidase, catalase, 2X 
SCC in NF-water) was loaded in the device to prevent photobleaching. Image stacks were 
acquired at multiple positions of the devices at 63x/1.25 NA, with a 300 nm spacing 
between slices, and the exposure times ranged from 0.5 – 3s on an epifluorescent 
microscope with a Hamamatsu Orca-D2 dual CCD camera  (15 pixels per micron) To 
quantify the number of mRNA molecules, the number of spots in the images would 
correspond to the number of mRNA molecules. We used a spot-quantification algorithm 
to determine the number of spots for each outlined cell. 
 
4.2.9 Statistical analysis 
Unsupervised K-means clustering using a built-in MATLAB functions was performed on 
the calcium dynamics data for all the cells to group the cells into distinct clusters, with 
each cluster containing cells exhibiting similar dynamics (Appendix A.4). Principle 
component analysis using built-in MATLAB functions was used to group data together at 
a single-cell level using the calcium data (area under the curve and maximum peak) and 
mRNA transcript count. 
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4.3 Device system overview 
4.3.1 Device functionality overview 
We have developed a system for longitudinal single-cell analysis using image-based 
analytical techniques. In this platform we show the use of a microfluidic device in 
performing longitudinal analysis of immune cells at a single-cell resolution. We utilize 
the platform developed in Chapter 3 with modifications to device operation to allow for a 
simple platform that can be easily setup in any biology lab since minimal auxiliary 
equipment is required to operate the device. Figure 4-1Figure 4-1 shows an overview of 
the sequence of data acquisition from the cells upon stimulation. This includes time-lapse 




Figure 4-1 Device function overview. Cells are loaded and stimulated while monitoring 
changes in Ca2+ levels, then incubated for a defined duration of time, and can be 
fixed/permeabilized and stained for specific molecular signatures.  
 
4.3.2 Device modifications and setup 
The device is a 2-layer PDMS device with 2 inlets and 2 outlets. There are 2 modules on 
the device; the cell layer where the cells reside and the fluid layer where all the fluids into 
the device are introduced (Figure 4-2a,b).  The device operation is relatively simple 
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requiring only gravity to drive the flow (Figure 4-2d, Figure 4-3). Enabled by the high 
density cell array that keeps the cells in defined spatial positions and robust fluid 
exchanges from the fluid layer, the cells can be analyzed through multiple assays such as 
monitoring calcium signaling, mRNA quantification and protein expression (Figure 4-2e) 
 
 
Figure 4-2 Simple microfluidic platform enables high-throughput, multidimensional data 
acquisition at a single-cell resolution. Schematic overview of the system operation. 
Microfluidic platform used for analysis of T cell signaling is a 2-layer PDMS device with 
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a cell trapping module and a fluid exchange chamber that facilitated fluid input using 
conventional pipette. (a) device filled with dye, b) cross-sectional and 3-D view of the 2-
layer device, (c) top-view micrograph with cells loaded, (d) illustration of the device 
simplicity, solutions and cells are introduced into the device using a pipette tip as a 
reservoir and gravity-driven flow, and (e) illustration of the assays conducted on the 
platform starting with tracking of calcium dynamics inside the cell using Ca2+-sensitive 
dyes and time-lapse fluorescence imaging, with subsequent mRNA quantification with 
smFISH and high-resolution fluorescence imaging and/or protein expression 
quantification using immunostaining and fluorescence microscopy. 
 
In addition to enabling acquisition of multiple parameters from the same sample, the 
simplicity in the setup and operation would make this platform to be easily transferable to 
other laboratories. To operate the device minimal auxiliary equipment is required. As 
shown in Figure 4-3a, the chip requires tubing, a syringe and a pipette to be setup, and 
these are readily available in many laboratories. The flow driving force is gravity that 
eliminates the use of other complex pressure sources or syringe pumps. All the solutions 





Figure 4-3 Device operation is simple and requires minimum auxiliary equipment. (a) 
microfluidic chip and all the required materials for running the device, and (b-g) 
sequence of operation from cell loading to analysis on the same chip. (b) the device 
cross-section outline showing the inlets and outlets of the cell layer and the fluid layer, 
(c) a syringe filled with PBS is connected to the outlet of the fluid layer, and thumb 
pressure is applied to remove bubbles from device, (d) protein coating step where aa 
pipette tip containing the protein solutions is placed at the fluid layer inlet and the 
solutions perfuse into the device via gravity-driven flow, (e) once the device is mounted 
on the microscope stage, a pipette tip containing the cell suspension at the cell layer inlet. 
Cells are loaded into the device using gravity-driven flow with simultaneous fluorescence 
imaging to track the Ca2+ dynamics, (f) cells are incubated for a defined time by placing 
the devices in the cell incubator. For long-term incubation (> 4 hours), media is perfused 
through the fluid layer, and a resistance channel is connected to the outlet to control the 
flowrate of the media to ~ 10 µL ml-1, (g) device setup for imaging. 
 
 
The device can be placed in a cell incubator after the Ca2+ live imaging for a defined 
duration of time with media being perfused from the fluid layer for long-term incubation. 
The average flow rate from the top layer during the protein coating and media perfusion 
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is ~ 20 μL hr-1. The low flowrate is achieved by having a resistance channel attached to 
the outlet of the fluid layer since the fluid layer has very low fluid resistance as described 
in Chapter 3. 
 
4.3.3 Device surface functionalization 
In Chapter 3, we developed this 2-layer PDMS platform for soluble cue delivery. Here, 
we use the same approach demonstrated in Chapter 2 to functionalize the surface with 
surface molecules of interest. We use physisorption of biotin-BSA and streptavidin and 
biotin coupling to anchor the stimulatory ligands to the surface. Therefore, we can now 
use this platform to perturb the cells with both dynamic soluble cues and surface-
anchored molecules. The surface-anchored molecules are a mimicry of the cell-cell 
receptor/ligand interactions in vivo. In Figure 4-4 we show the setup of the device during 
the protein modification process, where the flow in the device is driven by gravity. We 
used texas-Red-tagged BSA to demonstrate the physisorption of BSA and biotin-FITC to 






Figure 4-4 Device surface modification using protein physisorption and biotin-
streptavidin coupling. (a) illustration of device configuration during the functionalization 
process, a pipette tip filled with the protein solution is placed at the fluid chamber inlet 
and the flow is driven by gravity, (b) sequences of the protein functionalization process, 
and (c) brightfield and fluorescent micrographs showing the device and fluorescence of 
BSA-Texas Red and biotin-FITC used to verify the protein functionalization sequence.   
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4.3.4 Cell viability on chip 
The cell viability was tested in the device using the Jurkat hybridoma cell line. Because 
of the interest in performing longer incubation times of  2 – 24 hours, we wanted to 
ensure that the cells remained viable on chip. Figure 4-5 shows comparable viability of 
the cells cultured overnight in a multiwell plate and on chip and the viability was 
maintained above 90 %. This demonstrates that our microfluidic platform is capable of 
maintaining a healthy cell culture for the duration of our experimental studies. 
 
Figure 4-5 Viability in microfluidic platform and multiwell plate. Cells can be incubated 
in the device with comparable viability to off-chip conventional cell culture methods. (a) 
micrograph of cells stained with the live (green)/dead (red) fluorescent dye, and (b) cell 
viability before seeding and after 24 hour incubation on- and off-chip 
 
4.4 Performing single-molecule fluorescence hybridization on chip 
 
4.4.1 mRNA quantification using smFISH 
Single-molecule Fluorescence In-Situ Hybridization (smFISH) is used to quantify 
individual mRNA transcripts in intact cells. The technique utilizes multiple (20-50), 
fluorescently-labeled 20-bp oligonucleotides to target different regions of the same 
mRNA (Figure 4-6). Each oligonucleotide has a fluorophore attached to its 3’ end. The 
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binding of multiple oligonucleotides to different positions on the same target mRNA 
appear as individual spots in high magnification fluorescent images (168-170). Therefore, 
the number of mRNAs is determined by counting the number of spots in the image. 
Images are acquired as 3-dimensional z-stacks to enable the detection of all mRNA spots. 
Compared to other mRNA determination techniques such as RT-PCR, smFISH allows 
mRNA to be quantification in intact cells, therefore the spatial information of the mRNA 
transcripts can be obtained, and the mRNA quantification is at a single-cell level. In 
addition, smFISH enables mRNA copy number count without any amplification bias. 
However, because smFISH is a fluorescence imaging-based technique the number of 
different transcripts that can be analyzed in a single cell is limited to 3-4 on most 
microscope setups due to spectral overlap. Approaches that uses multiplexing, and 
spatial, and spectral barcoding have a potential in increasing the number of different 
molecules. Using super-resolution microscopy and combinatorial labeling, Lubeck and 
Cai were able to increase the number of mRNA species assayed simultaneously up to 30 
species (165).  Recently, Chen et al introduced multiplexed error-robust FISH 
(MERFISH), a technique that increases the number of species that can be analyzed using 
FISH up to thousands of RNA by implementing combinatorial labeling, multiple rounds 
of hybridization and encoding schemes for editing and error reduction (164).  This 
elevates smFISH to a technique that can be utilized in system-wide analysis. In addition, 
the detection of mRNA in intact cells also enables other molecules such as protein 
expression to be analyzed in combination with smFISH, thus enriching the data that can 
be obtained from a biological specimen.  
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Figure 4-6 smFISH enables the direct quantification of mRNA copy numbers with spatial 
information. (a) Short (20-base pair) complementary DNA oligonucleotides are 
hybridized to the target mRNA sequence, and (b) a maximum projection fluorescence 
image taken at 63x magnification showing the bright, diffraction-limited spots with each 
spot representing an individual mRNA molecule. 
 
Previous studies have demonstrated how smFISH is a powerful tool in mRNA 
quantification (168-170) and has great potential to be used to quantify up to hundreds of 
different mRNA molecules (164). However, this technique has been largely limited to 
applications on intact tissue or whole small organisms and adherent mammalian cells 
placed on coverslips. Applications on suspension-based cells are challenging as 
significant cell loss can occur during the multiple wash and centrifugation steps involved, 
and also the difficulty in placing the samples for imaging. Recently, Bushkin et.al. 
demonstrated the application of smFISH on suspension, immune cells, but used flow 
cytometry instead of the standard fluorescence microscope imaging used in smFISH 
(163). Here, we have demonstrated the application of smFISH for RNA quantification in 
T cells after antigenic activation. Being able to confine suspension cells in defined 
positions combined with robust fluid exchanges allows smFISH to be applied to 
suspension cells with ease, and for image-based analysis to be conducted. In addition, in 
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our platform we can also perform live imaging on the same sample allowing direct 
correlations between Ca2+ dynamics and mRNA expression to be elucidated.  
 
Even though smFISH can provide a powerful and quantitative tool for mRNA analysis, it 
is limited to analyzing cells with low RNA copy numbers, and the number of different 
mRNA copies analyzed is limited by the spectral overlap. With high copy number mRNA 
molecules RT-PCR can be used. 
 
4.4.2 mRNA spot quantification 
As described the number of mRNA molecules is determined by counting the number of 
spots in the image for each cell. The spots are easily detectable by eye (Figure 4-6b), 
however manual counting would be tedious as that would involve counting through 
stacks for each cell. We use the FISH-QUANT Matlab-based software developed by 
Mueller et al (171). The software automatically detects and quantifies the number of 
spots 3D images, which greatly facilitates the image processing of the large data sets that 
are obtained in our studies.  
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Figure 4-7. Automated spot quantification using FISH-Quant Software. smFISH 
quantification was performed using a Matlab-based algorithm. (a) example 3D stack,  (b) 
user-defined cell outlines, (c) Gaussian filtering to enhance the signal-to-noise ratio. 
Background signal is subtracted from the image, and the image signal is smoothed with a 
small Gaussian kernel, (d) the number of spots in one selected cell is computed over a 
range of user-defined intensities. Plotting the number of detected spots against intensity, 
the number of detected spots goes from infinity then plateaus before declining to zero. 
The intensity threshold is picked to be an intensity when the number of detected spots is 
invariant with the intensity changes, (e) The threshold intensity is applied to all the cells 
in the image stack and the number of spots are computed. The spots detected are then 
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visualized to verify accuracy and the detection setting can be altered to improve the 
accuracy of spot detection. After the detection settings have been optimized, the detection 
settings are applied to all the image stacks for the experiment (typically 50 – 100 stacks 
per experiment), and (f) the mRNA transcript distribution for a population of cells, and 
(g) observed intensity distribution showing that the intensity of the spots is relatively 
invariant, and therefore very little impact on the detection of the spots. 
 
 
In the future, algorithms that enabled automated cell detection in bright field images 
would reduce the image processing time for large data sets. The current algorithm relies 
on manual annotation of cell masks that can be time-consuming when handling large data 
sets as is the case in the analyses performed in this study.  
 
4.4.3 Application of smFISH on Jurkat cell line 
In the context of immune cells, smFISH could provide an additional technique for 
analyzing cell response to stimulation. Antibody staining with flow cytometry detection 
of expression levels is the one of the main techniques used in analyzing immune cell 
response. However, the analysis is limited by antibody availability whereas in smFISH 
only the sequence of the target mRNA is required to design probes for detection, and the 
probes are synthesized with established protocols commercially. In addition, detection of 
mRNA is much faster than protein expression changes, therefore allowing for more rapid 
assays to be developed for the detection of immune cell response to infection.   
To test our ability to perform smFISH on individual cells in our device, we analyzed 
changes in IκBα mRNA expression in Jurkat cells after stimulation with cytokine TNF-α 
or ionomycin/PMA. In the resting state, IκBα keeps NFκB sequestered in the cytoplasm. 
Upon cell stimulation, IκBα is phosphorylated and subsequently degraded. The NFκB is 
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released and translocates into the nucleus where it drives the transcription of a number of 
genes including IκBα (Figure 4-8). NFκB activation results in an increase in IκBα 
mRNA expression.  
 
Figure 4-8 Simplified NFκB/IκBα pathway. In the resting state, IκBα keeps NFκB 
sequestered in the cytoplasm, and when the cell is activated, IκBα undergoes 
phosphorylation-initiated degradation allowing the NFκB to enter the nucleus where it 
drives the transcription of many genes including IκBα thus resulting in an increase in 
IκBα mRNA expression within 30 minutes of activation. 
 
Cells were stimulated on chip then fixed, permeabilized and hybridized on chip. 3D z-
stacks were obtained at multiple positions of the device. Figure 4-9a shows a micrograph 
of the cells in the device with nuclear stain imaged in the green channel, and the 
transcript in the red channel. The number of spots in each cell was computed, and as 
expected there was an increase in IkBα expression upon stimulation with either 
ionomycin/PMA or TNFα (Figure 4-9). In addition, the data also shows that the mRNA 




Figure 4-9 Heterogeneity in mRNA expression levels in Jurkat cells. Cells were 
stimulated on-chip with ionomycin/PMA or TNF-α for one hour, then fixed and 
permeabilized overnight followed by hybridization with IkBα mRNA probes. (a) 
micrographs of the cells showing the nuclear stain (green), and probe imaging (red) at 
40x magnification and the insert image at 63x during smFISH imaging, (b) distribution of 
mRNA copy number in each cell for unstimulated cells (control) and cells under 
stimulation. Overall, there is an increase in IkBα expression after stimulation, and cells 
show a distribution in their expression levels.   
 
4.4.3.1 Repeatability of assay 
We wanted to ensure that our assay was repeatable to allow for comparison of data from 
different days. We performed smFISH on cells stimulated with TNFα (10 ngml-1) where 
the experiments were done on different days. We show that the cell populations show a 
similar distribution in mRNA expression levels with the heterogeneity in cell response 
evident in all the 3 trials that were performed (Figure 4-10).  
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Figure 4-10 The assay is repeatable on chip. Jurkat cells were stimulated with in separate 
experiments conducted on different days. Quantification of the IκBα mRNA expression 
who is similar distribution of expression level in 3 trials (n = 400+ for each trial) 
 
4.4.3.2 Combining with CA2+ imaging with smFISH imaging for mRNA level 
characterization 
Implementing smFISH on chip allows for easier handling of cells, and minimizes cell 
loss due to the number of wash steps that are involved in the process. In addition, this 
approach makes it easier to image the cells, the cells sit directly on the coverslip which is 
compatible with high resolution imaging. In addition, the cells are in a closed chamber 
that eliminates the challenges with controlling evaporation of liquids from the sample 
during mRNA hybridization and imaging. Previous we show how we can perform Ca2+ 
dynamic measurements at a single-cell resolution. Therefore, we sought to combine the 
Ca2+ dynamics measurements with the mRNA quantification. We used the Ca2+-sensitive 
dye Fluo-3 to monitor Ca2+ dynamics. Cells were stimulated with ionomycin/PMA or 
imaged without any stimulant as a control. As observed previously, the cells flux Ca2+ 
when stimulated with some cells responding more strongly than others (Figure 4-11a,b). 
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We wanted to find out the relationship between the Ca2+ response and the mRNA 
expression level on a single cell level. Therefore, we subsequently hybridized the cells 
after the imaging determined the IκBα expression level (Figure 4-11). With increasing 
ionomycin/PMA concentration, more cells had a higher mRNA expression level (Figure 
4-11c). With the spatial position of the cells, we were able to match the Ca2+ traces to the 
corresponding mRNA count. In Figure 4-11d, we show the maximum Ca2+ peak reach 
and the mRNA transcript count. In here we do not observe a correlation between the Ca2+ 
peak and the mRNA expression level, however this study demonstrates the ability of our 




Figure 4-11 Combined Ca2+ and IkBα mRNA quantification on chip. Fluo3-loaded Jurkat 
cells were loaded on the device, and stimulated with ionomycin/PMA or no stimulation in 
the buffer while monitoring changes in Ca2+ by fluorescence imaging for 1 hour. (a) Ca2+ 
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traces for the cell where only buffer was introduced, the cells show no appreciable 
increase in Ca2+ levels, (b) upon introduction of ionomycin/PMA the cells show a rapid 
increase in Ca2+ followed by a plateau (blue is low Ca2+ and red is high Ca2+), (c) after 
Ca2+ imaging the cells were subsequently fixed, permeabilized and hybridized with IκBα 
mRNA. The transcript levels for the cells under different stimulations, the error bars 
show the standard deviation from the mean indicated by the horizontal line for each 
condition, and (d) with the spatial information of the positions of the cells in the device, 
number of transcripts can be directly compared to the Ca2+ dynamics.  
 
4.5 OT-1 T cell activation to demonstrate longitudinal cell analysis with multiple 
assays 
Having optimized our system for image-based assays, we wanted to demonstrate the 
applicability of our platform in evaluating multiple parameters in immune cell response 
of primary immune cell. This provides an application relevant to the immunology field 
and mimics some of the physiological environment that the T cells encounter to mount an 
immune response. In this application we use the OT-1 transgenic mouse T cells harvested 
from the spleen. These T cells are reactive to ovalbumin peptide, OVA. In chapter 2, we 
show the Ca2+ flux the cells exhibit when they are exposed to a surface bearing the 
pMHC and costimulatory molecules that interact with CD28 and LFA-1. Here we further 
characterize more proximal phosphorylation signaling events and downstream signaling 
signals that include cytokine mRNA expression and protein secretion, and surface marker 
expression.  
 
4.5.1 Protein phosphorylation events propagate TCR signaling 
Protein phosphorylation events are key in T cell activation (11). Upon TCR-pMHC 
engagement, activated Lck on the coreceptor phosphorylates ITAMs on the CD3ζ chains 
leading to the recruitment of ZAP70 to the plasma membrane. ZAP70 is activated 
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through phosphorylation of Tyr 315, Tyr 319, and Tyr 493 by Lck. ZAP 70 then 
phosphorylates LAT and SLP-76. LAT and SLP-76 then signal a number of downstream 
processes including the production of IP3 from PIP2, and IP3 binds to the IP3 receptor on 
the ER membrane activating the release of Ca2+ from the intracellular stores. In addition 
LAT is involved in the pathway leading to Erk phosphorylation and Erk drives the 
transcription of many genes including IL-2 gene.  
 
4.5.2 Coagonism in T cell activation 
The role of CD4/8 coreceptor signaling has been of great interest, and has been shown to 
amplify T cell signaling through the TCR (6, 172-176).  While the role of CD4 is unclear 
and has been shown to have very little to no effect on T cell signaling, the absence of 
CD8 has been shown to alter T cell activation (177). The CD8 coreceptor binds to the 
invariant α3 chain of the MHC molecule, and it is connected to the TCR/CD3 complex 
via the cytoplasmic domain. The Lck associated with the coreceptor molecule facilitates 
phosphorylation of the CD3ζ chains that then leads to a cascade of protein 
phosphorylation events including the recruitment and phosphorylation of ZAP-70.  The 
CD8-MHC interaction kinetics has been shown to vary among different MHC alleles, and 
also with different T cells for the same MHC allele (137). However, the CD8-MHC 
interaction does have a lower affinity compared to the TCR-pMHC interaction. In 
addition, during TCR-pMHC interaction with an agonist, the CD8 coreceptor can interact 
with the MHC of the nonstimulatory/self pMHC that are more abundant on the cell 
surface leading to an enhanced T cell signaling. This has been termed coagonism where 
the presence of a nonstimulatory pMHC enhances the activation of a T cell upon 
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interaction with a cognate (agonist) pMHC. Previous studies have shown that in the 
presence of both the agonist peptide and a nonstimulatory peptide, T cells show increased 
CD69 expression and IL-2 secretion compared to having only the agonist peptide (172, 
178). These observations shed light on the role of endogenous peptide in amplifying T 
cell signaling. In addition to coreceptor contribution to T cell signaling, other 
costimulatory molecules such as LFA-1, CD28, CD45, CD2 and CTLA-4 are important 
to ensure a productive signal and complete T cell activation. Without costimulation, T 
cell can undergo deletion, become anergic or develop immune tolerance.  
In this study, we analyze the effect of coagonism in TCR-mediated T cell signaling by 
measuring both proximal (Ca2+ flux and phosphorylation) and distal signaling events 
(cytokine mRNA and secretion) in the same cell sample. 
4.6 Combined Ca2+ analysis and ZAP-70 and Erk phosphorylation 
 
Our initial analysis involved analyzing the first 10 minutes of activation. Here we draw 
insights that can be deduced from the proximal signaling events by evaluating Ca2+ flux 
and ZAP-70 and Erk phosphorylation. To evaluate the effect of coagonism, OT-1 
spleenocytes were activated on antigenic OVA pMHC- coated surfaces with and without 
coagonist, VSV, and also with coagonist only. VSV is nonstimulatory to OT-1 T cells. As 
shown before, we observe a rapid Ca2+ flux for T cells on OVA surface (Figure 4-12a,b). 
In the presence of coagonist peptide, rapid Ca2+ flux is observed even though the density 
of OVA on the surface is reduced 4-fold. The T cells on VSV surface showed no Ca2+ 
flux, supporting the previous findings that the coagonist peptide is nonstimulatory. From 
Figure 4-12d, the average response show that the presence of coagonist amplifies the 
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Ca2+ signal, an interesting finding given that the number of OVA molecules in the 
OVA/VSV experiment is reduced compared to the OVA only experiment. In addition, 
analyzing the individual Ca2+ traces, we extracted the area under the Ca2+ curve and the 
maximum Ca2+ peak, we observe that the coagonist results in more cells that have a 
higher Ca2+ lebel (Figure 4-12e,f).  
 
 
Figure 4-12 Coagonist, VSV amplifies Ca2+ signaling OT-1 T cells stimulated with 
agonist OVA. OT-1 spleenocytes are activated pMHC surfaces while simultaneously 
measuring Ca2+ flux. The cells were activated on surfaces coated with (a) OVA, (b) 
OVA/VSV, (c) VSV. The cells show no change in calcium on VSV peptide, and rapid 
Ca2+ flux with OVA antigenic peptide. However the presence of OVA/VSV peptides 
results in some cell that have a much higher Ca2+ level compared to the cells on OVA 
surface only. (d) average Ca2+ response show a higher Ca2+ level with the coagonist, and 
(e) and (f) show the area under the curve and the maximum Ca2+ peak for the individual 
cells showing that coagonism increases the number of cell with higher levels of Ca2+ 
responses. The mean for each condition is represented by the horizontal bar and the 




Next we asked how the coagonism might affect the propagation of TCR signaling by 
analyzing phosphorylation Erk, which is downstream of Ca2+ and also ZAP70 which 
occurs earlier in the TCR signaling cascade and also activates Erk. After Ca2+ 
measurements, the cells were fixed and permeablized and then stained with antibodies 
against phosphorylated ZAP70 and Erk on chip. Images were acquired and the intensity 
levels were measured for each cell. Figure 4-13 shows a representative micrographs of 
the pErk imaging. As expected, the nonstimulatory ligand, VSV shows lower intensity 
levels for both ZAP70 and Erk. The OVA-stimulated T cells showed a wider distribution 
with a fraction of cells having intensity values similar to those of VSV. These cells are 
likely to not have propagated the TCR-mediated signaling. In addition, the OVA 
condition show a positive correlation between pZAP70 and pErk. This observation is 
consistent with one of the proposed models where ZAP70 activates LAT and LAT 
activates the Erk pathway.  
 
 
Figure 4-13 Effect of coagonism on pZAP70 and pErk. After Ca2+ measurements the 
cells were fixed, permeabilized and stained against phosphorylated Erk and ZAP-70. (a) 
fluorescent image of anti-pZAP70, and (b) phosphorylation levels of ZAP-70 and Erk in 
cells stimulated with antigenic peptide, OVA, antigenic peptide OVA in the presence of 
coagonist peptide VSV, and only coagonist VSV.  
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Next, we made single-cell correlations of the Ca2+ data with the phosphorylation data. 
Looking at the OVA-stimulated cells, Figure 4-14a show cells that had high pZAP-70 but 
low Ca2+ levels that may be indicative of lack of signal propagation. This is in contrast to 
the coagonist condition where pZAP-70 low, and high Ca2+ level was observed (Figure 
4-14b). The low level of ZAP-70 phosphorylation may be attributed to the fewer number 
of OVA molecules on the surface. In the setup, the number of MHC molecules is 
identical in all setups, therefore with the coagonist the OVA density is lower. Coagonist 
only did not result in appreciable ZAP-70 phosphorylation. Similarly the same trends 
were obtained for Erk phosphorylation where in OVA-stimulated cells a fraction of cells 
show cells with low Ca2+ and high pZAP70. In the presence of a coagonist the Erk 
phosphorylation is loosely dependent of Ca2+ level. So far, we correlated the static 
parameters of phosphorylation events to a single parameter (Ca2+ peak intensity) of the 
Ca2+ dynamics. However, Ca2+ peak does not give a full picture of the Ca2+ dynamics. 
Other parameters such as area under the curve, the time the cell takes to response, and 
time to reach a percentage of the maximum response can also be used to describe the 
signaling events. In addition, unsupervised clustering algorithms may be used to group 




Figure 4-14 Correlation of Ca2+ signaling parameters and Erk and ZAP-70 
phosphorylation. The maximum peak for each Ca2+ trace was deduced from the Ca2+ 
data, and then matched to the corresponding pZAP70 and pErk intensity for the three 
stimulating conditions; agonist (OVA), agonist/coagonist (OVA/VSV), and coagonist 
(VSV).  (a-c) Ca2+ correlations with ZAP70 phosphorylation, and (d-f) Ca2+ correlations 
with Erk phosphorylation.  
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It is important to note is the dynamic nature of pZAP70 and pErk that might affect the 
analysis and insights obtained from these studies. Future work would include analyzing 
these phosphorylation events at different time points.  
 
4.7 Ca2+ and cytokine IL-2 and IFNG mRNA expression levels determination 
 
Detection of cytokine mRNA in immune cells could potentially be more insightful and 
complement cytokine secretion measurements. The short-lived nature of RNA compared 
to protein ensures that measurements made are a result of the stimulation and not due to 
prior conditions the cells were exposed to (163). In addition, with mRNA detection no 
pretreatment of the cell with protein transport inhibitors is required as would be needed in 
intracellular cytokine staining. In addition, RNA detection would be more useful in 
instances where no antibodies are available for the protein expression analysis to be done. 
Combined with Ca2+ imaging, we analyze IL-2 and IFNγ mRNA expression after 
stimulation with antigenic peptides.   
 
The time-dependent mRNA expression levels were determined by incubating the cells for 
0, 1, 4, and 18 hours before fixation, permeabilization then hybridization. Because 
smFISH is an endpoint assay, knowledge of the dynamics of mRNA is important in 
determining the time point for sampling the mRNA expression. Figure 4-15 shows the 
IFNγ mRNA expression variation in OT-1 T cells stimulated with OVA peptide for 
different durations. The maximum expression is reached between 1 and 18 hours. From 
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this, the incubation period of 4 – 6 hours was chosen for evaluating mRNA expression for 
the rest of the studies. 
 
 
Figure 4-15. IFNγ mRNA expression dynamics in OT1 CD8+ T cells after stimulation 
with OVA peptide. T cells were stimulated with OVA peptide for different durations 
before being analyzed for IFNγ mRNA expression. (a) micrograph of maximum 
projection for imaging IFNγ mRNA fluorescently-labeled probes, (b) number of mRNA 
transcripts per cell for 0, 1, 4 , 18 and 24 hours of stimulation, the horizontal bar is the 
mean transcript count and the vertical bars show the standard deviation for the cell 
population and (c) the population average expression levels.  * number of cells = > 600 
per condition.  
 
From the mRNA measurements at different time points, a stimulation time of 6 hours was 
picked for the subsequent studies. OT-1 T cells mRNA expression levels were 
determined using different stimulations; no stimulation using a BSA-coated surface, non-
specific stimulation with ionomycin/PMA, another positive stimulation via crosslinking 
of the TCR, and stimulation with the antigenic peptide OVA. The mRNA expression 
level within a cell population shows a range under these different stimulating conditions 
(Figure 4-16).  For each condition 400 – 600 cells were analyzed per stimulating 
condition demonstrating the large number of cells that can be assays in one experiment 
on the platform. For these studies, the limitation lies in smFISH imaging due to the high 
exposure times (1 – 3 seconds) required for imaging on a conventional epifluorescent 
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microscope. However, the long time it takes to image may be overcome with the use of a 
spinning disk confocal microscope.   
 
 
Figure 4-16. IFNγ expression in OT-1 T cells under different stimulating conditions. OT-
1 CD8+ T cells were stimulated with OVA, anti-TCR and a negative stimulation control 
on BSA surface for 4 hours. (a) Representative micrograph of the maximum Z-projection 
for smFISH probe imaging. The probes are tagged with TAMRA fluorophore, (b) mRNA 
transcript count for the 4 conditions, each data point represents the total mRNA count for 
an individual cell, and the mean and standard deviation are shown for each condition, (n 
= 400 – 600 cells per condition), and (c) histograms showing the distribution of total 
mRNA count per cell for OT-1 T cells treated under different conditions. 
 
4.8 Effect of coagonist peptide on Ca2+ and cytokine mRNA expression 
We further showed the effect of coagonists in both Ca2+ levels and mRNA expression 
levels in the same population with single-cell resolution. As previously demonstrated, the 
presence of coagonist OVA enhances the calcium response (Figure 4-12). In addition, 
the mRNA expression levels are very low in the presence of coagonist alone compared to 
 108 
the agonist OVA (Figure 8-12). To evaluate the effect of the coagnosist, cells were 
stimulated on surfaces coated with OVA agonist, OVA/VSV and VSV surface. In all the 
three conditions the MHC density was kept constant, therefore in the presence of a 
coagonist the OVA density was reduced by 4-fold. As previously observed, Figure 4-17 
show that T cells on OVA and VSV/OVA surfaces show rapid Ca2+ flux within the first 
120 s of the analysis. On the other hand in the VSV condition, only sporadic Ca2+ spikes 
are observed. Overall, the data shows on average a higher Ca2+ rise in the presence of the 
coagonist VSV, thus supporting the idea that the coagonist enhances T cell signaling 
(172, 173, 175, 179) . 
 
 
Figure 4-17. OT-1 Ca2+ dynamics with and without coagonist VSV.  OT-1 T cells were 
stimulated with the indicated peptide in the presence of anti-CD28 and anti-LFA1. 
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Heatmaps were plotted for the temporal Ca2+ dynamics for the individual cells under 
stimulation with, (a) OVA agonist, (b) OVA agonist and VSV coagonist, (c) VSV 
coagonist only, and (d) taking the population average for the three conditions, overall T 
cells show a higher Ca2+ response in the presence of a coagonist compared to having only 
the agonist.  
 
Furthermore, analyzing the Ca2+ response parameters such as the maximum peak reached 
and the overall Ca2+ dose calculated as the area under the calcium curve, we show the 
amplification of the Ca2+ signal by the coagonist. The coagonist amplifies the signal that 
is initiated by the TCR-pMHC interaction between the TCR and the OVA peptide. 
Without the agonist the T cells exhibit random Ca2+ fluctuations, showing that the 
interaction with the antigenic peptide is crucial in initiating the signal.  
 
 
Figure 4-18. Analyzing Ca2+ dynamics parameters show an overall higher calcium 
response in the presence of a coagonist. (a) The maximum Ca2+ reached for each cell, the 
average and standard deviation within each population are shown, and (b) area under the 
Ca2+ curve showing the total calcium dose during the first 10 minutes of stimulation. 
 
 
With the understanding of how the coagonist amplifies the Ca2+ signal, we analyzed how 
the signal is propagated downstream to cytokine mRNA expression levels. Previous 
studies have demonstrated increased IL-2 secretion and CD69 surface marker expression 
in the presence of an agonist (172, 178). The cytokine mRNA expression levels will 
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increase upon stimulation as has been shown in this chapter. The mRNA expression 
levels for IL-2 and IFNγ cytokines were evaluated. Figure 4-19a shows a higher IFNγ 
.mRNA expression levels for T cells on OVA surface. In addition, for the OT-1 T cells 
on OVA surface, the mRNA expression levels spanned a larger range. Surprisingly, the T 
cells on the OVA/VSV surface showed lower mRNA expression levels almost 
comparable to cells on VSV surface even though these cells showed an overall high Ca2+ 
level within the first 10 minutes of stimulation. Similar trends were observed with the IL-
2 mRNA expression (Figure 4-19b) with no observable mRNA spots on the VSV-
stimulated T cells. There are two possible explanations to these observations; the lower 
OVA density in the presence of the VSV (OVA/VSV condition) may have an overall 
effect on the different signals involved in T cell activation and thus result in reduced 
functional or response downstream of calcium. Alternatively, the mRNA peak expression 
levels for OVA/VSV condition may appear earlier after activation compared to OVA-
stimulated cells. Sampling at earlier times could help sheds light on the dynamics of 
cytokine mRNA levels in the presence of a coagonism.  
In addition to evaluating the effect of coagonists in T cell activation by measuring Ca2+ 
changes and mRNA expression levels, we took advantage of our platform to analyze how 
the Ca2+ dynamics are related to the cytokine mRNA levels. The platform enables defined 
spatial positioning of individual cells on a small footprint, and this high density of cells 
enables the analysis of hundreds of cells for Ca2+ dynamics in a single field of view. The 
spatial positioning of the individual cells is kept throughout the experiment, and the cells 
can be incubated in the device for up to 24 hours as has been demonstrated (Figure 4-5). 
The ability to incubate the cells for long time while maintaining their positions, and the 
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ease of introducing different fluids into the device allows further analysis to be performed 
including immunostaining and smFISH hybridization after Ca2+ live imaging.  
 
 
Figure 4-19. mRNA expression levels. After 6 hours of stimulation, cells were fixed, and 
subsequently hybridized with mRNA probes for IL2 and IFNγ. (a) T cells stimulated on 
OVA peptide surface show higher mRNA expression level, and a larger dynamic range 
compared to cells on OVA/VSV and VSV surface, (b) OVA-stimulated surface show a 
slightly higher IL2 mRNA expression level, and no detectable spots were observed in 
cells that were on VSV surface.  *number of cells = 600 – 800 for each condition. 
 
 
Therefore, with the information on the identity of each cell in both Ca2+ imaging and 
cytokine mRNA imaging, the Ca2+ parameters derived from the Ca2+ curves were 
examined on how they can inform on the cytokine expression levels that can have 
functional consequences. Overall, no obvious correlations were observed between area 
under the Ca2+  curve and mRNA expression levels (Figure 4-20). These results may 
indicate that the high Ca2+ cells may not necessarily become functionally productive. 
However, further studies that also probe at the mRNA dynamics would be crucial in 
determining if there is really a correlation or no correlation between the Ca2+ dynamics 
and cytokine mRNA expression levels. In addition, more conditions will need to be tested 
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including the presence of a coagonist but with the same agonist density compared to the 
condition with the agonist only condition. 
 
Figure 4-20. Direct correlation of Ca2+ response and IL-2 and IFNγ mRNA expression 
levels.  With the identity of each cell conserved throughout the assays, direct correlations 
between the Ca2+ dynamics and mRNA expression were drawn at a single cell level. 
Overall the data shows no correlation between the Ca2+ does and IL2 or IFNγ mRNA, 
thus demonstrating that the observation of cells exhibiting high Ca2+ may not be enough 
in identifying functionally responsive T cells. Ca2+ dose vs IFNγ expression for (a) OVA, 






4.8.1 Multiplexed data correlations using clustering algorithms 
In addition, more rigorous analysis of the measured calcium and mRNA data is required 
to better understand any correlations between these parameters. I used k-means clustering 
algorithm to group together cells that exhibited similar calcium traces. The k-means is an 
optimization algorithm that minimizes the distance from the center of the cluster for each 




Figure 4-21. Ca2+ dynamics clustering using k-means clustering algorithm. The 
individual calcium traces for OT-1 T cells on either OVA or OVA/VSV surface. For the 
OVA/VSV surface the OVA density was 0.2 compared to the condition with OVA only. 
Heatmaps showing individual calcium traces arranged by the clusters, (a) OVA, (b) 
OVA/VSV. The clusters are indicated on the heatmaps. Average calcium trace for each 
cluster for (c) OVA and (d) OVA/VSV. Distinct calcium traces are observed for each 
cluster.  
 
To capture the temporal calcium dynamics and group the cells in similarly behaving 
groups, k-means to group the cells into 4 distinct clusters for the T cells treated on OVA 
and OVA/VSV surface. Figure 4-21 shows the clusters that the calcium traces were 
grouped into. From the heatmap plots (Figure 4-21a,b), the different clusters can be 
visualized. In addition, by taking the average calcium response for each cluster, the data 
shows that each cluster is unique (Figure 4-21c,d), with the clusters having different 
maximum peak values. In particular, for the OVA-treated cells, cluster 4 average calcium 
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curve show a very distinctive behavior that might indicate that the cells within this cluster 
had multiple Ca2+ bursts during the stimulation (Figure 4-21c). In addition, all the 
clusters have different peak values and rise time that can also be analyzed to describe the 
difference in the calcium behaviors. On the other hand for the OVA/VSV treated cells, 
the 4 clusters show similar peak rise but different peak levels.  
 
Combining the calcium data with the mRNA count analysis, PCA was used to analyze 
the correlations between the early calcium signaling and late mRNA expression. Figure 
4-22 show the calcium clusters (color of each point) after PCA. For the OVA-treated 
cells the different subsets are described by the first PC (Figure 4-22). However, for the 
OVA/VSV-treated cells, there was no separation of the calcium clusters in the PCA 
analysis. This observation may be a result of the lower OVA density on the surface (20% 
coverage compared to the OVA only condition) that may have an impact on the signal 
propagation of mRNA expression since higher calcium levels were observed within the 




Figure 4-22. Clustering of OT-1 T cells stimulated on OVA surface by PCA of the Ca2+ 
dynamics and mRNA expression. The color for each data point represents the clusters of 
the cell from the k-means clustering of the calcium dynamics above as indicated in the 
legend. (a,b) for the OVA-treated cells the 4 clusters from k-means clustering are 
separated, showing a positive correlation between the calcium dynamics and mRNA 
expression levels, and (c,d) for the OVA/VSV treated cells, the calcium clusters are 
diffuse in the PCA analysis showing no direct correlation with the mRNA expression 
levels.  
 
Additionally, we analyzed the expression profiles for both IL-2 and IFNγ mRNA count. 
Figure 4-23 shows the PCA for OVA-treated T cells. IFNγ mRNA expression showed 
some distinct subsets (Figure 4-23a,b) compared to the IL-2 mRNA expression that did 
not show any obvious correlations (Figure 4-23c,d). From this analysis, it is possible that 
for the CD8+ T cells, the calcium dynamics and IFNγ mRNA expression may have a 
correlation that may be used to determine functional response from calcium data.  
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Similar analysis on the OVA/VSVS-treated cells showed cells with high IFNγ mRNA 
separated from the main cluster of cells, however no distinct subsets were observed for 
the IL-2 mRNA count (Figure 4-24).  
 
Figure 4-23. Clustering of OT-1 T cells stimulated on OVA surface by PCA of  the Ca2+ 
dynamics and mRNA expression. The variance contribution is 83.4 % for PC1 and 14.7 
% for PC2. (a) plot of the three principal components , the color of each point represents 
the IFNγ mRNA count (blue = low, and red = high), (b) PC1 and PC2 plot show that the 
IFNγ mRNA count is described by the first PC. (c,d) The color of each point represents 
the IFNγ mRNA count (blue = low, and red = high), (c) a plot for the 3 principal 





Figure 4-24. Clustering of OT-1 T cells stimulated on OVA/VSV surface by PCA of  the 
Ca2+ dynamics and mRNA expression. The variance contribution is 98.6 % for PC1 and ~ 
1 % for PC2. (a) plot of the three principal components , the color of each point 
represents the IFNγ mRNA count (blue = low, and red = high), (b) PC1 and PC2 plot 
show that the IFNγ mRNA count is described by the first PC. (c,d) The color of each 
point represents the IFNγ mRNA count (blue = low, and red = high), (c) a plot for the 3 
principal components, and (d) plot of first 2 PCs show no distinct subsets for IL-2 mRNA 
expression.  
 
Finally, we analyzed the ability to identify cells that were under different stimulating 
conditions using PCA (Figure 4-25). Data from OVA, OVA/VSV, and VSV was pooled 
together and analyzed. Figure 4-25 show that the cells from the different stimulating 




Figure 4-25. PCA clustering of the combined data for OVA, OVA/VSV and VSV 
conditions for calcium dynamics and IFNγ mRNA expression. The variance contribution 
is 85.6 % for PC1 and ~ 14.1 % for PC2. All the data for the T cell activation with OVA, 
OVA/VSV, and VSV was pooled together and PCA was performed. 3 distinct groups are 
observed that correspond to the cells under the different treatment conditions are 
observed. The color for each point represents the stimulating condition for that cell.  
 
Overall, the ability to perform longitudinal T cell activation analysis has been 
demonstrated that allows multiple parameters to be measured employing different 
analytical techniques.  
 
4.9 Conclusions 
Here we have presented a simple, integrated platform combined with image-based 
approaches for longitudinal analysis of immune cell signaling events. We take advantage 
of the platform developed in Chapter 3 that enables high-density cell trapping and robust 
fluid exchanges to allow the analysis of hundreds of cells in a single experiment at a 
single cell resolution and multiple stain and wash steps for the determination of different 
molecular signatures on the same sample. The ability to perform multiple assays on the 
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same sample in a sequential manner while maintaining the identity of each cell allows 
direct comparisons of different molecular readouts.  
 
The platform requires minimal peripheral equipment, relying only on gravity to drive the 
flow and no specialized equipment is required to run the device. Therefore, the platform 
is easily transferable to other laboratories and can be used on a typical microscopy setup 






5 LEUKOCYTE SEPARATION, STIMULATION AND 
IMMUNOPHENOTYPING FROM LESS THAN A DROP OF 
WHOLE BLOOD 
 
Ultimately, I would like to take advantage of the small scale offered by microfluidics to 
reduce the amount of samples required for an assay. Enabling direct preprocessing of 
cells will allow for smaller volumes to be used in the experiment. This can be important 
when using patient samples such as blood, where it is necessary to reduce the burden on 
the patient, or when working with blood from small mammalians such as mice. In this 
chapter I demonstrate the use of our modified cell trap for the separation of white blood 
cells from whole blood, thus requiring only 1 – 5 μL of whole blood for an 
immunophenotyping assay. 
5.1 Introduction 
5.1.1 Blood for immune analysis 
Blood is a more tractable tissue to study as it can be easily acquired through minimally 
invasive techniques such as the finger prick, and is useful in disease diagnosis and 
monitoring. Blood is a complex mixture of ~ 55 % plasma and 45 % cells that include 
platelets (thrombocytes), white blood cells (leukocytes) and red blood cells 
(erythrocytes), and carries a lot of information about the physiological stage of organs 
and tissues in the body. Analysis of blood components, both plasma and blood cells 
provide very important information on the health status of an individual. Changes in the 
blood cell composition and the different cell subtypes can provide insights on 
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autoimmunity, chronic illness, acute infection and inflammation. In blood cell analysis, 
leukocytes are the target cells as they are a critical part of the immune system.  
Leukocytes total and differential count (Table 2) are critical in evaluating inflammation, 
chronic illness and infection. However, as indicated in Table 1 there are 1,000 red blood 
cells for each leukocyte cell. As a result, there is need to separate leukocytes for analysis 
since the overwhelming number of red blood cells that can confound the findings 
especially in RNA-based assays.  
 




Leukocytes are crucial in both innate and adaptive immune system response. Changes in 
the differential composition from the normal (Table 2) is used in diagnosis especially in 
inflammation, burns patients and sepsis. Moreover, the CD4+ T cell count from blood 
has been used to monitor the immunocompetence of HIV-infected patients (180-182).  
 
Conventional techniques for separating blood components include density gradient 
centrifugation, fluorescence-activated cell sorting (FACS), magnetic-activated cell 
sorting (MACS) (183) and erythrocyte lysis (184-186). These approaches generally 
require at least milliliters of blood that can be challenging when analyzing samples from 
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patients especially pediatric patients or small experimental organisms such as mice. In 
addition, these techniques involve complex sample preparation techniques that required 
experienced individuals, and the sample manipulation can cause cell stimulation thus 
distorting the immune phenotypes of the cells (187, 188). Unintended activation of 
neutrophils have been observed leading to increased expression of neutrophil activation 
markers, CD11b/CD18 (188). In addition to techniques for separation, subsequent 
analytical tools are employed for the identification of the different cell types, and 
stimulation and analysis of immune response, and genomic and proteomic analysis of 
molecular expression. Flow cytometry is the gold standard technique use to analyze 
blood cells allowing for the differential enumeration of leukocytes based on morphology 
and surface marker expression. While flow cytometers are accessible in research 
laboratories, they are bulky equipment that would not be suitable for point-of-care 
analysis in low resource setting, or in a doctor’s office. The need for point-of-care 
diagnosis challenges the development of portable and easy-to-use platforms (189-191). 
Therefore, there are opportunities to develop new integrated tools that are portable, easy 
to use, require minute sample sizes, and enable multiple assays to be performed to allow 








Table 2. Differential Leukocytes count in whole blood (192, 193) 
 
 Cell Type Number of cells per 
μL 
Size (μm) 
Granulocytes neutrophils 3 – 7 x 103 15 – 20  
eosinophils 50 – 400  6 – 8  
basophils 25 – 100  10 – 15  
 Monocytes 200 – 800  15 – 20  
Lymphocytes T cells 800 – 3,200 6 – 15  
B cells 100 – 600  8 – 15 
Natural killer Cells 50 – 400  10 -15 
 
5.1.2 Microfluidic-based platforms for cell separation 
Microfluidics lends itself to be a technique that utilizes small sample sizes that could 
enable the use of less than a drop blood in routine testing and the compact size makes 
microfluidic platforms viable candidates for the development of portable devices. 
Moreover, the inherent small size and ability to integrate multiple functions on the same 
chip makes microfluidic platforms amiable to point-of-care diagnostics, and for use in 
elucidating response to perturbations for analysis of drug response and immune system 
competence. Microfluidic platforms for blood separation and analysis have been 
developed to either mimic the separation techniques in conventional assays so as to 
reduce the required sample size or implement new techniques that would otherwise not 
be applicable in macroscale techniques. Previous platforms have used differences in cell 
size and mechanical properties, differential displacement under flow, antibody capture, 
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and constricted geometry for the separation of plasma (194-196), leukocytes (197) and 
circulating tumor cells from whole blood (198). These different separation approaches are 
based on taking advantage of the heterogeneous properties of blood include size, 
mechanical, electrical, and magnetic properties, and differential expression of surface 
markers. Sethu et al developed a microfluidic chip that enable precisely timed exposure 
of blood cells to deionized water for red blood cell lysis to isolate leukocytes and perform 
genomic expression analysis on leukocytes before and after exposure to Staphylococcal 
enterotoxin B (199). This approach relies on the differential duration it takes for cells to 
undergo lysis, red blood cells rapidly undergo cell lysis compared to leukocytes. The 
microfluidic systems enables much shorter exposure times to the lysis solution, thus 
reducing the chances of nonspecific activation of leukocytes during the separation 
process.  
 
The differential size of blood cells make it an easy characteristic to exploit when 
separating cells with sizes ranging from 2 μm for platelets, 6 – 8 μm for red blood cells 
and 6 – 20 μm for leukocytes. Geometric restriction has been utilized to separate blood 
cells from plasma for analysis of plasma components (194, 196, 200). In addition, 
differences in cell sizes have been applied to separate leukocytes from red blood cells, 
and also tumor circulating cells from blood cells. However, the filtration approaches can 
often lead to clogging by the red blood cells and therefore not robust. 
 
Another approach that uses differences in cells sizes and mechanical rigidity is 
deterministic lateral displacement. Here geometry restriction and flow is used to direct 
 126 
cells of different sizes to different outlets of the channel; thus similarly size particles are 
collected together. Surface patterning with specific antibodies (201) or receptor-specific 
ligands enable the separation of specific cellular subtypes (202, 203). In addition, the 
deformability of red blood cells have been used in removing red blood cells using lateral 
displacement in a microfluidic channel (204-206). Combining the lateral displacement 
under flow and asymmetric patterning of P-Selection, Bose et al demonstrated successful 
separation of neutrophils from whole blood (207). Neutrophils exhibit a rolling behavior 
on p-selectin surfaces (208-210), and this interaction on an asymmetric p-selectin pattern 
displaces the neutrophils to one size of the channel where they exit through a separate 
channel from all the other cells (207). However, this platform does not enable for further 
on chip analysis of the separated cells relying on off-chip analysis that may require large 
number of cells, and also may suffer from cell loss. In addition, approaches that rely on 
capture of cells on coated surfaces may become problematic in diseased samples where 
the surface interaction properties may be altered.    
 
In this chapter, I use the microscale tools and techniques developed in Chapters 2, 3 and 4 
to implement a simple technique for separating leukocytes from whole blood by 
exploiting the differences in sizes and deformability of blood cells, and passive 
hydrodynamic trapping to selectively trap only leukocytes in defined microstructures. 
Erythrocytes, while about 6-8 μm in diameter are highly deformable and tend to flow in 
the channel or pass through the traps when directed into the traps by the flow, and 
therefore are not trapped in the device. On the other hand, less flexible leukocytes are 
directed into the traps by hydrodynamic flow and remain trapped. Our platforms allows 
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integrated leukocyte separation, stimulation and analysis of response on chip, thus 
minimizing sample handling and loss, and reagent use, and overall reducing donor burden 
on drawing large amounts of blood. The ability to separate leukocytes from whole blood 
utilizing the high-density cell trap-based platforms described in the preceding chapters 
enables the development of a complete package of analytical techniques from. The 
platform will integrate cell separation from whole blood, perturbation of target cells, and 
subsequent analysis of cell behavioral responses using image-based approaches.  
5.2 Materials and Methods 
5.2.1 Device fabrication 
The devices were fabricated as outlined in Appendix A.  
5.2.2 Device preparation 
Prior to use, the devices were steam autoclaved to sterilize them. Devices were primed 
with remove bubbles and then the device channels were filled with 2% BSA in PBS and 
incubated for 30 minutes to passivate the surface so as to prevent nonspecific adhesion of 
cells on the device surfaces.  
5.2.3 Blood preparation 
Blood was collected into an EDTA Vacutainer collection tube (BD), and the blood 
sample was used within an hour after draw. The dilution buffer (RPMI 1640, 2 % BSA) 
was added to blood to dilute the blood 10-fold so as to prevent clogging of the narrow 
device channels. The diluted blood was then aspirated in a pipette tip and the tip placed 
on the device inlet. The blood then flowed into the device by gravity-driven flow, and 
allowed to run for 15 minutes before the device channels were washed with the dilution 
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buffer. Once all the excess cells are removed, stimulation or antibody staining was done. 
Leukocytes were then stimulated with 100 ng/ml lipopolysaccharide (Sigma Aldrich, 
L3012) for 4 hours. After the stimulation, cells in the device were washed with the buffer, 
and solution of antibodies against CD11b and CD66b surface markers was added and 
incubated for 1 hour before washing and them imaging on an epifluorescent microscopes 
 
5.3 Device design and operation principle 
 
 
Figure 5-1 Device operation.  (a) Single inlet/single outlet device for the separation of 
leukocytes from whole blood, (b) depiction of the separation of the removal of red blood 
cells. The red blood cells are very flexible and can pass through very small gaps, 
therefore in the device the red blood cells can pass through the 2 μm constriction at the 
cell trap while the more rigid leukocytes are directed to the cell trap and remain in the 
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cell traps, (c) micrograph of the device showing the array of cell traps in the device, and 
(d) jurkat cells after being separated from red blood cells and trapped in the device.  
 
The device platform represents a new application of the high density cell trap array to 
enable processing of whole blood (Figure 5-1). As previously described, the platform 
consists of microstructures for cell trapping with a single inlet and a single outlet, and has 
been demonstrated to enable cell trapping on mammalian cells in a highly robust manner. 
The separation of the red blood cells is based on the differential size and mechanical 
rigidity of the cells. Platelets are very small (1 – 3 μm) and therefore cannot be trapped in 
the device’s microstructures. On the other hand, red blood cells are very flexible and can 
squeeze through very small channels thus allowing them to pass through the cell traps, 
and leukocytes that have size ranging 6 – 20 μm are trapped in the device (Figure 5-1). 
The optimal cell trapping microstructures were 10 μm wide and 20 μm tall, and the 
restriction channel was 2 μm tall. The devices have a capacity of 1,000 – 8,000 cells 




Figure 5-2. Microfluidic platform enables rapid analysis of minute quantities of blood. 
Multiple analysis can be performed on chip starting with the removal of reds blood cells 
and trapping of leukocytes for subsequent analysis including differential leukocyte 
counting, stimulation and time-lapse analysis and measurement of activation marker 
expression and gene expression of specific cells. The platform is very simple, and the 
flow is driven by gravity-driven flow implemented by suspending the outlet tubing to a 
height, h ≈ 15 cm.  
 
With this platform leukocytes are separated and analyzed on the same chip. Figure 5-2 
give an overview of the functional capacity of the microfluidic system. Gravity-driven 
flow is used to drive the 10-fold diluted blood in the device and the red blood cells and 
platelets exit through the outlet while the white blood cells are trapped in the device. 
Once the white blood cells are trapped, differential leukocyte counting is performed using 
surface marker expression. In addition, further analysis can be performed on the immune 
response by stimulating the trapped cells, and evaluating activation markers such as 
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elevation of surface marker expression, cytokine secretion, oxidative burst, calcium 
dynamics and gene expression as have been shown in chapters 2, 3 and 4 (Figure 5-2). 
Therefore, the platform would offer a simple, high-throughput platform for processing 
and analysis of leukocytes using a microliter of blood. 
 
5.4 Demonstrating the ability to separate out RBCs 
The main goal of this chapter was to enable the removal of RBCs from whole blood to 
enable immunophenotyping of leukocytes. We characterized the deformability of red 
blood cells and the ability to remove red blood cells using a mixture of human red blood 
cells spiked with Jurkat cell to mimic leukocytes. In the mixture, the ratio of RBC to 
Jurkat cells was 1,000 to 1 to mimic the proportion in blood. Although in this case there 
is no blood plasma that might affect the flow dynamics, the setup helps us understand the 




Figure 5-3. Capture of Jurkat cells mixed with red blood cells. Jurkat Jurkat cells mixed 
with red blood cells (1,000 red blood cells per Jurkat cells), and then introduced into the 
device. (a) device micrograph, (b) Jurkat cells capture in the device, (c) cell tracker red 
imaging of Jurkat cells. After trapping the cell were loaded with Fluo3 calcium-sensitive 
dye and stimulated with ionomycin (1 μg/ml) with simultaneous calcium imaging. (d) 
heatmap showing the individual cell response upon stimulation with ionomycin, and (e) 
individual curves and the average (red) calcium response. 
 
The height of the tubing was optimized to 15 cm to enable a flow rate of ~ 12 μL/hr, 
allowing about 3 μL to be delivered into the device in 15 minutes. The mixture was 
diluted 10-fold to prevent clogging of the device channels by red blood cells. In 3 μL, 
there are ~ 600,000 red blood cells and 600 Jurkat cells. Here we used a device with a 
single chamber and a capacity of 1,000 cells. We were able to capture ~ 450 cells, thus 
giving a trapping efficiency of at least ~ 75 % of Jurkat cells assuming all the cell went 
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through the device. In addition, very few red blood cells were trapped in the device and 
some traps were left unoccupied. Therefore, the platform has a great potential in 
enriching the concentration of leukocytes, allowing more sensitive analysis such as 
genomic expression to be performed. Furthermore, once the cells are separated and 
trapped in the device, additional analyses can be performed as demonstrated in chapters 
2, 3, and 4. Here, we show the stimulation of cells with ionomycin/PMA while 
simultaneously measuring calcium dynamics (Figure 5-3d & e). Cytosolic Ca2+ influx 
was observed after addition of ionomycin/PMA as shown in Figure 5-3d.  
5.5 Whole blood separation, stimulation and immunophenotyping 
5.5.1 Leukocyte separation from whole blood 
After showing the removal of red blood cells from a mixture of Jurkat cells and red blood 
cells, we moved to separate leukocytes from whole blood. Leukocytes are of interesting 
in evaluating the immune cell response, and the high abundance of red blood cells 
(Figure 5-4a) makes it necessary to deplete red blood cells in leukocyte 
immunophenotyping. The red blood cells mostly flow through the main serpentine 
channel and some go through the traps (Figure 5-4b). In Figure 5-4b the trajectory of 
two red blood cells are tracked as indicated in the figure. The red blood cells flow 
through the channel and are directed to the cell trap by the passive hydrodynamic flow 
and the flexibility of the red blood cells allow them to go through the cell traps. Loading 
of leukocytes starts in the first row of the device, demonstrating again the sequential 
loading characteristic of the device (Figure 5-4c). Once the leukocytes had been 
separated from red blood cells and trapped in the device, further analysis on the subtype 
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of the leukocytes can be conducted using differential surface marker expression. In 





Figure 5-4 Whole blood in the device. (a) Whole blood in device at 10-fold dilution, (b) 
demonstration of the escape of red blood cells through the cell traps allowing the red 
blood cells to exit the device channel, and (c) the first 2 rows on the platform showing 
trapping of leukocytes.  
 
5.5.2 Stimulation and surface marker based immunophenotyping  
Whole blood was diluted 10-fold with PBS without Ca2+/Mg2+ with 2%  BSA and 2mM 
EDTA, and introduced into the device. Leukocytes were captured in the device, and the 
excess cells were washed with the buffer. The leukocytes were then stimulated with 10 
ng/ml lipopolysaccharides (LPS) for 4 hours. LPS is found on the membrane of gram-
negative bacteria, and elicits a strong immune response in immune cells. In addition, LPS 
endotoxin is common in sepsis condition in patients. After the cell stimulation, the cells 
were stained for CD11b, and CD66b. Neutrophils constitutively express CD66b, and the 
expression of CD11b increases when the neutrophils are activated (211, 212).  
 
Here, the focus was on the response of neutrophil, however the analysis was done on all 
leukocytes trapped in the device. Neutrophils were of interest because they are the most 
abundant leukocytes (30 – 80 % of leukocytes), and are also important in monitoring 
inflammation and infection. Stimulation with LPS and subsequent immunofluorescence 
staining showed differential surface marker expression of CD66b and CD11b (Figure 
5-5). In Figure 5-5 fluorescent images for imaging for both CD66b and CD11b, showing 
the cells stained on chip. 
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Figure 5-5. Fluorescence imaging to characterize surface marker expression levels. 
Stimulated cells were stained for CD66b (a), and CD11b (b) expression levels. (c) 
Merged micrograph image. 
 
The average intensity of each cell were quantified for both CD11b and CD66b (Figure 
5-6), and cells expressing only CD11b or CD66b or both or none were observed.  Figure 
5-6a shows an image of a cell expressing only CD11b (center), and cells expressing both 
CD11b and CD66b but with different intensities. Neutrophils constitutively express 
CD66a-d and elevated levels of CD11b when activated, and monocytes also express 
CD11b (213). However, other granulocytes and lymphocytes are CD11b-CD55b-, and 
they are represented among the CD66blow and CD11blow cells (Figure 5-6). Figure 5-6b 
shows the quantified expression levels of CD11b and CD66b. Leukocytes expressing 
high levels of both CD11b and CD66b (top right quadrant) are likely activated 
neutrophils. The bottom right quadrant show cells that are CD66b high and CD11b low, 
which are likely neutrophils that did not respond to stimulation. The left, bottom quadrant 
would be a mix of all the leukocytes including neutrophils as well. With the addition of 
other specific markers such as CD3 for lymphocytes, CD14 for monocytes, differential 
leukocyte counting can also be performed on the same cells. However, the number of 
markers that can be probed in ultimately limited by the number of spectrally resolved 
fluorophores. Overall, the assay demonstrated the ability to separated leukocytes from 
whole blood, perform stimulation of the leukocytes and analysis of activation markers.  
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Figure 5-6 Surface marker expression of neutrophils after stimulation with LPS. 
Leukocytes separated from whole blood and stimulated with LPS were stained for CD66b 
and CD11b surface marker expression. (a) micrograph for fluorescence imaging in green 
and red channel (merged) for imaging of expression of CD66b and CD11b showing cells 
that express both CD11b and CD66b and a cell expressing CD11b only, and (b) 
Expression levels of CD66b (x-axis) and CD11b (y-axis). The cells were divided into a 
quadrant representing CD66blow and CD11blow, CD66blow and CD11bhigh, CD66bhigh and 
CD11bhigh, and CD66bhigh and CD11blow. Neutrophils constitutively express CD66b and 
CD11b, and higher levels of CD11b when stimulated. (n = 401) 
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The main challenge in operating the platform is the unavoidable settling of blood due to 
the cell differential density. Through time the cells settle in the pipette tip and this can 
result in the clogging on the narrow device channels (30 μm).  In performing long-term 
analysis, the 2-layer PDMS device presented in Chapter 4 can be used. The 2-layer 
platform allows better fluid exchange capabilities, that may be necessary for long-term 
incubation times.  
5.6 Conclusions 
In this chapter we have presented a new application of the high density cell trap array 
device and image-based approaches in separating and analyzing leukocytes from whole 
blood. The approach relies on the differences in mechanical rigidity and size differences 
between red blood cells and leukocytes. Red blood cells are disc-shaped compared to the 
more spherical while blood cells and are very flexible and are therefore able to squeeze 
through very small constriction gaps. We use this characteristics to selectively trap 
leukocytes in the device while allowing red blood cells to exit the device. Therefore, the 
platform can enable absolute and relative enumeration of leukocytes and subtypes given 
high trapping efficiency on-chip, and differential leukocyte counting using surface 
marker expression and differential RNA/DNA expression. In addition, as demonstrated in 
the previous chapters, further analysis of immune response to stimulation can be 
implemented. Ultimately, these microfluidic platforms can be coupled with cheap optical 
imaging technologies (189, 190, 214) to allow for the development of complete packages 
for point-of-care, and point-of-procedure technologies for use in both resource poor 
settings where technological expertise and infrastructure is scarce and in developed 
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settings where the time for patient sample analysis is long due to need to send samples to 




6 TOWARDS A HIGH-THROUGHPUT PLATFORM FOR 
MEASURING ADHESION KINETICS OF MEMBRANE-
ANCHORED RECEPTORS AND LIGANDS 
 
So far, we have focused on determining the intracellular signaling signatures after 
stimulation via receptor-ligand interactions. However, the first step in T cell signaling 
happens at the cell surface requiring the cells to be in contact, and whether these surface 
interactions result in a productive signal may depend on the kinetics of the receptor-
ligand interactions.  Analyzing the first step in the activation involving membrane-bound 
receptors and ligands can help us understand some of the observed differences in T cell 
function. Current platforms developed to measure receptor/ligand interaction kinetics are 
laborious, difficult to implement for non-expert, and low throughput as they only allow a 
single cell to be analyzed at a time. Here we combine some of the intricate features 
developed in microfluidic systems to design a platform that could be used to measure 
interaction kinetics of cell membrane bound receptors and ligands. This assay could also 
be combined with fluorescence-based calcium imaging demonstrated in the previous 
chapters to allow for direct observation of both adhesion events and subsequent calcium 
signaling. 
6.1 Introduction 
6.1.1 Receptor-ligand interaction kinetics 
Receptor-ligand interactions mediate cell adhesion and activation in a wide variety of 
physiological processes including the initiation of T cell activation through the 
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interaction of the TCR on the T cell with the pMHC molecule on the antigen presenting 
cell (APC). Kinetic analysis of receptor-ligand interactions may help better understand 
how the T cell interacts with a number of different pMHC but only mount an 
immunological response to a specific antigen.  These cross-junctional interactions at the 
interface between the TCR and pMHC are two-dimensional (2D) because the molecules 
involved in the interactions are anchored to the membrane surface. This differs from 
interactions of surface receptors with ligands in three-dimensional (3D) fluid phase. 2D 
interactions can be analyzed using the adhesion frequency assay, which has been 
performed using the micropipette adhesion frequency assay (64, 137, 215), biomembrane 
force probe (58), atomic force microscopy (AFM), and laser tweezers (63, 64).  These 
techniques enable kinetic parameters such as affinity, off rate and on-rate to be deduced. 
The differences in the kinetic rates of the immune cells can have functional implications. 
Therefore, these measurements can be insightful in evaluating the immunological 
potential of T cells. However, these current technologies suffer from being generally 
expensive, low throughput, laborious, and have been largely challenging to implement in 
most laboratories. Microfluidic technology enables parallelization of experiments 
allowing ease of acquisition of large quantities of data. In addition, microfluidic systems 
allow the integration of multiple functions on the same chip, which enables further 
downstream analysis to be done simultaneously. Furthermore, automation of the system 
minimizes handling and ultimately human error. 
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6.1.2 Conventional techniques for 2D receptor-ligand kinetics measurements 
6.1.2.1 Flow chamber platform 
Flow-based assays such as the parallel-plate flow chamber allow adhesion events to be 
determined on both a population and single cell level (216-222). Similarly, microfluidic 
systems have been developed for studying interaction events in platelet adhesion under 
flow at varying shear stresses and shear rates (216-218, 223). However, these adhesion 
events are random, and factors such as the contact area that determines bond density, 
duration of contact, collision frequency and densities of the ligands and receptors that 
determine the adhesion probability are variables in the system rather than constants (63, 
64, 221, 224). As a result, the kinetic parameters obtained are a function of the 
aforementioned parameters. In addition, transport may play a significant role in the 
formation and dissociation of bonds which may have an impact on the measured kinetic 
constants (63). Therefore, there is a need to develop new technologies that would be able 
to better measure cell adhesion events at a high throughput.  
6.1.2.2 Micropipette adhesion frequency assay and biomembrane force probe 
The micropipette assay utilizes a human red blood cell (RBC) as picoforce transducer to 
detect adhesion events in the system owing to its low spring constant that makes it an 
excellent candidate for sensing small forces (10-100pN) (63, 64). As shown in Figure 
6-1, the RBC is coated with the ligand of interest via covalent linking as previously 
described (63) and aspirated on a micropipette connected to a piezo-driven 
micromanipulator. On the other side is a target cell bearing the receptor of interest 
(Figure 2). The two cells are brought into repeated contact and separation using the 
micromanipulator at defined contact durations for tens to hundreds of times. Binary 
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adhesion data is obtained; (1) for adhesion observed as the elongation of the red blood 
cell when the cells are separated, and (0) for no adhesion. The dependence of adhesion 
frequency on contact duration enables kinetic rates to be determined from a probabilistic 
model at constant ligand and receptor densities and constant contact area between the 
cells (Equation 1) (64). The probabilistic model is based on the analysis of kinetics for 
small systems which assumes a small number of bonds are formed between the receptor 
and the ligand during the adhesion events(63) and that the adhesion events are infrequent 
and follow a Poisson distribution (64, 225). 
 
Figure 6-1. Micropipette assay setup. A red blood cell (RBC) bearing the ligand (pMHC) 
is aspirated on a micropipette and the cell bearing the interacting receptor (TCR) is 
aspirated on another micropipette. The cells are brought into contact for a defined 
duration using a piezo-driven micromanipulator. If there is bond formation, the RBC 




Where P is the adhesion frequency, mr and ml are receptor and ligand site densities 
respectively determined by flow cytometry, Ac is the contact area obtained from imaging, 
t is the contact time, defined by the user, Ka and koff are the affinity constant and the 
 
P = 1− exp(−mr m l Ac Ka [1− exp(−koff t)])
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dissociation rate respectively. From these parameters the on-rate (kon) can also be 
determined (Ka=kon/koff) (64).  
 
A similar but more sensitive platform, the biomembrane force probe, enables the 
measurement of adhesion events and force (58, 64). In this approach a bead bearing the 
interacting molecules is attached to the red blood cells, and repeated contacts with the 
receptor-bearing cell are made. These assays enable single-cell analysis of the binding 
events, and kinetic rates measurements. However, in the micropipette assay only one cell 
can be interrogated at a time, making this a laborious, low throughput technique. 
Therefore, this assay would not be suitable for screening a large number of heterogeneous 
cells such as polyclonal T cell populations where the frequency of antigenic T cells is 
low. In addition, the complexity in the setup makes it a significant technical barrier in 
being implemented in a non-expert laboratory.   
 
Therefore, there are opportunities to develop new platforms that would build on the 
strengths of the existing platforms and address the low throughput challenges in the 
current systems. Ideally, we want a platform that enable measurement of cell adhesion 
events and perform force-dependent adhesion measurement at a single-cell resolution.  
To address this challenge, we developed microfluidic-based designs that would allow for 
the measurement of adhesion events in multiple cells simultaneously with single –cell 
resolution. To our knowledge there are no existing platforms for measuring adhesion 
frequency between receptor and ligand pairs. 
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The goal of this project was to design and develop a microfluidic-based platform that 
would enable measurement of adhesion frequency of receptor/ligand interactions of 
multiple cells simultaneously. Figure 6-2 summarizes the main aspects of the assay, and 
the key parts. The ligand can be on a surface, or another cell, and the receptor is on the 
cell of interest. These juxtacrine interaction is initiated by bringing the surfaces together 
for a define time and then retracted at which point the occurrence of bond formation is 
detected and recorded (58, 63, 64, 137, 222). This process will be repeated to get enough 
data points to extract kinetic parameters using Equation 6.1. However, the assays 
developed so far can only analyze a single cell pair at a time, thus limiting the number of 
pairs that can be assayed in a single experiment. 
 
 
Figure 6-2. Design concept overview. The figure depicts the design concept for 
developing a platform. A ligand-coated surface or cell and receptor bearing cell needs to 
come into contact for a defined period of time and then adhesion events are detected and 
the process is repeated > 50 times to get adhesion probability. From the adhesion 
probability data kinetic parameters can be computed.  
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6.1.3 Microfluidic platforms 
Through parallelization, automation and integration of multiple functionalities, 
microfluidic systems may help in closing the technological gaps. Parallelization enables 
the same experiment to be conducted in individually addressable compartments 
simultaneously on the same chip, thus increasing the throughput of the experiment. In 
addition, automated microsystems eliminate the labor-intensive normal laboratory 
manipulations and reduce the variability in data due to human error and improve the 
repeatability of the assay (70, 71, 111). Another way of improving the throughout is 
through integration. Integration enables multiple analyses to be conducted on the same 
chip, which also makes the device more compact. We utilize integration of different 
components to develop our system including incorporation of cell trapping geometries 
already discussed in this thesis and elastomeric single-layer (in-plane) microvalves. 
 
Microfluidic platforms developed for cell-cell interactions have focused on measuring the 
intracellular signaling process downstream of the initial surface receptor-ligand 
interactions. Dura et al developed a parallelized device with individual trap for pairing 
antigen presenting cells and T cells and evaluated the Ca2+ dynamics induced by the 
interactions. 
  
6.1.3.1 Single-layer valves 
Elastomers such as PDMS allow for the fabrication of active mechanical components 
such as valves and pumps. PDMS microvalves consists of a very thin membrane that can 
be deflected to partially or completely close microchannels by application of hydraulic or 
 147 
pneumatic force. The use of active valves enables the incorporation of movable part in 
the devices (76, 226-230) that are useful in the development of our platform. Membrane 
valves can either be in plane where both the control and flow channels are in the same 
plane or top-down valves where the flow channel is below the control channel (Figure 
6-3). The single-layer valves have reduced complexity in the fabrication process (226-
228) and we utilize these single-layer microvalves in our microfluidic design.  
 
 
Figure 6-3. PDMS valves. The deformability of the PDMS polymer can be modulated by 
varying the crosslinking ratio used in the polymer curing. Two main types of valves are 
used (a) top-down valves that require a 2-layer PDMS device, the top channel is a control 
layer that is pressurized to deflect the bottom flow channel, and a single-layer (in-plane) 
valve where both the control and flow layer are on the same plane, and the control 
channel is deflected into the flow layer. With both valves the control and flow layer are 
separated by a thin PDMS membrane, and the aspect ratio of this membrane determines 
that maximum deflection that can be achieved. 
 
In microfluidic platforms single layer valves have been utilized immobilization of the 
nematode, C. elegans for imaging (75, 231) by constricting the channels in which the 
worm is loaded thus restricting the motion of the organism. In addition, the single layer 
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valves have been used in flow switching for generating dynamic chemical signals (91) 
and particle sorting (228, 232). In this chapter we present a new application of these 
single layer valves in making timed contacts with receptor-bearing cells todevelop an 
automated, parallelized microfluidic platform that will increase the throughput and ease 




6.2 Design concept 1: Membrane-based platform for repeated cell contact 
To increase the throughput of the number of cell pairs that can be analyzed 
simultaneously, we designed a microfluidic platform that integrates a cell/particle 
trapping module for cell handling and a single-layer control valve module for repeated 
contact of the cells with ligand-bearing surface (Figure 6-4). The cell trapping module 
has microstructures that fit cells or beads of sizes ranging from 10 – 20 μm with each trap 
size accommodating an individual particle as shown in Figure 6-4c. Opposite the cell 
trap module is the control layer than has multiple channels with each channel directly 
opposite each cell trap structure. The control layer has a single inlet for pressurizing the 
device to deflect into the cell trapping module resulting in the membrane wall contacting 
the particles trapped in the cell trap module (Figure 6-4). This membrane wall is coated 
with the ligand of interest prior to the cell/particle loading. With the repeated membrane 




Figure 6-4. Combined single-layer valve control and cell trapping platform. (a) device 
outline showing the cell trapping module (blue) and the control layer (red), the cell 
trapping module has 2 or 3 inlets (1-3) and two outlets (4,5). The control layer has a 
single inlet (6) and no outlet, (b) micrograph of device showing the cell trapping area and 
the membrane channel. Each cell trap has a corresponding membrane channel on the 
opposing side, and (c) illustration of how the device works showing beads loaded in the 
device, membrane actuation to allow the beads to contact the membrane wall bearing the 
ligand, and after membrane retraction where some beads bind and remain stuck to the 
wall of the membrane.  
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The cell trapping module traps are 10 μm wide, and the width of the channel is 30 μm. 
The cell traps are connected a 2 μm that direct the cells/beads for loading, and the 
restricted height ensures that the particles are trapped and do no pass through the traps. 
The overall height of the device is 40 μm (Figure 6-5).  The overall height of the device 




Figure 6-5. Device design layout. (a) top view of device design showing the cell trapping 
module (blue), and the single-layer membrane valve (red), (b) cross-sectional view (Z  
Z’) , (c) cross-sectional view showing the position of the cell in the device, and 
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(membrane actuation that deflects into the cell trapping module channel to contact the 
loaded cell/bead.  
 
6.2.1 Selective surface functionalization using laminar coflow 
The ligand molecules are coated on the membrane wall using biotin-BSA physisorption 
and biotin-streptavidin coupling as depicted in Error! Reference source not found.. In 
coating the device with the ligand to the device, only the membrane wall should bear the 
wall to prevent unwanted interaction of the cell receptor with the ligand. We take 
advantage of the inherent laminar flow (Figure 6-7) in microfluidic channels to 
selectively coat the ligand to one side of the channel by coflowing three different 
solutions in the device. The membrane to contact the cells will be coated with the protein 
of interest on the flow channel side using biotin-streptavidin coupling to immobilize a 




Figure 6-6. Interacting molecules on the device platform.  On the platform the receptor is 
on the cells/beads loaded in the trapping microstructures and the ligands are coated on the 
side of the membrane using biotin-BSA physisorption and biotin-streptavidin coupling, 
and laminar coflow for restricted coating of the ligands to the membrane wall only. 
 
The laminar flow allows adjacent stream flow with mixing only by diffusion, and 
depending on the flowrates the mixing can be negligible (Figure 6-7). Laminar coflow 
(107) was used to introduce solutions of biotinylated bovine serum albumin (BSA) and 
BSA into the device via the three inlets, with the biotinylated bovine serum albumin BSA 
solution on the side of the membrane to be coated and  the subsequent steps are carried 
out by filling the channels with the appropriate solution (Figure 6-8). The formation of 
the laminar flow streams and effective coating of the device channel was visualized using 
fluorescently-labels BSA (BSA-FITC). The BSA molecules physisorb on the device 
channel surface, and the BSA-FITC is visualized during the coating processes and after 
the device channel is rinsed with PBS buffer (Figure 6-8).  
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Figure 6-7. Laminar flow in microfluidic channels enable coflow of multiple streams and 
mixing between adjacent streams is by diffusion. The flow in microfluidic channels is 
laminar, and convective transport between adjacent streams is minimized. In a 3 inlet 
channel device, the relative flow rates introduced will determine the width of the 
individual streams. (a) the streams will have equal widths if the flow rates are the same 
for all inlets, and (b) changing the relative flow rates will alter the widths of the streams, 
thus allowing for patterns of different widths to be made in the device, and these can also 
evolve over time.  
 
The effectiveness of this approach is enabled by the flow characteristics in 
microchannels. Microchannels have very low Reynolds number and lateral mass transfer 
is negligibly small and only through diffusion enabling the flow streams to have distinct 
interfaces (97). In our device the Reynolds number is low (Re ~ 6) and the Peclet number 
is very high (Pe ~ 108), therefore mixing between adjacent streams is essentially 
negligible, thus allowing effective selective coating (97). Laminar flow has been used to 
pattern cells and molecules on PDMS and glass surfaces (107, 233-236). By optimizing 
the operating parameters we ensured that the diffusion timescale (τdiff  ~ 10 s) was much 
less than the residence time (τres ~ 0.01 s) of the protein in the microchannel to minimize 
protein diffusion towards the cell-trapping region. In addition, the flow rate for the stream 
containing the biotinylated BSA was 10 times lower than that with BSA (or BSA-FITC 
for visualization purposes)  to ensure a very thin portion of the channel  (Figure 6-7b) 
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will be coated with the ligand (237). The coating of ligand was optimized to ensure 
homogenous protein surface density by varying the concentration of the ligand, flow rate 
of the ligand and buffer solution and infusion time. 
𝑅𝑅 = 𝜌𝜌𝜌
𝜇
           𝑃𝑅 = 𝜌𝑈
𝐷
           𝜏𝑑𝑑𝑑𝑑 =
𝑈2
𝐷
              𝜏𝑝𝑝𝑟 =
𝜌
𝐴𝑐𝑐
   Equation 6.2 
 
where U is the flow velocity, W is the channel width, L is the width of the flow stream 
containing the biotin-BSA, Acs is the cross-sectional area, D is the diffusion coefficient of 





Figure 6-8. Laminar flow-enabled selective device functionalization with stimulating 
molecules. (a) coflowing of solutions of biotin-BSA and BSA (or BAS-FITC for 
visualization) with the biotin-BSA stream flowing over the membrane wall enables the 
membrane well to be biotinylated to coupling of biotinylated ligands using biotin-
streptavidin coupling. Micrographs for visualizing the fluorescently tagged stream (BSA-
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FITC) to verify the fidelity of the maintenance of the laminar flow stream in the device, 
(b) upstream, and (c) in the center of the device.   
 
6.2.2 Bead and cell loading  
The loading of beads/cells in the device was achieved by passive hydrodynamic flow into 
cell trapping microstructures. The microstructures are similar in design to those 
developed in the cell trap array discussed in Chapter 2 – 5. The beads were loaded in the 
device using pressure-driven flow from a pressurized reservoir. We demonstrate the 
ability to trap both beads and cells in the device (Figure 6-9). The key difference 
between cells and beads is their mechanical properties, beads are more rigid, and cells are 
more flexible. These mechanical properties can affect the loading efficiency. However, 
our platform uses very low flowrates (~ 10 μL/hr), and at this flowrate we can trap either 
cells or beads of different sizes with high efficiency.  
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Figure 6-9. Cell and bead loading in the device.  (a) Device setup during loading, (b) cells 
loaded in the device, and (c) beads loaded in the device.  Cell and bead loading has an 
efficiency > 90 % for single cell/bead loading.  
 
The beads are loaded after the device has been coated with the ligand of interest. To 
ensure that the beads/cells bearing the receptor do not come into premature contact with 
the ligand-coated membrane wall, the bead suspension is flown in through the third inlet 
as depicted in Figure 6-9a while simultaneously flowing buffer through the other inlets. 
Once the cells are loaded then the adhesion frequency measurements can be performed. 
Each trap on the device accommodates a single cell (Figure 6-9b) or bead (Figure 6-9c). 
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A single-cell loading of > 90% was achieved in the platform ensuring more than 40 cells 
were arrayed in parallel for analysis. However, these cells do not fit in one field of view, 
and the current set up allows up to 10 cells to be viewed simultaneously.  
 
6.2.3 Membrane deformation characterization 
The contact between the ligand-coated membrane and receptor-coated bead is enabled by 
the actuation of the membrane using positive pressure to deflect the cell trapping channel 
(Figure 6-4c & Figure 6-5d). The flexibility of PDMS elastomer is flexible can be 
modulated by changing the crosslinking ratio added to the polymer for curing. In addition 
to the stiffness of the PDMS mold, the dimensions of the membrane are critical in 
determining the extent of deflection of the membrane. The pressure required to obtain 
enough deflection such that the membrane comes into contact with the cells was 
determined by varying the pressure applied to the valves using a pressure gauge until the 
membrane was in contact with cell (30-35psi). An optimal pressure was obtained by 
varying the crosslinking ratio of the elastomer (22:1 was used) and also by optimizing the 
thickness of the membrane. The aspect ratio, height-to-thickness of the membrane, will 
impact the extent of deflection. In general, thinner membranes will have a larger 
deflection at a given pressure but they have to be able to withstand the pressure without 
rupturing (226). 
To pressurize the device, the membrane channels were filled with 50 % glycerol in water 
w/w, and pressurized at a defined pressure. We characterized the repeatability of the 
membrane deflection by measuring the deflection against pressure applied to the valve in 
different devices made in different batches (Figure 6-10). As shown in Figure 6-10b, the 
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deflection at a given pressure is fairly reproducible from device to device at the same 
elastomer cross-linking ratio. We further verified that the membrane deflection at 
different channels across the device were the same (Figure 6-10c. It is useful to have a 
uniform deflection across the device to ensure that all the beads loaded come into contact 
with the membrane. However, we note that with cells due to heterogeneity in particle 
different deflections might be required to contact the cells to be different to contact. 
Presorting the cells by size would tighten the size distribution.  Overall, we found that 
using 22:1 PDMS ratio for our device, a pressure input of 30 psi was sufficient for the 
membrane to contact the beads loaded in the device. 
 
Figure 6-10. Membrane deflection characterization.  The membrane channels were filled 
with 50 % glycol w/w and the inlet of the control module was connected to a pressure 
source with a electronically-controlled solenoid valve controlling the opening and closing 
of the valve. (a) micrographs of the device before pressure is applied and at 10, 30, and 
40 psi showing the deflection of the membrane into the cell trapping channel, (b) 
deflection of the membrane as a function of pressure for different devices, (c) deflection 
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at the indicated pressures on different channels along the device, and (d) membrane 
deflection with beads loaded in the device at 25 psi and 35 psi.  
 
However, one major drawback with the design was the difficulty in visualizing the point 
of contact between the bead and the membrane, and this would be more significant when 
using cells. From Figure 6-10d, it is difficult to ascertain whether the membrane was in 
contact with the beads at 25 psi. This is mainly because the maximum point of deflection 
is above the bead position since the channel is twice the diameter of the bead. As a result, 
the membrane can occlude imaging. To determine the precise pressure and deflection at 
which the membrane comes into contact with the, we used fluorescently-labeled beads 
and filled the membrane channels with a fluorescent dye FITC, and visualized the 
position of the beads and the membrane channels during deflection in 3D using confocal 
microscopy (Figure 6-11a). Once the membrane is actuate, one can easily see the point 
of contact between the membrane and the beads is 3D with fluorescence imaging. In our 
analysis, we found that an actuation pressure would ensure that the membrane just 
contacts the beads. However, understanding that there might be device to device 
variation, it will be still challenging in using this approach since the samples we would 
use are not fluorescently labeled and it is impossible to characterize each device used in 
the experiment.  
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Figure 6-11. Visualizing the contact between membrane wall and beads by confocal 
microscopy. To get a clear view of the contact point between the membrane and the bead, 
confocal imaging was performed, the device membrane channels were filled with FITC 
dye, and red fluorescent beads were loaded in the device. (a) Beads loaded, membrane 
valve closed, and (b) membrane valve open, the beads are in contact with the membrane.  
 
6.2.4 Adhesion events detection 
Finally, once the contact is made for a defined amount of time, the adhesion events are 
detected through observation of the particle movement when the membrane is retracted. 
When a bond is formed, the cell/bead becomes attached to the membrane and upon 
retraction, the bead/cell will be dragged along with the membrane. The bead will either 
detach if the drag force against the bead movement is stronger than the bond(s) formed or 




Figure 6-12. Observing adhesion to the ligand-coated membrane wall.  Upon contact with 
the membrane, the receptor-bearing beads can form a bond with the ligand on the 
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membrane, when the membrane is retracted if the bead forms an attachment with the 
membrane it will be dragged out of the trap for a distance and may detach if the drag 
force becomes larger than the bond force.  When the bead detaches it may return to the 
trap or flow along the channel. In the figure the third bead from the left disappeared 
during membrane retraction as a result of being washed away with the flow induced 
during membrane movement.  
 
6.2.5 Measuring streptavidin/biotin interactions 
Having characterized the bead loading and membrane actuation, we demonstrated the 
potential of the platform by measuring the interaction of biotin and streptavidin. The 
device membrane wall was coated with biotin-BSA and then streptavidin-coated beads 
were loaded. The membrane was actuated and retracted 10 times while taking time-lapse 
images to then analyze the adhesion off-line. An adhesion event was defined as when the 
bead was observed to move a distance half the diameter of the bead or when the bead 
remain attached to the membrane after membrane retraction. We measured the adhesion 
events at 2 s and 5 s contact time, and observed an increase in adhesion frequency from 2 
s to 5 s as shown in Figure 6-13. In addition, we analyzed the effect of site density of the 
interacting ligands. At the concentration we analyzed, there was no difference in the 
adhesion probability at 5 s contact time. The reason might be two-fold, saturation of the 
number of interacting molecules and also saturation of the adhesion probability curve at 
long contact times. Previous, adhesion frequency data show that the curve plateaus after 2 
s contact time (64). Overall, this data demonstrates our ability to perform adhesion 
measurements in the platform. In this study, we are able to observe up to 10 cells 
simultaneously, thus allowing faster acquisition of the data. With more improvement to 




Figure 6-13. Adhesion events between biotin and streptavidin interactions. Repeated 
contacts between the biotinylated membrane and streptavidin-coated beads loaded in the 
device, and adhesion events were counted. (a) Contact time dependent adhesion events at 
2s and 5 s contact time, and (b) density dependent adhesion frequency showing no 
change in adhesion frequency at the two concentrations used in the experiments.  
 
6.2.6 Challenges with the setup 
While we have demonstrated the ability to perform adhesion measurements on the 
platform, the platform presented challenges in how to accurately detect when the 
membrane is in contact with the beads. This is a critical factor in the setup since these 
adhesion events measurements are time dependent with measurements taken over a range 
of 0.1 s to 10 s. Therefore, the ability to determine when the membrane contacts the bead 
is crucial in making these timed contacts. In addition, the platform currently was not 
amiable to perform similar measurements in mammalian cells. Unlike beads that are 
rigid, cells are more flexible and susceptible to damage by harsh mechanical forces that 
they might experience upon contact with the moving membrane. One way to address the 
harsh contact by the membrane is by using a voltage-controlled pressure valve to ramp up 
the pressure instead of using the on/off solenoid valves used so far. That way one would 
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be able to control the rate at which the membrane deforms, and effectively the impact 
force the cells may feel upon contact with the membrane.  
 
6.2.7 Using a bead attached to the membrane to make the contact 
To address the issue of the visualization of the contact point and occlusion of the 
cells/beads by the membrane, we devised a new format for the device where beads 
attached to the membrane were used to contact the receptor-bearing beads/cells (Figure 
6-14). These beads were functionalized with the ligand of interest, and streptavidin. The 
device is coated with biotin-BSA as described above using laminar coflow. Streptavidin 
beads are then introduced into the device and loaded in the traps. The membrane is 
actuated to contact the beads for 10 s to ensure that all the beads have an opportunity to 
form multiple interactions with the biotin molecules on the membrane surface (Figure 
6-14a). Finally the membrane is retracted and the beads remain attached to the membrane 
as shown in Figure 6-14a due to the strong biotin-streptavidin interaction (144). With 
this setup, the ligands are coupled to the streptavidin beads via biotin-streptavidin 
coupling (Figure 6-14b), and these ligands can be coated on the beads in the device once 
the beads are attached to the membrane or before the beads are loaded using 
subsaturating concentrations of the ligands to ensure that some of the biotin binding sites 
are available for the beads to attach to the membrane. Finally, we were able to 




Figure 6-14. Setup using membrane-bead actuation. (a) Streptavidin beads are loaded in 
the device after the device membrane wall is coated with biotin-BSA. The membrane is 
then actuation for 10 s to ensure all the beads attach to the membrane via the biotin-
streptavidin interaction, and then the membrane is retracted, and we can see that the 
beads are attached to the membrane. (b) Molecule configuration on the membrane side. 
The streptavidin beads also have streptavidin molecules coupled to biotinylated beads, 
and (c) second set of beads bearing the receptor are loaded into the traps  
 
Once the beads are paired repeated and timed contacts were made to measure probability 
of binding events (Figure 6-15). The contact with the beads offers better precision of the 
contact area that can now be easily visualized on regular microscope setup (Figure 6-15). 
In addition, the site density of both the receptors and ligands can be determined by flow 
cytometry. In the first setup, it is difficult to determine ligand densities. The ligand and 
receptor densities have an effect on the binding probability and are parameters in the 
probability equation used to determine the kinetic parameters (Equation 1). Moreover, the 
smaller pressure input < 10 psi are required to contact the beads, using lower pressures is 
beneficial in minimizing chances of the membrane rupture, and reducing the overall 
deformation of the device.  
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We observed attachment of the biotin beads to streptavidin beads, and the biotin beads 
would remain attached to the streptavidin beads. With this platform we anticipate 
measuring binding events between ligands coated on the bead surface and cells bearing a 
cognate receptor. In line with the goal of this thesis, we are interesting in making binding 
measurements between the T cell receptor and pMHC coated on the streptavidin beads. 
Being able to measure these binding events will close the gap in our ability to measure 
the initial interacting and then couple with the functional response measurements such as 
calcium dynamics, and protein expression shown in the preceding chapters. 
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Figure 6-15. Bead-bead contact enables better visualization of contact area. (a) Pairing of 
streptavidin beads (on the membrane), and biotinylated beads (in the trap), (b – d) 
membrane actuation at increasing pressures shows that the bead pairs come into contact 
at 5 psi.  
 
Compared to the micropipette adhesion frequency assay, this platform will allow parallel 
measurements of individual cells thus increasing the throughput of the assay. The 
increased throughput is important in expanding the breadth of inquiry that can be done in 
immune cells. Often with the micropipette adhesion frequency assays monoclonal T cells 
are used where all the T cells have a common antigenic peptide. However, in the case of 
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studying interaction T cells from a polyclonal population where only a small percentage 
of the cells are antigen specific, the current throughput of the micropipette assay makes it 
impossible to analyze polyclonal populations. Such analysis would require a platform that 
can assay hundreds to tens of thousands of cells in a single run.   
 
Here we show that we have designed the first generation microfluidic-based adhesion 
frequency platform that will allow the measurement of receptor/ligand interaction 
kinetics on the cell surface. More work will need to be done to ensure efficient bead 
attachment to the membrane > 90% to maximize the number of cell pairs that can be 
analyzed simultaneously. Through the trapping of tens of cells parallel measurements of 
cell binding events can be performed simultaneously, and we anticipate the ability to 
scale up the platform to allow for hundreds of cells to be analyzed simultaneously. 
Coupling this platform with automated imaging and data processing will enable high-
throughput receptor-ligand interaction kinetics. Also, by coupling this system with 
fluorescence imaging as has been previously demonstrated (58), Ca2+ dynamics can 
simultaneously captured to correlate the binding events with the Ca2+ data. In our Ca2+ 
measurements we do not know the timing of the bond formation and the subsequent Ca2+ 
signaling, and this setup can give us insights on the timing of these signaling events. In 
addition, with the addition of other control and flow modules, further downstream 
analysis can be performed on the same cells after measuring the binding events.  
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6.3 Design concept 2a: Flow-based adhesion frequency platform 
6.3.1 Device design and setup 
In parallel to the membrane-based adhesion frequency described above, we developed an 
adhesion frequency platform based on flow control, which we term flow-based adhesion 
frequency platform. In the membrane design, we used an actuated PDMS membrane to 
make a contact between ligand-coated surface and a receptor-bearing cell/bead. One 
drawback with this approach is that it is difficult to control the membrane impact force 
that may have an influence on the adhesion measurements. In the flow-based approach, 
pressure controlled fluid flow is using as a driving force.  
 
 
Figure 6-16. Flow-based adhesion frequency platform. The device consists of 2 inlets for 
use in laminar coflow. The device is a single layer PDMS mold, and is molded from a 2-
layer SU8 mold. The main channel is 20 μm and cell traps are 10 μm wide with 2 μm 
restriction channels. The first configuration had cell traps on one side of a channel and 
restriction channels 2 μm tall, and the second configuration has cell traps on both sides of 
the main channel.  
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6.3.2 Working principle of the flow-based device 
The ligands are coated on one side of the channel using laminar coflow, the same 
approach used in the membrane-based platform described above. During the protein 
coating, only outlet 4 is open, outlets 1-3 are closed using a clamp-style pinch valve. 
Once the ligand is coated, in our proof of concept study we used biotin-BSA, with biotin 
being the ligand of interest, streptavidin beads were loaded in the device on the side 
without the ligand (Figure 6-17). Modulating the pressure difference in the device then 
allows the beads to move to the ligand coated surface, and they are in contact with the 
surface for a defined time. The pressure is switched to move the non-interacting beads 
from the ligand surface followed by a larger pressure to move all the beads from the 




Figure 6-17. Fluid flow setup for device operation. (a) device inlets/outlets, (b) beads 
are loaded through inlet 1, while P1 =  1 atm, P2 & P3 are off, and the outlet is at 
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atmospheric pressure, and (c) the beads are moved to the ligand-coated surface by 
pressure-driven flow, P1 = 0.5 psi, P2 and P3 are off.  
 
The challenge is in modulating the pressure differences, and ensuring that the applied 
flow is enough to allow the beads to be move back and forth and well-controlled to 
enable determination of the binding events. The pressure control can be automated, the 
pressure difference is controlled by on/off solenoid valves. We measured the binding 
events for streptavidin beads on biotin-BSA-coated beads at 5 s contact time. The 
measure adhesion probability was lower than expected (< 10 %) likely because the flow 
force was much larger and resulted in bond breakage before the bond formation was 
detected. More characterization of the hydrodynamic force will need to be done to ensure 
all binding events are detected, and account for nonspecific interactions. One of the 
advantages of this approach over the membrane-based approach is the ability to have the 
cell traps densely packed enabling up to 40-50 cells to be analyzed simultaneously, with 
great potential to increase the throughput through arraying of traps to a throughput of 100 
– 300. 
 
6.4 Design Concept 2b: Combined microfluidics and magnetic tweezers 
Implementing fluid flow is challenging since it is dependent on the flow resistance in the 
device which may vary from device to device, and may change if some of the device 
channels become occluded. Moreover, it is difficult to achieve a uniform flow 
distribution along the device channel, thus resulting in differential force application along 
the device channel. An alternative approach that can be explored in the future is to utilize 
magnetic force to drive the bead movement, and use the device with cell traps on both 
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sides of the channel shown in Figure 6-16. Magnetic tweezers have been used in single-
molecule measurements including DNA twisting and stretching (238-244). Magnetic 
tweezers can be easily integrated on conventional microscopes (245) or alternatively 
magnetic electrodes can be integrated on chip.  In addition, magnetic tweezers allow for 
force measurements and force dependent interactions to be analyzed (239, 241, 244, 246-
248). 
 
Figure 6-18. Using magnetic force to drive movement of ligand-coated beads. In the 
proposed setup two electromagnets are setup. Cells or beads are loaded in the device, and 
then magnetic, ligand-coated beads are loaded on the adjacent traps. Ligand-coated beads 
come into contact with the receptor-bearing beads/cells by turning on electromagnetic 1 
for a defined time and then electromagnet 1 is turned off and electromagnetic 2 is turned 
on to break the contact. Adhesion is observed by the ability to observe movement of the 
receptor-bearing bead/cell. 
 
For this setup, two electromagnets are setup on each side of the device as shown in 
Figure 6-18, and alternating turning on of the magnets allows for the movement of the 
magnetic, ligand-coated beads to come into repeated contact and no contact with the 
receptors on the cell surface. The detection of the binding events is based on the observed 
movement of the cell when the ligand beads are moved from the cells. When a bond is 
formed between the ligand and the receptor, moving the bead drags the cell with it, and 
then a small suction is applied at the cell traps to reload the cell in the cell trap. The 
approach would require force measurements of the force exerted by the magnetic 
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tweezers, the suction force for retrapping the cells after each contact cycle to allow 
repeated measurements on each pair. This lays the background on the designs that can be 
developed further for a platform for high-throughput adhesion frequency assay. 
6.5 Conclusions 
Here I have demonstrated a proof of concept for the ability to design and develop a 
microfluidic-based platforms for measuring receptor/ligand interactions on cell 
membranes and surfaces. Surface molecules are critical in initiating signaling 
transduction pathways, and understanding these interaction kinetics can be insightful in 
understanding the mechanisms in these signaling molecules and differentiate between 
normal and diseased state. Current assays for evaluating surface molecule receptor/ligand 
interactions are low throughout and require sophisticated equipment and expertise that 
hampers the dissemination of the assays in more laboratories (63, 64, 137). To my best 
knowledge no platform exists that enables parallel analysis of receptor/ligand interaction 
kinetics at a single-cell resolution. Taking advantage of the ability to integrate multiple 
modules and parallelize measurements, microscale based platforms were developed that 
would enable measurements of cell receptor interactions with a surface-anchored 
molecule were developed.  
 
The first approach integrates the characteristic single-layer valves and cell trapping 
microstructures. The trapping microstructures enable deterministic array of cells or beads 
on the platform and the single-layer valve channels allow for repeated contact between 
receptors and ligands for determination of adhesion frequency. In the future, with better 
control of the valve actuation, force measurements can also performed similar to those 
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performed with the biomembrane force probe with the added advantage of measuring 
multiple cells in parallel. The second platform design integrates cell trapping and 
magnetic bead trapping with off-chip magnets to drive the bead bearing the ligands. I 
envision this platform will be coupled for software for controlling the external magnetic 
tweezers and image acquisition software, and image analysis software for the detection of 
adhesion events. Together these two designs presents a new approach in developing 
simple, high-throughput platforms for receptor/ligand interaction kinetics.  
 
 The increased throughput in the assay will enable measurements beyond kinetic 
parameters including the determination of frequency of interacting cells within a 
population of cells.  In addition to measuring receptor/ligand interactions, this line of 
work can be expanded to include simultaneous or sequential determination of 
intracellular signaling events and functional outcome. With the integration of other 
modules such as the perforated membrane presented in Chapter 3 and 4, more robust 
fluid exchanges can be performed on chip to enable on-chip staining for 
immunofluorescence staining and smFISH for mRNA quantification of the cells after the 
binding events. The next step would be implementation of the platform with mammalian 
cells. So far we have demonstrated the use of the device in measuring binding events in 
beads bearing streptavidin on a biotin surface. Biotin/streptavidin form stronger 
interactions compared to the receptor/ligand interactions in most biological molecules. 
These platforms will be applicable to many different cell types beyond T cells where 








7 CONCLUSIONS AND FUTURE DIRECTIONS  
 
In this thesis, new microfluidic-based tools for single-cell analysis in immune cells have 
been introduced with the goal to bridge the gap in the some of the shortcomings 
encountered in conventional approaches. Evaluating immune cell response specifically in 
T cells requires tools that allow both dynamic signatures such as Ca2+, mitochondrial 
polarization, and actin dynamics and static signatures to be evaluated. Thus far, most 
approaches such as flow cytometry, and western blot have enabled the measurement of 
one specific readout, and enable the analysis of cells in a bulk population that can mask 
cell heterogeneity. As an emerging technology, microfluidic systems can address the gaps 
to advance the type of data that can be obtained.  
 
Utilizing the inherent small size of microfluidic systems, this thesis focused on 
developing tools that would enable robust handling and positioning of single-cells for 
stimulation and subsequent analysis of response on a single-cell levels and over a large 
number of cells for population statistics to be derived.  In chapter 2, the versatile 
application of the high density cell trap array is shown for a simple analysis T cell 
response to both soluble and surface-molecule stimulation. The assay enable rapid 
analysis of Ca2+ signaling as a functional readout for a large number of cells per 
condition. This allows screening of Ca2+ functional response of T cells to different 
antigenic peptides, and also analysis of responsiveness of a T cell population. In chapter 
2, a monoclonal population was used to demonstrate capability, however this assay would 
be critical in evaluating immune response in polyclonal T cell population such as for 
samples obtained from human tissues. The assay has been applied to a number of projects 
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in the lab including a recent publication in evaluating Ca2+ response in cells during the 
early stages of T cell development (249). 
 
In Chapter 3, the development of an integrated high-density cell trap coupled with a 
perforated membrane for dynamic soluble cue generation was introduced. The platform 
enables the cellular microenvironment to be experimentally modulated in a precise 
manner with simultaneous observation of cell response to extracellular space changes. 
This enabled, the modulation of Ca2+ signaling in our studies that would then enable the 
design of studies that aim to evaluate how the intracellular signaling dynamics affect 
gene expression and functional response of immune cells (16, 93, 140). The platform is 
currently being used in independent projects in the laboratory that aim to evaluate the 
effect of oscillatory input signals on the output signal. In addition, the perforated 
membrane design can be coupled to other existing chip designs beyond the cell trap array 
including platforms that have been developed for handling small organisms such as the 
nematode (1). To expand on the utility of the device, further optimization of both the cell 
traps and the pore dimensions will be needed to allow for application with cells of 
different sizes. The pore dimension is useful in ensuring efficient fluid transport and also 
efficient cell loading; smaller and more flexible cells can pass through relatively larger 
pores.  
 
Furthermore, this 2-layer platform has multifaceted applications that are demonstrated in 
Chapter 4 based on the robust fluid exchanges. The device enables multiple assays to be 
performed both simultaneously and sequentially, thus allowing different types of readouts 
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to be obtained. Ca2+ signaling dynamic, protein phosphorylation, mRNA expression and 
cytokine secretion measurements are demonstrated with at least 3 of these different 
molecular readouts being performed on the same sample, thus enabling direct correlations 
to be drawn. We envision, that this microchip will be broadly applicable in enabling 
single-cell analysis to different types of stimulation and functional readouts, and the 
assays are applicable to other cell types. Furthermore, the dimensions of the cell trap 
array can be modified to fit different cell sizes; thus allowing the application of the 
platform in different cell types beyond immune cells. Furthermore, the methodology for 
operating the platform is relatively easy, making it easy to be used in any biology 
laboratory with conventional microscopy setups. In this thesis, the ability to keep the 
cells in the device for up to 24 hours was demonstrated, and this characteristic may be 
used for long-term monitoring of cell signaling dynamics such as NFκB nuclear 
localization dynamics on microscopy setups that have a cell incubation chamber.   
 
In addition to the hardware, further improvements in image and data processing will be 
important in enabling multiparametric analysis. Developing an automated approach that 
allows cell indexing at both low magnification used in calcium imaging and at high 
magnification used in smFISH imaging would eliminate manual cell annotation. 
Moreover, the use of a scanning confocal microscopy for smFISH imaging may provide a 
faster way to acquire data. Also, with a controlled cell incubator chamber on the 
microscopy setups, longer duration live imaging may be performed which ensuring that 
the cells are not under any stress induced by low oxygen or changes in humidity.  
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In addition to performing stimulation and functional analysis on a single-cell level over a 
large number of cells, another area of focus is the preprocessing of samples before 
performing an assay both in conventional assays and microfluidic platforms. Usually, 
separation techniques are employed to separate the cells from a crude sample that can be 
either from spleen, thymus, biopsy tissue or whole blood. In Chapter 5, we introduced 
another new application of the high-density cell trap array in enabling the removal of red 
blood cells and trapping of leukocytes in the device from less than a drop of blood. 
Therefore, the platform can be used for multiple functions; (1) separation of leukocytes, 
(2) stimulation of leukocytes on chip, (3) functional analysis of leukocytes, and (4) 
leukocytes differential counting that can be informative in disease diagnosis and 
monitoring. The relative simplicity in device operation lends the platform to being easily 
disseminated in other labs with little to no expertise in microfluidics. In addition, to use 
in research lab settings, this presents work towards the development of a platform that 
can be used for point-of-care diagnosis and routine monitoring assays that use blood. The 
assay uses 1 μL of blood, therefore only a finger prick would be require. The minimized 
blood sample requirement is especially critical in pediatric patients, and experimental 
animals such as mice. We envision that in the future coupling the microfluidic chip and a 
cheap, simple optical imaging system, a complete package for rapid immunophenotyping 
of specific immune cells from whole blood can be performed with potential for use in 
both research and clinical settings.  
 
Finally, understanding that the immune cells response for T cells is initiated by molecular 
interactions at the cell surface, the ability to probe these interactions can provide insights 
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on how the interactions occur and identify any loss of function that may occur at the 
initial interaction.  Motivated by the ability of microfluidic systems to enable high-
throughput handling of hundreds of cells and the ability to integrate multiple functions, 
we introduced microfluidic system designs that have a potential to be used to evaluating 
the interaction of receptor/ligand interactions on the cell surface. Furthermore, in the 
future the platform can be coupled with additional modules to allow for further functional 
response of cells after the molecular interactions as demonstrated in Chapters 2 – 4.  
 
Overall, this thesis focused on the development of new tools for the analysis of immune 
cells at a single-cell level. With the implementation of microfluidic systems, and imaging 
and analysis software, robust and easy-to-use microfluidics-based systems were 
developed that will have broad applications in single-cell analysis beyond immune T 
cells. Moreover some of the impact of the thesis have already been realized with interest 






A.1. Device Fabrication 
A.1.1. Device design and fabrication process 
Microfluidic devices were fabricated using standard lithography techniques (108, 109). 
The fabrication process involves: (1) the design of the device based on application using 
a computer-aided design software, AutoCAD, (2) master mold fabrication, and (3) replica 
molding in PDMS. From the AutoCAD design, negative masks are printed on a 
transparency at a resolution of 20 000 dpi. For the master mold fabrication, SU8 negative 
photoresist (Microchem, Woburn MA) of varying viscosities were used depending on the 
desired heights, and fabrication is performed in a cleanroom, facility. SU8 was poured on 
a silicon wafer and spun at a specific speed to achieve the desired thickness based on 
manufacture’s protocol (Error! Reference source not found.). For example, to achieve 
a 10 μm thickness, SU8 2010 was poured on the wafer, and the wafer was spun at 3 000 
rpm for 30 s. After spinning the SU8, the wafer is baked on a hot plate following 
instructions manual (Microchem), then the wafer was placed in a mask aligner with the 
mask on top of the wafer, and exposed to 365 nm UV light  through the photomask. The 
exposed portions of the SU8 photoresist crosslink and become resistant to developer. The 
wafer is then baked again to complete the crosslinking process. After baking the wafer is 
developed in propylene glycol monomethyl ether acetate (PGMEA, Doe & Ingalls 
K447200402) for a single-layer master. For multilayer masters, after baking the second 
layer is spun and process repeated until all the layers have been made, and finally the 
master is developed (Figure 8-1). Heights of the structures can be measured with a 
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profilomter. The master molds are then treated with trodecafluoro-1,1,2,2-
tetrahydrooctyl-1-trichlorosilane (United Chemicals Technology) to enable ease of 
release of PDMS during replica molding. 
 
 




A.1.2. PDMS replica molding 
 
Once the master molds are fabricated, device in PDMS mold (Figure 8-2). For a single 
layer PDMS device, PDMS prepolymer is mixed with crosslinker at a ratio of 10:1 (other 
ratios can be used depending on the desired stiffness of the PDMS). The PDMS is poured 
on the wafer, and then baked at 70 degrees to cure PDMS, then peeled off and individual 
devices are cut out and access holes punched. The devices are then cleaned with tap to 
remove any dust, treated with oxygen plasma for 20 s and bonded to a coverslip. 
 
 
Figure 8-2 Device PDMS molding for a single-layer PDMS device. PDMS prepolymer is 
mixed with the curing agent at a ratio of 10:1 w/w prepolymer to crosslinker. The PDMS 
is degassed is a vacuum desiccator, then poured on the silicon master mold. The PDMS is 
baked at 70 degrees Celsius for at least 2 hours. The cured PDMS mold is then peeled off 
the mold, individual devices are cut out, and access holes are punched at the device inlets 
and outlets with a blunt 19-gauge needle. The devices are treated with oxygen plasma and 
bonded to a coverslip. 
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A.2. Calcium Response Analysis 
 
A.2.1. Calcium assay protocol 
A.2.1.1. Materials 
Imaging buffer of choice (may vary depending on cells, but usually used cell culture 
media (RPMI in our case) without phenol red with 10% fetal bovine serum) 
Fluo-3 AM calcium indicator dye (Life Technologies # F-1242) 
PBS 1X pH 7.4 (Life Technologies # AM9625) 
Biotin-BSA (Sigma Aldrich # A8549) 
Streptavidin (Sigma Aldrich # S0677 ) 
Biotinylated pMHC (NIH Tetramer Facility) 
Cell trap devices 
10 ml syringe (VWR # 309604) 
0.45 μm syringe filter (VWR) 
Tygon tubing (McMaster Carr # 8349T11 ) 
24 gauge plastic dispensing luer lock tips (McMaster Carr # 6699A6) 
19 gauge stainless steel tubing (McMaster Carr # 8987K51) 
 
A.2.1.2. Device preparation 
*ensure that all the solutions used are filtered to remove dust and particles that might clog 
the devices. 
1. Fill the syringe with PBS, attach the syringe filter and tubing to syringe, and 
connect the tubing to the device 
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2. Prime the device with PBS to remove bubbles by applying pressure to the syringe 
plunger using your thumb. 
3. Check under the tissue culture microscope to ensure the device channels are free 
of any bubbles. 
4. Allow a puddle of liquid to form at the inlet of the device. Pipette 10 µL of biotin-
BSA (500ug/ml) and place the pipette tip at the inlet. The puddle of liquid at the 
inlet prevents trapping of bubbles when placing the pipette at the inlet. 
5.  Suspend the outlet tubing to a height of ~10cm to allowing the solution in the 
pipette to flow through the device. This gives a flowrate of ~10 µL/hr. Let the 
fluid perfuse through the device for 1hr for the biotin-BSA coating. Check 
regularly to ensure that the solution does not completely drain out of the pipette 
tip, thus introducing bubbles in the device. If bubbles get in the device, prime the 
device with PBS to remove the bubbles.  
6. After 1 hour, wash the device with PBS by placing a pipette filled with PBS at the 
inlet and letting the outlet tubing at a height of ~ 90 cm.  
7. Repeat steps 4-6 to coat the device with streptavidin (0.5 mg/ml).  
8. Repeat steps 4-6 to coat the device with biotinylated pMHC (10 µg/ml) or any of 




Figure 8-3 Device preparation for the Calcium assay. (a) This a simple assay that requires 
the microfluidic chip, tubing with a 19-gauge pin, syringe filter and a syringe, (b & c) the 
syringe is filled with PBS used to prime the device to remove bubbles, (d) can see a 
puddle of fluid at the inlet of the device, (e) insert a pipette tip filled with solutions for 
coating the device at the inlet, and (f) allow the solution to perfuse for a defined time with 
flow driven by gravity. 
 
A.2.1.3. Cell preparation 
1. Resuspend cells in either PBS, HBSS or cell media. Add Fluo-3 dye (500µg/ml) 
to final concentration of 5µg/ml (5µL to 500uL cell suspension). 
2. Incubate at 37 degrees for 30mins 
3. Wash twice with PBS and resuspend cells in imaging buffer at final concentration 
of 106 cells/ml 
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A.2.1.4. Calcium assay 
1. Pipette the cell suspension on a coverslip mounted in the stage insert and view 
under fluorescent microscope. Establish the exposure time and all the camera 
settings for the image acquisition. Imaging is done at 10x. 
2. Mount the device on the stage insert. Ensure the device is primed with either PBS 
or imaging buffer and that there are no bubbles.  
3. Pipette 5-10 μL of cell suspension (5 x 106 cells/ml), and place the pipette tip at 
the cell inlet, mount on the scope.  
4. Start imaging once you see cells start loading.  
5. Acquire images every 3s for 20 minutes 
 
A.2.1.5. Automated image analysis code 
function IntensityAnalysis() 
%%  
% this algorithm is used for the automated segmentation and intensity 
% determination in a time series stack. The code is used for analyzing 
% changes in calcium intensity levels visualized by Fluo3 calcium sensitive 
% dye. The cells are automatically segmented using one of the slices with 
% the highest intensities for better contrast, and the mask is applied to 
% all the stacks. 
clear all;  
close all; 
clc 
%% load image stack  
[FileName,PathName] = uigetfile('*.tif','Select the tif file'); 
Stack = tiffread(FileName); 
NbImages = length(Stack) 
%% image segmentation to identify the individual cells in the image 
prompt = 'enter slice number for segmentation'; 
ImSlice = input(prompt); 
Im = Stack(ImSlice).data; 
ImAdjust = imadjust(Im); 
imshow(ImAdjust), title('ImAjust') 
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[~, bw1] = thresh_tool(ImAdjust); 
figure 
imshow(bw1), title('bw1') 
bw2 = imfill(bw1, 'holes'); 
bw3 = imopen(bw2, ones(5,5));  
figure 
imshow(bw3), title('bw3') 
bw4 = bwareaopen(bw3,20); % remove objects too small to be cells 
bw4_perim = bwperim(bw4); 
overlay1 = imoverlay(ImAdjust, bw4_perim, [.3 1 .3]); 
figure, imshow(bw4), title('bw4'); 
%% opening-closing by reconstruction 
se = strel('disk', 4); 
ImErode = imerode(Im, se); 
Iobr = imreconstruct(ImErode, Im); 
figure, imshow(Iobr, []), title('Iobr') 
Iobrd = imdilate(Iobr, se); 
Iobrcbr = imreconstruct(imcomplement(Iobrd), imcomplement(Iobr)); 
Iobrcbr = imcomplement(Iobrcbr); 
figure, imshow(Iobrcbr, []), title('Iobrcbr') 
%% locate regional maxima 
fgm = imregionalmax(Iobrcbr); 
se2 = strel(ones(3,3)); 
fgm2 = imclose(fgm, se2); 
figure, imshow(fgm, []), title('fgm') 
fgm3 = imerode(fgm2, se2); 
fgm4 = bwareaopen(fgm3, 10); 
%% watershed-based segmentation 
I_c = imcomplement(Im); 
I_mod = imimposemin(I_c, ~bw4 | fgm4); 
L = watershed(I_mod); 
figure, imshow(fgm4, []), title('fgm4') 
overlay2 = imoverlay(fgm4, bw4_perim, [0.3 1 0.3]); 
figure, imshow(overlay2), title('overlay2') 
%% object labeling 
[L2, NUM] = bwlabel(L); 
stats = regionprops(L, 'PixelIdxList'); 
figure, imshow(label2rgb(L,'jet','w')) 
figure, vislabels(L) 
%% meassuring intensity for easch object in all image slices 
CellIntensityC = zeros(length(Stack), NUM); 
CellIntensityCorrBack= zeros(length(Stack), NUM); 
CellIntensityCorr = zeros(length(Stack), NUM); 
% CellIntensitySync = zeros(length(Stack), NUM); 
% CellIntensityInitial = zeros(10, NUM); 
% CellIntensityFinal = zeros(length(Stack), NUM); 
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% CellIntensityInitialAvg = zeros (1,NUM); 
for i=1:NUM % for all the selected objects 
    for j=1:length(Stack) % for all the images  
    CellIntensity(j,i)= mean(Stack(j).data(stats(i).PixelIdxList)); %mean intensity for each 
cell on each image 
    CellIntensityCorr (j,i) = CellIntensity(j,i) - CellIntensity(j,1); % subtract the 
background intensity for every image 
    end 
end 
  
Background = CellIntensity(:,1); 
BackgroundAvg = mean(Background); 
BackgroundStdev = std(Background); 
IntensityThreshold = 3; 
CellIntensityCorr(:,1) = []; % remove the first column that represents background 
CellIntensity(:,1) =[]; 
nCols = size(CellIntensityCorr,2); 
nRows = size(CellIntensityCorr,1); 
CellIntensityC = zeros(nRows,nCols); 
% CellIntensityNorm = zeros(length(Data), nCols); 
  
for i=1:nCols % all columns 
    for j=1:nRows  
        CellIntensityC(j,i) = CellIntensityCorr(j,i); 
        if CellIntensityC(j,i) <= IntensityThreshold% remove values at the time the cell trap 
was unoccupied 
            CellIntensityC (j,i) = NaN; 
        else 
        CellIntensityC (j,i) = CellIntensityC (j,i); 
        end 
        CellIntensitySync{i}time = CellIntensityC(~isnan(CellIntensityC(:,i)),i); % 
synchronize the cells' time zero 
        CellLength = cellfun('length',CellIntensitySync); 
        CellIntensityFinal(1:CellLength(i),i) = CellIntensitySync{i}; 
   end 
end 
  
% CellIntensityFinal = zeros(length(Data), nCols); 
  
%         CellLength = cellfun('length',CellIntensitySync); 
% %         CellIntensityInitial = zeros(10,CellLength); 
nCols = size(CellIntensityFinal,2); 
nRows = size(CellIntensityFinal,1); 
CellIntensityInitial = zeros(10,nCols); 
CellIntensityNorm = zeros(10,nCols); 
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for k = 1:nCols 
    for m = 1:10 
        for n = 1:nRows 
        CellIntensityInitial(m,k) = CellIntensityFinal(m,k); 
        CellIntensityInitialAvg(:,k) = mean(CellIntensityInitial(:,k)); 
        CellIntensityNorm(n,k) = CellIntensityFinal(n,k)/CellIntensityInitialAvg(:,k); 
        %CellIntensityNorm(1:CellLength(k),k) = 
CellIntensityFinal(1:CellLength(k),k)/CellIntensityInitialAvg(:,k); 
    end 
    end 
end 
%% parameter calculation 
% prompt = 'time between frames'; 
% FrameRate = input(prompt); 
% Time = 0:FrameRate:FrameRate*(length(Data)-1); 
% CellIntensityTrunc = zeros(1200, length(CellIntensityNorm)); 
% MaxIntensityNorm = zeros(1, length(CellIntensityNorm)); 
% AreaUnderCurve = zeros(1, length(CellIntensityNorm)); 
for i = 1:size(CellIntensityNorm,2) 
    for j = 1:nRows 
        CellIntensityTrunc(j,i) = CellIntensityNorm(j,i); 
        MaxIntensityNorm(:,i) = max(CellIntensityTrunc(:,i)); 
        AreaUnderCurve(:,i) = trapz(CellIntensityTrunc(:,i)); 
    end 
end 
  
FrameRate = 3; 
% measures mean fluorescence intensity for all objects 
CellIntensityAvg =(mean(CellIntensityTrunc'))';            
CellIntensityStd =(std(CellIntensityTrunc'))'; 
CellIntensitySde =CellIntensityStd/sqrt(nCols-1); 
AveData = [CellIntensityAvg CellIntensityStd CellIntensitySde]; 
  







xlswrite('FileName.xlsx',AveData','AveData');    
  
Time =1:3:3*nRows; 




plot(Time, CellIntensityTrunc, 'b') 







% % Time = 1:1:nRows; 
% figure, 
% hold on 
% plot(Time,CellIntensityTrunc) 
% set(gca,'Fontsize',[16],'Xlim',[0 900]) 
% xlabel('Time (s)'); 






y = 1:1:nCols-1; 








A.2.2. Calcium Assay Supplemental results 
 
Figure 8-4. Heterogeneous calcium response of Jurkat E6.1 on anti-CD3-coated surfaces 
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A.3. Multilayer design fabrication and characterization 




Figure 8-5. Fabrication of the 2-layer PDMS device. The device mold fabrication utilizes 
multilayer lithography and thermal bonding between the PDMS layers. (a) The cell trap 
layer is molded by spinning PDMS prepolymer:crosslinker (10:1) at 1500rpm for 5 
minutes to make a ~10-15 um layer of PDMS such that the features of the posts used to 
make pores in the PDMS are protruding and then partially baked for 15 minutes. This 
layer is then partially baked and then aligned to the partially baked top layer, and then 
fully baked, (b) for the top layer, PDMS (10:1) is poured on the wafer and partially baked 
for 20 -25 minutes, and (c) individual devices from the top layer mold are cut out and 
aligned to the cell trap layer mold. PDMS is poured on the master mold and then baked at 
70 degrees for at least 2 hours, the PDMS is peeled off, access holes are punched and 




Figure 8-6 Microfluidic device components. (a) overall depiction of the device showing 
the top view of the stimulus and device layer which consists of the cell trapping module, 
and (b) an illustration of the different layers of the device module, the cell trap and 
perforated membrane make up one module and the access holes on the membrane 
connect fluid exchange between the stimulus layer and the cell trap layer. 
 
A.3.2. Flow characterization 
 
Figure 8-7 Characterization of the pulse signal showing the periodicity in each row (5 s) 
and the risetime. The period is approximately the same regardless of the position in the 
device and the rise time is on average 150 ms. 
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A.3.3. Additional Calcium Oscillation data 
 
Figure 8-8 Calcium response of cells exposed to 20 s pulses of calcium and 100 s of 




A.4. Muitiplexed single-cell analysis on chip 
A.4.1. Statistical analysis algorithms for correlating different readouts 
Unsupervised clustering using k-means is performed to group cells with similar calcium 




%load calcium data 
[FileName,PathName] = uigetfile('*.xlsx','Select the xlsx file'); 
C = xlsread(FileName,3); 
% number of clusters for analysis defined by user 
N_clusters = 4; 
idx = kmeans(C',4); 
xlswrite('ClustersOVA.xlsx',idx); 
 
To obtain correlations between the calcium data and the mRNA transcript quantification, 
PCA analysis was performed using the area under the calcium curve, maximum calcium 
peak, and the mRNA transcript as variables using the script shown below.  
function CalciumClusters() 
clear all;  
close all; 
clc 
%load file with the parameters for each cell 
% parameters: area under curve, calcium peak, IFNG mRNA count, IL2 mRNA 
% count 
[FileName,PathName] = uigetfile('*.xlsx','Select the xlsx file'); 
data = xlsread(FileName,1); 
%load data for the cluster each cell belongs to determined by k-means 
%clustering 
cluster1=xlsread(FileName,2); 
%perform PCA analysis 
[pc] = pca(data);  
pc=pc'; %principle components 
  
% data plots 
c1 = cluster1(:,1); 
figure 
scatter(pc(1,:),pc(2,:),[],c1,'.');  
title('Ca2+ clusters'); xlabel('PC 1'); ylabel('PC 2') 
 figure 
 scatter(pc(1,:),pc(3,:),[],c1,'.');  
 title('Ca2+ clusters'); xlabel('PC 1'); ylabel('PC 3') 
  figure 
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    scatter(pc(2,:),pc(3,:),[],c1,'.');  
    title('Ca2+ clusters'); xlabel('PC 2'); ylabel('PC 3') 
    figure 
     scatter3(pc(1,:),pc(2,:),pc(3,:),[],c1,'.') 




title('Ca2+ AUC/mRNA Count') 
    xlabel('Ca2+ AUC'); ylabel('IFNG'); zlabel('IL2') 
     figure 
scatter3(data(:,2),data(:,3),data(:,4)) 
title('Ca2+ peak/mRNA Count') 
    xlabel('Ca2+ peak'); ylabel('IFNG'); zlabel('IL2') 
  
% vs mRNA count 
c1 = data(:,3); 
figure 
scatter(pc(1,:),pc(2,:),[],c1,'.');  
title('IFNG'); xlabel('PC 1'); ylabel('PC 2') 
 figure 
 scatter(pc(1,:),pc(3,:),[],c1,'.');  
 title('IFNG'); xlabel('PC 1'); ylabel('PC 3') 
  figure 
    scatter(pc(2,:),pc(3,:),[],c1,'.');  
    title('IFNG'); xlabel('PC 2'); ylabel('PC 3') 
    figure 
     scatter3(pc(1,:),pc(2,:),pc(3,:),[],c1,'.') 
    title('IFNG'); xlabel('PC 1'); ylabel('PC 2'); zlabel('PC3'); 
  
     
     [COEFF,latent,explained] = pcacov(data); 
     %variance contribution for each principle component 
      PC_percentage = explained; 
    %IL2 
     
   c1 = data(:,4); 
figure 
scatter(pc(1,:),pc(2,:),[],c1,'.');  
title('IL2'); xlabel('PC 1'); ylabel('PC 2') 
 figure 
 scatter(pc(1,:),pc(3,:),[],c1,'.');  
 title('IL2'); xlabel('PC 1'); ylabel('PC 3') 
  figure 
    scatter(pc(2,:),pc(3,:),[],c1,'.');  
    title('IL2'); xlabel('PC 2'); ylabel('PC 3') 
    figure 
     scatter3(pc(1,:),pc(2,:),pc(3,:),[],c1,'.') 





    
    
 198 
    figure 
    plot(data(:,1),data(:,3),'.') 
    title('total RNA count'); xlabel('Ca2+ AUC'); ylabel('IFNG count') 
    figure 
    plot(data(:,1),data(:,4),'.') 
    title('total RNA count'); xlabel('Ca2+ AUC'); ylabel('IL2 count') 
    figure 
    plot3(cluster1,data(:,3),data(:,4),'.') 
    title('Ca2+ Peak/mRNA Count'); xlabel('Ca2+ Peak'); ylabel('IFNG 
count'); zlabel('IL2 count') 
    figure 
    scatter3(pc(1,:),pc(2,:),pc(3,:),[],c1,'.') 
    title('Principle Components'); xlabel('PC 1'); ylabel('PC 2'); 
zlabel('PC3'); 
    figure 
    plot3(data(:,1),data(:,3),data(:,4),'.') 
    title('Ca2+ AUC/mRNA Count') 
    xlabel('Ca2+ AUC'); ylabel('IFNG'); zlabel('IL2') 
    figure 
    c1 = data(:,3); 
    scatter3(pc(1,:),pc(2,:),pc(3,:),[],c1,'.') 
     title('PC/IFNG') 
      xlabel('PC 1'); ylabel('PC 2'); zlabel('PC3'); 
    figure 
    c1 = data(:,4); 
    scatter3(pc(1,:),pc(2,:),pc(3,:),[],c1,'.') 
     title('PC/IL2') 
















Figure 8-10. Device setup and operation setup demonstrate ease of use. The platforms 
requires very few simple peripheral supporting systems for operation. (a) The autoclaved 
device is primed with sterile PBS through the fluid layer outlet/inlet using the thumb 
finger pressure to remove bubbles and fill the device with PBS, (b) the device setup 
during protein coating. Protein solutions are introduced through the fluid inlet by gravity-
driven flow, (c) cell loading by gravity-driven flow and simultaneous image acquisitions, 
(d) device configuration during incubation, fixation, hybridization and immunostaining 
steps, and (e) imaging. 
 
A.4.2. mRNA probe sequence design 
Probes for mRNA quantification using smFISH were designed using an online software 
(available at: https://www.biosearchtech.com/stellarisdesigner/) by inputting the mRNA 
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coding sequence of the molecule of interest. The probes were 20-nucleotides long with a 
fluorophore tag. Here we had IL2 and IFNγ mRNA probes tagged with Quasar 670 and 
TAMRA fluorophores respectively. For mRNA quantification, stimulated cells were 
fixed in 4% formaldehyde, and permeabilized in chilled 100 % methanol. The cells were 
then washed in hybridization wash buffer (2X SSC and 10% formamide in nuclease-free 
water). smFISH probes were pooled in hybridization buffer (0.1g/ml dextran sulfate, 10% 
formamide, 200 ug/ml BSA in nuclease-free water) to a final concentration of 200 nM for 
each probe set. Cells were incubated overnight in the probe solution, then washed with 
prewarmed hybridization wash buffer.  
 
IFNγ mRNA sequence (http://www.ncbi.nlm.nih.gov/guide/howto/find-transcript-gene/) 
 1 atagctgcca tcggctgacc tagagaagac acatcagctg atcctttgga ccctctgact 
       61 tgagacagaa gttctgggct tctcctcctg cggcctagct ctgagacaat gaacgctaca 
      121 cactgcatct tggctttgca gctcttcctc atggctgttt ctggctgtta ctgccacggc 
      181 acagtcattg aaagcctaga aagtctgaat aactatttta actcaagtgg catagatgtg 
      241 gaagaaaaga gtctcttctt ggatatctgg aggaactggc aaaaggatgg tgacatgaaa 
      301 atcctgcaga gccagattat ctctttctac ctcagactct ttgaagtctt gaaagacaat 
      361 caggccatca gcaacaacat aagcgtcatt gaatcacacc tgattactac cttcttcagc 
      421 aacagcaagg cgaaaaagga tgcattcatg agtattgcca agtttgaggt caacaaccca 
      481 caggtccagc gccaagcatt caatgagctc atccgagtgg tccaccagct gttgccggaa 
      541 tccagcctca ggaagcggaa aaggagtcgc tgctgattcg gggtggggaa gagattgtcc 
      601 caataagaat aattctgcca gcactatttg aatttttaaa tctaaaccta tttattaata 
      661 tttaaaacta tttatatgga gaatctattt tagatgcatc aaccaaagaa gtatttatag 
      721 taacaactta tatgtgataa gagtgaattc ctattaatat atgtgttatt tataatttct 
      781 gtctcctcaa ctatttctct ttgaccaatt aattattctt tctgactaat tagccaagac 
      841 tgtgattgcg gggttgtatc tgggggtggg ggacagccaa gcggctgact gaactcagat 
      901 tgtagcttgt acctttactt cactgaccaa taagaaacat tcagagctgc agtgaccccg 
      961 ggaggtgctg ctgatgggag gagatgtcta cactccgggc cagcgcttta acagcaggcc 
     1021 agacagcact cgaatgtgtc aggtagtaac aggctgtccc tgaaagaaag cagtgtctca 
     1081 agagacttga cacctggtgc ttccctatac agctgaaaac tgtgactaca cccgaatgac 
     1141 aaataactcg ctcatttata gtttatcact gtctaattgc atatgaataa agtatacctt 










Table 3. IFNγ mRNA probe sequences labeled with TAMRA. 
 









































IL2 mRNA sequence http://www.ncbi.nlm.nih.gov/nuccore/BX519775,%20K02292 
 1 tatcaccctt gctaatcact cctcacagtg acctcaagtc ctgcaggcat gtacagcatg 
       61 cagctcgcat cctgtgtcac attgacactt gtgctccttg tcaacagcgc acccacttca 
      121 agctccactt caagctctac agcggaagca cagcagcagc agcagcagca gcagcagcag 
      181 cagcagcacc tggagcagct gttgatggac ctacaggagc tcctgagcag gatggagaat 
      241 tacaggaacc tgaaactccc caggatgctc accttcaaat tttacttgcc caagcaggcc 
      301 acagaattga aagatcttca gtgcctagaa gatgaacttg gacctctgcg gcatgttctg 
      361 gatttgactc aaagcaaaag ctttcaattg gaagatgctg agaatttcat cagcaatatc 
      421 agagtaactg ttgtaaaact aaagggctct gacaacacat ttgagtgcca attcgatgat 
      481 gagtcagcaa ctgtggtgga ctttctgagg agatggatag ccttctgtca aagcatcatc 
      541 tcaacaagcc ctcaataact atgtacctcc tgcttacaac acataaggct ctctatttat 
      601 ttaaatattt aactttaatt tatttttgga tgtattgttt actatctttt gtaactacta 
      661 gtcttcagat gataaatatg gatctttaaa gattcttttt gtaagcccca agggctcaaa 
      721 aatgttttaa actatttatc tgaaattatt tattatattg aattgttaaa tatcatgtgt 
      781 aggtagactc attaataaaa gtatttagat gattcaaata taaaa 
 
Table 4. IL2 mRNA probe sequences labeled with Quasar 670 fluorophore 
 




























Table 5. IκBα mRNA probe sequences with TAMRA fluorophore 


















































A.4.3. Additional smFISH data 
 
Figure 8-11 Ca2+ dynamics and subsequent mRNA quantification. Jurkat cells were 
stimulated while simultaneously measuring the calcium dynamics and subsequently 
mRNA transcripts were hybridized. On a population average, the higher average calcium 
level measured by the area under the calcium curve corresponded with higher average 





Figure 8-12 IFNγ and IL-2 mRNA expression of OT-1 T cells. OT-1 CD8+ spleenocytes 
were stimulated with either OVA or VSV peptides in the presence of anti-CD28 and anti-
LFA1 for 6 hours. As expected T cells stimulated on OVA surface showed significantly 
higher IFNγ mRNA expression levels compared to those on VSV, nonstimulatory surface 
but the IL-2 mRNA expression was comparable.  
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A.5. Single-layer valve device fabrication in PDMS 
The device master molds are fabricated in SU8 as outlined in Appendix A. For the 
molding of the membrane-based adhesion device, PDMS prepolymer-to-crosslinking 
ratio of 22:1 was used for the device, and a layer of 10:1 ratio PDMS was poured on top 
as a support layer for the device as shown in Figure 8-13.The 22:1 PDMS is more 




Figure 8-13 Membrane-based adhesion device replica molding. (a) Device 2-layer master 
mold, (b) 22:1 PDMS prepolymer-to-crosslinker ratio was poured and partially baked for 
30 minutes then a 10:1 PDMS PDMS prepolymer-to-crosslinker ratio was poured on top 
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